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A variety of diseases, both inherited and acquired, affect muscle tissues in 
humans. The anchoring of muscle fibers to their surrounding environment is critical for 
muscle homeostasis. Muscle fibers attach to their microenvironment through cell-matrix 
adhesion complexes. These anchoring complexes are placed under repeated stress during 
muscle contraction. Genetic mutations in these complexes weaken the attachment 
between muscle fibers and their microenvironment, making fibers more susceptible to 
damage and death. This increased fiber degeneration eventually leads to progressive 
muscle wasting diseases, known as congenital muscular dystrophies. Although clinical 
trials are ongoing, there is presently no way to cure the loss of muscle structure and 
function associated with congenital muscular dystrophies.
CELL-MATRIX ADHESION IN MUSCLE
DEVELOPMENT AND DISEASE
Animal models of human diseases are used to gain insights into mechanisms of
disease pathogenesis and to screen for potential therapeutic compounds. The zebrafish
model system, well-known for its use in developmental biological studies, is rapidly
becoming widely-accepted as a useful model for biomedical research. We utilized 
zebrafish embryos to study the initial morphogenesis of substructures in the muscle 
microenvironment and the initial stable cell-matrix adhesions formed in muscle tissue. As 
the muscle fiber microenvironment is abnormal in congenital muscular dystrophies and 
cell-matrix adhesions are weakened, studies elucidating how strong, stable cell-matrix 
adhesions form in development could be informative in the effort to treat congenital 
muscular dystrophies.
Using this approach, we identified a previously undescribed cell-matrix adhesion 
pathway required for normal organization of an important substructure in the muscle 
tissue microenvironment. We show that activation of this cell-matrix adhesion pathway in 
dystrophic zebrafish not only significantly reduces muscle degeneration, but also 
improves swimming ability. The results presented in this dissertation identify proteins 
that function in this cell-matrix adhesion pathway and use dystrophic zebrafish to show 
the benefits and limitations of this pathway in treating symptoms of congenital muscular 
dystrophies. Our findings suggest that activation of this pathway has the potential to 
ameliorate loss of muscle structure and function in multiple muscular dystrophies.
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CHAPTER 1 
THE TRANSLATIONAL SCIENCE IMPLICATIONS OF DEVELOPMENTAL 
BIOLOGY
1.1. Perspective
Research in the basic sciences (e.g. physics, chemistry, biology) attempts to better 
understand the phenomena occurring in our natural world. In addition to being 
intrinsically interesting, findings from basic sciences research can be applicable to 
translational scientific efforts to improve the human condition. This dissertation provides 
an example of how findings from developmental biology can begin to be translated into 
novel potential treatments for human diseases.
Development encompasses an organism’s journey from an egg cell to its adult 
form. A process so complex, yet so vitally important to life, must be exquisitely 
orchestrated and tightly regulated both spatially and temporally. Developmental 
biologists study how biological processes are regulated over developmental time by 
chemical and mechanical signals to give rise to the proper size, shape, organization and 
function of a new life form. Developmental biology is both inherently interdisciplinary 
and fractal in nature. Mechanisms of development bridge scientific fields and occur 
simultaneously across different size scales, ranging from molecular level biochemical 
reactions to cell biological tissue interactions to whole organism level fitness and 
survival. Thus, findings from developmental biology have great potential to apply to and 
inform a broad range of scientific disciplines.
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This dissertation will provide examples of two ways in which developmental 
biological findings can be used to guide translational science research. First, one aim of 
developmental biological studies is to elucidate what genes are necessary and/or 
sufficient for certain developmental processes to occur normally. Chapter 2 details a 
study in which a novel pathway involved in cell-matrix adhesion, the ‘Nrk2b pathway,’ 
was elucidated and components in this pathway are shown to be necessary and/or 
sufficient for development of the myotendinous junction basement membrane in 
zebrafish. Findings such as these not only lead to a better understanding of the 
mechanisms underlying development, but as developmental processes are often disrupted 
in disease, these data provide insights into mechanisms of disease pathogenesis and genes 
that could potentially serve as therapeutic targets.
Second, developmental biologists aim to elucidate ‘intrinsic compensatory 
mechanisms’ through challenging embryos and characterizing the innate adaptations that 
occur in response to developmental perturbations. As cell adhesion contributes to 
virtually every developmental process and must be robust, disruptions in cell adhesion 
invoke many innate adaptations, such as changes in the expression or functionality of 
other cell adhesion components or complexes. Activation of these intrinsic compensatory 
mechanisms in disease models is yet another developmental biological approach that can 
be employed to potentially provide protection against disease progression and new 
treatment options to pursue. Chapter 3 describes a study in which activation of the Nrk2b 
pathway was tested as an intrinsic compensatory mechanism and potential therapy in
multiple cell-matrix adhesion-deficient zebrafish models of muscle disease.
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A valuable lesson learned over the course of my graduate research experience is 
the translational science implications of developmental biological findings. Without 
building off of developmental biology research, manipulation of the Nrk2b pathway may 
not have emerged at the present time as a potential therapeutic avenue for treatment of 
muscle diseases. Therefore, as is usually the case, the synergy of findings across 
scientific disciplines will best inform and guide translational science and optimize the 
benefits to people in need.
1.2. Introduction
The overall aim of my graduate research project was to investigate how proteins 
involved in cell adhesion to the extracellular matrix contribute to the development of 
muscle tissue in zebrafish embryos. Because developmental biology findings have the 
potential to apply to human health and diseases, an additional aim of my research became 
to investigate manipulation of certain cell-extracellular matrix adhesion molecules as 
novel, potential therapies using zebrafish models of congenital muscle diseases.
1.2.1. The Extracellular Matrix Microenvironment in Development and Disease 
In multicellular organisms, in addition to the vital functions carried out by cells 
themselves, important processes occur in the region between cells, an area containing 
what is known as the extracellular matrix. The extracellular microenvironment consists of 
proteins and other molecules that are secreted by cells. Extracellular matrices form 
specific 3D structures with differing relative molecular compositions and therefore 
physical characteristics and functions. These structures external to cells provide scaffolds
on which cells can migrate or stably adhere. However, the extracellular matrix is more
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than just a static scaffold for cell adhesion and migration. Extracellular matrices with 
certain physical properties can regulate the availability of molecules involved in cell 
signaling. Extracellular matrix proteins themselves can also act as signaling molecules, 
relaying instructive or permissive cues to cells and modulating processes such as 
development, morphogenesis, homeostasis and aging (reviewed in 1-6). Cells, in turn, 
affect their extracellular microenvironment and can remodel the physical attributes (e.g. 
molecular composition, density, rigidity) of their surrounding extracellular matrix. This 
bi-directional co-regulation between cells and the extracellular microenvironment is 
referred to as dynamic reciprocity (7).
One example of dynamic reciprocity in development and homeostasis is 
illustrated through the interactions that occur between cells and a specialized extracellular 
matrix substructure called the basement membrane. Basement membranes are layered, 
sheet-like structures densely packed with concentrated extracellular matrix proteins, 
primarily Laminin and Collagen type IV. Basement membranes surround some individual 
cell types and sit below all epithelia, separating epithelia from their underlying 
mesenchymal tissues. Basement membranes act to anchor cells within tissues and serve 
as a mechanical barrier between tissue types. Additionally, adhesion between cells and 
extracellular matrix ligands in the basement membrane result in bi-directional signaling 
that is essential for cell survival and proliferation as well as the proper form and 
functioning of all epithelia.
In skeletal muscle tissue, basement membranes both surround individual muscle
fibers and concentrate to form the basement membrane at the myotendinous junction
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(which is the site of force transmission from muscle to the skeletal system). During 
human skeletal muscle development, basement membranes first assemble at 
myotendinous junctions and then form around individual muscle fibers; the Laminin 
isoform composition of these basement membranes also continually changes over 
developmental time (8). Throughout the developmental remodeling of skeletal muscle 
basement membranes and the ‘life’ of a muscle cell, adhesion to the basement membrane 
must be maintained. These adhesions and the dynamic reciprocity that occurs through 
these adhesions are vital for the survival of muscle cells and thus the ability of skeletal 
muscle to perform its function of voluntarily contracting and relaxing to move the 
skeletal system.
Given the importance of maintained adhesion to the basement membrane for 
muscle cell survival and proper muscle tissue function, it is not surprising that disruptions 
in this adhesion cause muscle diseases. Basement membrane abnormalities are one way 
in which this adhesion and dynamic reciprocity can be perturbed in muscle tissue. 
Consequently, basement membrane defects are known to be associated with some human 
early-onset muscle diseases, such as Fukuyama congenital muscular dystrophy, Merosin- 
deficient congenital muscular dystrophy and Walker-Warburg syndrome (9-13). Despite the 
critical need for adhesion to the basement membrane in muscle tissue, as well as in other 
tissues, relatively little is known about how muscle tissue basement membranes develop 
normally in vivo. In Chapter 2, a novel cell-matrix adhesion pathway operating during 
zebrafish skeletal muscle development is shown to be required for normal in vivo 
development of the basement membrane at the myotendinous junction.
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As described in Section 1.1, the genes discovered to be required for in vivo 
basement membrane development could potentially serve as therapeutic targets to 
strengthen or better repair basement membranes in muscle diseases where basement 
membranes are compromised. Basement membrane augmentation has been shown to be 
protective in zebrafish or mouse models of Laminin alpha2-, Laminin beta2-, Integrin 
alpha7- and Dystrophin-deficient muscle diseases (14-24). Despite these exciting advances, 
these previous gene therapy-based methods of basement membrane augmentation have 
not been translated into human muscle disease therapies. In Chapter 3, an alternate, 
chemical-based approach to basement membrane augmentation is explored in zebrafish 
models of human muscle diseases.
1.2.2. Cell-Matrix Adhesion Complexes in Dynamic Reciprocity, Basement 
Membrane Assembly and Disease
Dynamic reciprocity is the bi-directional signaling between cells and their
extracellular matrix. In order for cells to communicate with their extracellular matrix and
vice versa, groups of proteins are assembled into functional units called cell-matrix
adhesion complexes. These complexes span from extracellular matrix ligands through the
plasma membrane to the intracellular actin cytoskeleton. Thus, these adhesions form a
mechanical link between the cytoskeleton of cells and the extracellular matrix which can
bi-directionally transduce signals that result in biochemical reactions. The protein
composition of these adhesions can differ depending on the specific extracellular matrix
ligand(s) to which they bind and different protein compositions lead to adhesions with
differing functions. The proteins associated with an adhesion can change over
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developmental time or in response to stimuli, thus creating adhesions with functions that 
are dynamic and capable of being modulated. Very little is known about how assembly, 
disassembly or regulation of the protein composition of these adhesion complexes affects 
their function in vivo. Findings presented in Chapter 2 begin to tease apart cell-matrix 
adhesion complex regulation by showing that the localization of a ubiquitously-expressed 
cell-matrix adhesion protein can be regulated in a cell-autonomous and tissue-specific 
manner.
For adhesion between muscle cells and the basement membrane ligand Laminin, 
two varieties of cell-matrix adhesion complexes are utilized. The Dystrophin- 
glycoprotein complex links the basement membrane to the actin cytoskeleton through the 
extracellular, Laminin-binding protein alpha-Dystroglycan, plasma membrane-spanning 
proteins (beta-Dystroglycan, the Sarcoglycans and Sarcospan), and intracellular proteins 
(the Syntrophins and F-actin-binding Dystrophin). The other Laminin-binding receptor 
complexes, Integrin heterodimers, consist of one alpha and one beta Integrin subunit, 
which span the plasma membrane and bind Laminin extracellularly and numerous 
adaptor proteins intracellularly. These Integrin-associated adaptor proteins, namely 
Paxillin, Focal Adhesion Kinase, Src, Vinculin and Talin, can bind one another and some 
bind F-actin.
Given that the Dystrophin-glycoprotein complex and Integrins mediate dynamic 
reciprocity between cells and basement membranes, it is logical that proteins in these 
receptor complexes would play roles in basement membrane formation in vivo. While 
Laminin and Collagen type IV can self-assemble into meshworks in vitro (25,26),
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interactions between these proteins and other extracellular matrix molecules as well as 
cell-matrix adhesion receptor proteins add layers of complexity and regulation to in vivo 
basement membrane assembly (reviewed in 27). Dystroglycan and Integrin betal are 
known to be required for normal basement membrane formation in mouse embryos or 
embryoid bodies (28-32). In mouse embryoid bodies, the basement membrane assembly 
roles of Dystroglycan and Integrin betal were shown to be unique: Dystroglycan is 
required for initial adhesion between cells and Laminin and Integrin betal is required for 
assembly of higher order Laminin structures (33). It is likely that other proteins involved 
in cell adhesion to Laminin also contribute to the regulation of basement membrane 
assembly in vivo. Elucidating unknown roles for other cell adhesion proteins in this 
poorly understood developmental process (as is done in Chapter 2) will enhance our 
understanding of in vivo basement membrane formation.
Disruption (e.g. genetic mutation) to any of the components of cell-matrix 
adhesion complexes can affect intracellular signaling downstream of these adhesions as 
well as the physical characteristics of the extracellular microenvironment and contribute 
to the onset or progression of a disease. Mutations that affect Laminin, transmembrane 
receptors for Laminin or some intracellular proteins involved in adhesion to Laminin are 
known to cause muscle diseases in humans (reviewed in 34). In vivo studies utilizing 
animal models of human muscle diseases have suggested that an intrinsic compensatory 
mechanism (see Section 1.1) exists between the Dystrophin-glycoprotein complex and 
Integrins, such that when one is disrupted the expression or functionality of the other is 
increased.
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Multiple lines of evidence lend support to the idea of compensation between the 
Dystrophin-glycoprotein complex and Integrins in adhesion to Laminin. First, in cultured 
mouse myoblasts, Integrin alpha7 and alpha-Dystroglycan were shown to bind distinct 
regions in the G-domain of Laminin (35) and disruption of both Laminin receptors in mice 
results in more severe muscle disease than disruption of either complex alone (36,37). 
Together, these findings suggest that these two receptor complexes cooperate in Laminin 
adhesion. Second, expression of components in the uncompromised Laminin receptor 
complex are frequently upregulated in mouse models of muscle disease (38-41) and 
overexpression of components of the uncompromised receptor complex can reduce 
disease severity (42-46). These findings not only describe an intrinsic compensatory 
mechanism involved in adhesion to Laminin, but also begin to test the use of these innate 
adaptations as disease therapies. Identification of additional intrinsic compensatory 
mechanisms that occur in response to developmental disruptions or alternate approaches 
to activate previously characterized innate adaptations will provide new therapeutic 
avenues and potential therapeutic molecules to investigate. The discovery of a novel, 
Integrin-based cell adhesion pathway involved in zebrafish muscle development (see 
Chapter 2) inspired a study to explore components in this pathway as activators of the 
intrinsic compensatory mechanism between the Dystrophin-glycoprotein complex and 
Integrins in zebrafish muscle disease models where muscle cell-Laminin adhesion is 
compromised (see Chapter 3).
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1.2.3. Zebrafish Muscle: A Paradigm to Study Cell-Matrix Adhesion during Muscle 
Development and Disease
Given the complexity of the contributions of cell-matrix adhesion to muscle 
development and diseases, there is a need for simple model organisms in which cell- 
matrix adhesion can be studied and manipulated. Mutations in or ‘pseudo-genetic’ 
manipulation of the same cell-matrix adhesion component genes that cause the human 
muscle diseases described in Section 1.2.2 result in similar muscle diseases in animal 
model organisms, such as mice (reviewed in 47) and zebrafish (reviewed in 48-51). Despite 
being more evolutionarily distant from humans than mice, there are numerous advantages 
to using zebrafish (Danio rerio) as a model organism. Due to the overlap between 
developmental biology and translational science described in Section 1.1, the same 
advantages that make zebrafish embryos attractive for developmental biological studies 
(i.e. genetic and embryological tractability) also make zebrafish an advantageous model 
for biomedical research (reviewed in 51).
The common embryonic origin, conserved genetic regulatory networks of muscle 
development and abundance of skeletal muscle tissue make zebrafish embryos a well- 
suited system in which to study muscle form and function. Most skeletal muscle in 
vertebrates, including zebrafish, mice and humans, is derived from conserved, transient 
embryonic structures called somites. Somites are comprised of sclerotome, myotome and 
dermatome cell lineages, which give rise to vertebrae, skeletal muscle and dermis, 
respectively. Zebrafish somites consist of these three cell types, but contain a smaller 
proportion of sclerotome cells and a greater proportion of myotome cells compared to
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mouse or human somites (reviewed in 52,53). Muscle tissue structures with analogous 
functions in fish, mice and humans also add to the power of using zebrafish to study 
skeletal muscle development and disease. Basement membranes and myotendinous 
junctions serve analogous functions across vertebrates (54-56) and cell-matrix adhesion 
proteins and their functions are conserved from invertebrates to vertebrates (57). As in 
human skeletal muscle development, zebrafish muscle tissue basement membranes first 
form at myotendinous junctions (21,58-60) and then assemble around individual muscle 
fibers (55) and the expression of laminin chains changes over developmental time (61). 
Zebrafish muscle tissue architecture is simplified and more homogeneous compared to 
humans, however, conserved transcriptional regulators (reviewed in 62,63), muscle tissue 
structures and cell adhesion proteins allow findings from zebrafish muscle research to 
have great potential to apply to human muscle development and disease.
Zebrafish muscle disease models not only recapitulate symptoms of human 
muscle diseases, but have also led to novel insights into muscle disease pathogenesis that 
would have been difficult or impossible to achieve using other model organisms. 
Common skeletal muscle disease phenotypes in mammals (including muscle 
degeneration, fibrosis, inflammation, muscle regeneration, fiber size variation and fibers 
with centralized nuclei) all occur in zebrafish muscle disease, with the exception of fibers 
with centralized nuclei (64). The ability to watch muscle degeneration in zebrafish 
embryos identified, for the first time, the myotendinous junction as the site of adhesion 
failure in dystrophin mutants (65). While the myotendinous junction as a site of muscle 
disease pathology has not been confirmed in human patients because muscle biopsies are
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taken at a distance from the tendon to avoid damaging it, MRI studies have shown that 
muscle damage can be more severe near the myotendinous junction (66,67).
Therapeutic insights into muscle diseases also come from the ability to conduct 
rapid and thorough chemical-genetic screens using zebrafish. Kawahara et al. used sapje 
mutant zebrafish and a library of chemicals approved for human use to identify novel 
therapeutics for Dystrophin-deficient muscle diseases. They found a compound affecting 
cAMP-dependent PKA signaling to be the most effective therapeutic in the Prestwick 
chemical library (68). This finding not only implicates PKA signaling pathway 
components as potential drug targets for the treatment of Dystrophin-deficient muscle 
diseases, but is also of interest to developmental biologists as it suggests the operation of 
PKA-dependent mechanisms in muscle tissue development and homeostasis. Taken all 
together, the published findings discussed above show that zebrafish muscle development 
and the resulting muscle tissue structure is similar to that in humans, thus making 
zebrafish an ideal model organism in which to investigate cell-matrix adhesion in skeletal 
muscle development and disease.
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CHAPTER 2
NRK2B AND NAD+ REGULATE CELL ADHESION AND ARE REQUIRED FOR
MUSCLE MORPHOGENESIS IN VIVO
2.1. Chapter Abstract
Cell-matrix adhesion complexes (CMACs) play fundamental roles during 
morphogenesis. Given the ubiquitous nature of CMACs and their roles in many cellular 
processes, one question is how specificity of CMAC function is modulated. The clearly 
defined cell behaviors that generate segmentally reiterated axial skeletal muscle during 
zebrafish development comprise an ideal system with which to investigate CMAC 
function during morphogenesis. We find that Nicotinamide riboside kinase 2b (Nrk2b) 
cell autonomously modulates the molecular composition of CMACs in vivo. Nrk2b is 
required for normal Laminin polymerization at the myotendinous junction (MTJ). In 
Nrk2b-deficient embryos, at MTJ loci where Laminin is not properly polymerized, 
muscle fibers elongate into adjacent myotomes and are abnormally long. In cultured 
mouse myoblasts, MIBP/Nrk2 binds the cytoplasmic tail of Integrin betal and in yeast 
and human cells, an alternate function of Nrk2 is phosphorylation of Nicotinamide 
Riboside to generate NAD+ through a salvage pathway (69-72). We find exogenous NAD+ 
treatment rescues MTJ development in Nrk2b-deficient embryos, but not in laminin 
mutant embryos. Both Nrk2b and Laminin are required for localization of Paxillin, but 
not beta-Dystroglycan, to CMACs at the MTJ. Overexpression of Paxillin in Nrk2b- 
deficient embryos is sufficient to rescue MTJ integrity. Taken together, these data show 
that Nrk2b plays a specific role in modulating subcellular localization of discrete CMAC
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components that in turn play roles in musculoskeletal development. Furthermore, these 
data suggest that NAD+ regulates Laminin assembly/polymerization and Paxillin 
subcellular localization during MTJ development. These results indicate a previously 
unrecognized complexity to CMAC assembly in vivo and also elucidate a novel role for 
NAD+ during morphogenesis.
2.2. Introduction
One fundamental question in developmental biology is how tissue architecture is 
generated and maintained. Both cell-cell adhesion and cell-matrix adhesion are critical 
for organogenesis. However, despite the spatial and temporal regulation of cell adhesion 
in nearly all morphogenetic events, the dynamic modulation of cell adhesion during 
morphogenesis is not well understood. Zebrafish axial skeletal muscle, because of its 
reiterated nature and simple structure, is an ideal model system with which to analyze cell 
adhesion complex assembly and specificity of cell adhesion dynamics during different 
cellular behaviors.
Cell-matrix adhesion mechanically links cells to the extracellular matrix (ECM) 
through transmembrane receptors (e.g. Integrins). In vitro, these adhesion sites have 
different names depending on their size and composition (73). A recent review proposed 
use of the umbrella term Cell-Matrix Adhesion Complexes (CMACs, pronounced 
seeMACs) to refer to all cell-matrix adhesion structures (74). CMACs are dynamic 
structures that are alternately formed and disassembled during cell migration. CMAC 
assembly involves Integrin clustering and the recruitment and phosphorylation of 
numerous cytoplasmic proteins that link to the cytoskeleton. Two well known
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cytoplasmic proteins that modulate dynamic adhesion are Focal Adhesion Kinase (FAK) 
and Paxillin. FAK is a non-receptor tyrosine kinase that is phosphorylated upon adhesion 
to the ECM (75). FAK is over expressed in many types of cancerous cells (76) and is 
thought to promote cell motility by facilitating CMAC turnover (77). Counter intuitively, 
FAK also plays a role in stabilizing adhesion: FAK is required for costamerogenesis in 
muscle cells (78) and FAK concentration increases subsequent to muscle loading (79). 
Similarly, the scaffolding protein Paxillin can also promote both CMAC assembly and 
disassembly. Paxillin is one of the first proteins recruited to nascent CMACs and is 
hypothesized to play a role in mediating the molecular composition of assembling 
CMACs (80). However, Paxillin is also required for adhesion turnover: cells without 
Paxillin exhibit stabilized adhesions (81). Many in vitro studies have looked at the order in 
which intracellular proteins are recruited to CMACs. The uniting conclusion from these 
studies is that the order of recruitment is context dependent. Even less is known about 
CMAC dynamics in vivo. Given the complexity of CMACs in vitro, along with the fact 
that the same proteins can promote different cellular behaviors, it is likely that a complex 
combinatorial code of the post-translational modifications and interactions of CMAC 
proteins mediates cell behavior in vivo.
One important question is how an adhesion code mediates interaction of cells with
their ECM microenvironment. The bidirectional signaling that occurs between cells and
their ECM through CMACs is called “dynamic reciprocity” (7). Signaling from the ECM
modifies intracellular signaling, gene expression and cell morphology. Signals from
within the cell modify the molecular composition and structure of the ECM. The
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basement membrane is one specialized compartment of the ECM and is required for 
muscle development and physiology. Basement membranes surround individual muscle 
fibers and concentrate at the myotendinous junction (MTJ). Adhesion to Laminin in 
basement membranes is required for normal muscle development in both zebrafish and 
mice (reviewed in 48,5U2,83). Multiple human myopathies result from disruption of muscle 
to basement membrane adhesion (82,83). Despite the critical importance of adhesion 
between muscle and the basement membrane, the mechanisms that mediate initial 
attachment and assembly/polymerization of the basement membrane are not known.
Given the ubiquitous and dynamic nature of cell adhesion, one fundamental 
question is how cell adhesion modulates multiple cell behaviors. Muscle Integrin Binding 
Protein (MIBP) is a novel, muscle-specific protein that binds to the Laminin receptor 
Integrin alpha7beta1 (69). MIBP is a splice variant of Nicotinamide riboside kinase 2 
(Nrk2), which has also been designated Integrin beta1 Binding Protein 3 (ITGB1BP3). 
Human Nrk1 and Nrk2 phosphorylate Nicotinamide Riboside to generate Nicotinamide 
Adenine Dinucleotide (70-72). Several lines of evidence suggest that Nrk2 plays a critical 
role in muscle development and physiology: (1) overexpression of mibp disrupts myotube 
formation in vitro (84), (2) itgb1bp3 is the second most upregulated muscle transcript in 
myostatin - / -  cows (85), and (3) nrk2 is the most highly upregulated tissue-restricted 
transcript in alveolar soft-part sarcoma (86). Taken together, these data suggest that Nrk2 
is a critical regulator of muscle growth and development. Thus, we asked whether Nrk2 is 
required for animal development in general and zebrafish muscle development 
specifically.
16
There are at least two zebrafish orthologs of Nrk2. We focused on Nrk2b (a.k.a. 
MIBP2) because it is expressed during muscle development. We used morpholino- 
mediated knockdown to ask whether Nrk2b is required for muscle development in vivo. 
Embryos injected with morpholinos targeted to nrk2b resemble laminin mutants, 
suggesting that Nrk2b functions in adhesion to Laminin in vivo. In support of this, 
injecting laminin mutants with nrk2b morpholinos resulted in a laminin mutant 
phenotype and not a more developmentally disrupted phenotype. This epistasis analysis 
suggests that Nrk2b functions in the Laminin pathway. Although a basement membrane 
at the MTJ does form in nrk2b morphants, it is significantly less organized than in control 
embryos. Genetic mosaic analysis suggests that Nrk2b is non-cell autonomously required 
for proper basement membrane polymerization. However, Nrk2b is cell autonomously 
sufficient for localization of Paxillin to CMACs at the MTJ. To our knowledge, this is the 
first identification of a vertebrate protein that cell autonomously mediates the molecular 
complexity of CMACs in vivo. Human and yeast Nrk proteins function in an alternative 
salvage pathway to generate NAD+ (70,71,87-89). Exogenous NAD+ rescues discontinuous 
MTJs in nrk2b morphants but not in laminin mutants. These data suggest that NAD+ 
functions upstream of Laminin adhesion/signaling during zebrafish muscle 
morphogenesis. Taken together, these data show that this understudied protein and NAD+ 
are novel cell adhesion regulators that impart specificity to the assembly of cell adhesion 
complexes.
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2.3. Materials and Methods
2.3.1. Zebrafish Husbandry/Mutant/Transgenic Lines
Adult zebrafish were kept at 28.5 °C on a 16 hour light/8 hour dark cycle. 
Zebrafish embryos were collected from natural spawnings of these adult fish. Embryos 
were staged according to (90). Gup/laminin beta1tg210 and sly/laminin gamma1ti263A 
mutants were a generous gift from the Tuebingen stock center. A transgenic line 
expressing GFP fused to the C-terminus of Paxillin was generated by cloning full length 
Paxillin from 24 hours post fertilization (hpf) zebrafish cDNA, cloning the PCR product 
into the pDONR221 plasmid (Invitrogen) and then cloning, along with p5E-bactin2 
(ubiquitous beta-actin promoter, a 5' entry clone vector from the Tol2Kit 91) and p3E- 
EGFPpA (EGFP for C-terminal fusions, plus SV40 late polyA, a 3' entry clone vector 
from the Tol2Kit 91), into a pDestTol2pA plasmid (a destination vector from the Tol2Kit 
91) via a recombination reaction. Linearized pCS2-TP plasmid (kindly provided by Koichi 
Kawakami) was used as a template to generate capped mRNA encoding Tol2 transposase 
by in vitro transcription using SP6 polymerase (Message Machine, Ambion). Plasmids 
were co-injected with mRNA encoding Tol2 transposase into embryos at the single cell 
stage. GFP expressing zebrafish from the F0 generation were grown up and then spawned 
to detect for germ line incorporation of the transgene. The F1 generation, offspring of the 
F0 generation with germ line incorporation of the transgene, stably over expressing 
Paxillin was used for experimentation.
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2.3.2. Morpholino Injections
MOs were obtained from Gene Tools, LLC. The nucleotide sequence of the 
nrk2bm1 MO is 5'-GAACTTCATCCTCGACGTGATTTT G-3' and the sequence of the 
nrk2bm2 MO is 5'-CGTCAAAGTAGAGAAAAATTGG CTA-3'. The sequence of the 
standard control MO is 5'-CCTCTTACCTCAGTTACAATTTATA-3'. All MOs were 
diluted in sterile water to a stock concentration of 6 mM. The nrk2b MO cocktail was 12 
ng nrk2bm1 plus 6 ng nrk2bm2. 12 ng of the standard control MO was injected. 
dystroglycan MO was injected according to (92). Thep53 MO sequence is 5'- 
CCCTTGCGAACTTACATCAAATTCT-3'. Equal amounts of nrk2b MOs and thep53 
MO were combined and co-injected. MOs were injected with a MPPI-2 Pressure Injector 
from ASI. Embryos were injected in the yolk at the 1-cell stage. The laminin MOs used 
have been previously described and recapitulate the mutant phenotype (93).
Suppression of GFP fluorescence when the target sequence is co-injected with 
MOs: full length nrk2b was amplified using cDNA from 24 hpf zebrafish. The PCR 
product was cloned using the Tol2Kit and injected as above, with or without nrk2b MOs.
2.3.3. NAD+ Treatment
Beta-NAD (Sigma) was dissolved in Embryo Rearing Medium to a stock 
concentration of 15 mM. The treatments used were 100 ^M and 1 mM NAD+ (94). 
Embryos were treated from shield stage through live imaging/fixation.
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2.3.4. Antibody Staining/Immunohistochemistry
All Abs were diluted in block (5% w/v Bovine Serum Albumin (BSA) in 
Phosphate Buffered Saline (PBS) with 0.1% Tween20). Alexa Fluor 488 phalloidin 
(Molecular Probes) staining involved fixing embryos in 4% Paraformaldehyde (PFA) for 
4h at room temperature (RT), washing 5 times for 5 min each (5 x 5) in 0.1% PBS- 
Tween, permeabilizing for 1.5h in 2% PBS-Triton, washing 5x5 and then incubating in 
phalloidin (1:20) for 1-4 h at RT. Ab staining followed phalloidin staining or started with 
blocking for 1 h at RT, incubating in 1° Ab overnight at 4 °C, washing for 2-8 h at RT, 
incubating in 2° Ab overnight at 4 °C, then washing for 1 h. 1° Abs: anti-beta-Catenin 
1:500 (Sigma); anti-beta-Dystroglycan 1:50 (Novocastra); anti-Laminin-111 1:50 
(Sigma); anti-Paxillin 1:50 (BD Biosciences); anti-pan-FAK-c-20 1:50 (Santa Cruz 
Biotechnology); anti-pY-397-FAK, anti-pY-861-FAK 1:50 (Biosource). 2° Abs: GAM/ 
GAR 488, 546, 633 1:200 (Invitrogen).
2.3.5. Whole Mount In Situ Hybridization
Dechorionated embryos were fixed and washed as above, treated with Proteinase 
K (Fisher) for 1 to 15 min and then fixed (20 min) and washed 5x5. Embryos were 
incubated in prehybridization solution (50% Formamide, 5x sodium chloride-sodium 
citrate buffer, 50 p,g/mL Heparin, 500 ^g/mL Yeast tRNA, 0.1% Tween20, pH of 6.0 with 
citric acid) for 4 h at 65 °C, and then hybridized overnight at 65 °C with a digoxygenin- 
labeled probe. Embryos were washed using serial dilutions into and out of 2X SSC, then
incubated in anti-digoxygenin Ab (Roche) for 2 h at RT, washed and then developed in a
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0.45% NBT/0.35% BCIP (Roche) in PBS-Tween solution until the desired color was 
obtained. Controls and morphants hybridized with the same probe were developed for the 
same amount of time. The developing process was stopped by fixing or rinsing 4 times in 
sterile water.
2.3.6. Westerns
Protein was prepared from 24h post fertilization zebrafish embryos using 
previously described methods (95). Protein was resolved on a 10% SDS-PAGE gel, 
transferred to PVDF membrane, blocked in 5% dry milk, incubated in 1° Ab (anti- 
Paxillin 1:1000, BD Biosciences) at 4 °C overnight, washed, incubated in 2° Ab, washed, 
detected with Supersignal West Dura (Pierce) and developed on a CCD LAS 4000 Fuji 
camera.
2.3.7. Genetic Mosaics
Embryos were injected with MOs as described above and 10,000 MW fluorescent 
(wavelength 546 or 633) dextrans (Molecular Probes). Transplants were performed as 
described in (96).
2.3.8. Comparative qRT-PCR
RNA was isolated from whole embryos at 24 hpf via Qiagen's RNeasy Mini Kit.
One-step comparative qRT-PCR was conducted with Quanta kit reagents and Rox
reference dye. A Mx400 machine was used and the annealing temperature was 60 °C.
Approximately 50 ng of RNA template was used per reaction. We used beta-actin as our
normalizing transcript. See Table 2.1 for a complete list of primer information.
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Table 2.1. Primer Sequences, Product Sizes and Concentrations.
Primer Sequence Product size Final conc.
beta-actin forward 5’-TCGTGACCTGACAGACTACCTGAT-3’ 84 base pairs 250 nM
beta-actin reverse 5’-CGGACAATTTCTCCTTCGGCTGTG-3’
lamininalphal
forward
5’-TGCTGGAGCTCATCAACAAC-3’ 220 base pairs 150 nM
lamininalphal
reverse
5’-TTTTCCAGCACAGACACTGC-3’
lamininbetal
forward
5’-GCAGCTCAAAAAGGATCTGG-3’ 160 base pairs 150 nM
lamininbetal
reverse
5’-AAGTTTCTCGCTGGCCTGTA-3’
laminingammal
forward
5’-GGTTGCAAACCATGTGACTG-3’ 231 base pairs 150 nM
laminingammal
reverse
5’-CAAATTCTGCAGGTCAAGCA-3’
paxillin forward 5’-CAGCAACACCCAACGATATG-3’ 184 base pairs 75 nM
paxillin reverse 5’-TGATGAGACAGGGACAGCAG-3’
The qRT-PCR results shown are the averages of the three biological replicates for
each primer and RNA treatment (each biological replicate being an average of three 
technical replicates) and the error is standard error of the mean. See Table 2.2 for qRT- 
PCR results.
Table 2.2. Quantitative Real-Time PCR Results.
Primer RNA Treatment Average AAct S.E.M. AAct Range
laminin alphal nrk2b MO injected 2.65 0.18 2.43-3.01
laminin betal nrk2b MO injected 1.53 0.21 1.21-1.94
laminin gammal nrk2b MO injected 1.37 0.11 1.17-1.55
paxillin nrk2b MO injected 1.26 0.09 1.16-1.44
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2.3.9. Imaging
All images were obtained on a Zeiss Axio Imager Z1 microscope with a Zeiss 
ApoTome attachment. Embryos were deyolked in PBS, side mounted in 80% glycerol/ 
20% PBS and viewed with the 10x, 20x or 40x objective. For images where fluorescence 
levels were to be compared, exposure times were kept constant throughout the imaging of 
that experiment. Images were optimized by averaging up to 5 frames.
For ISH images, embryos older than 16 somites were deyolked and side mounted 
as above. Younger embryos were whole mounted by clearing their yolks in MeOH for 15 
min followed by 1:2 Benzyl Alcohol:Benzyl Benzoate for 15 min, then dorsally orienting 
them in Permount. Image modifications in Adobe Photoshop were one round of linear 
adjustments, Gaussian filtering (0.3 pixel) and unsharp mask (50%, 1 pixel) prior to being 
collated in Adobe Illustrator.
2.3.10. Measuring Myotome Boundary Angles
Zeiss Inside 4D software was used to calculate the angle of the chevron shaped 
myotome boundary from brightfield images. The angle degrees were averaged within in a 
treatment and then graphed and statistically analyzed for significance.
2.3.11. Normalized Fluorescence Intensity
Images were imported into ImageJ (freely available online) and the profiles were 
plotted. The resulting data were imported into Excel for normalization. For each panel, in
order to control for varied exposure times, the maximum intensity of phalloidin was
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determined and the values were all normalized to this intensity. Thus, what is shown is a 
“percentage of maximum intensity.”
2.3.12. The 2D Wavelet Transform Modulus Maxima Method
The 2D WTMM method is a multifractal image analysis formalism that has been 
adapted to perform a structural, multi-scale anisotropic analysis of image features having 
a complex geometry (97,98). At a given scale a, the WTMM are defined by the positions 
where the Wavelet Transform Modulus is locally maximum in the direction A of the 
gradient vector. These WTMM lie on connected chains called maxima chains. Vectors 
along the maxima chains corresponding to positions where the image gradient is locally 
maximal on the maxima chain are the WTMM maxima, or WTMMM. Their angle 
indicates locally the direction where the signal has the sharpest variation.
At all size scales a, the probability density functions (pdfs), Pa(A), of the angles, 
A, are associated to each WTMM vector. A flat pdf indicates random directions of 
sharpest intensity variation (i.e. isotropy). The anisotropy factor has been defined in such 
a way that a theoretically isotropic surface will have a value of Fa = 0, while any value 
greater than 0 quantifies a departure from isotropy.
2.4. Results
2.4.1. Characterization of nrk2b Expression and Morpholinos Targeting nrk2b
nrk2b is expressed in muscle tissue at 26 hpf (99). We found that nrk2b expression
is initiated in the paraxial mesoderm at tailbud stage (data not shown) and persists
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through at least 35 hpf (Fig. 2.1 panels A-A6). In order to determine the function of 
Nrk2b in muscle development, we designed two non-overlapping, translation-blocking 
MOs targeting nrk2b (Fig. 2.1 panel B). Injection of 12 ng of control MO did not elicit a 
phenotype (Fig. 2.1 panels C-C1). Injection of either 24 ng MO1 or 12 ng MO2 disrupted 
muscle development: myotomes were U-shaped and thinner in the anterior-posterior 
dimension than in controls (Fig 2.1 panels D-E1). Injection of half the functional amount 
of MO1 or MO2 did not disrupt muscle development (Fig. 2.1 panels F-G1). Co-injection 
of 12 ng MO1 + 6 ng MO2 elicited the same phenotype as embryos injected with higher 
levels of single MOs (compare Fig. 2.1 panels H-H1 to D-E1). This synergy suggests that 
these MOs disrupt translation of the same gene product (100). The MO cocktail of 12 ng 
MO1 + 6 ng MO2 was injected in all the ensuing experiments.
A nrk2b:gfp fusion construct containing the MO target sequences was generated 
using the Tol2Kit (91) to test the effectiveness of the nrk2b MO cocktail in blocking 
translation of Nrk2b protein. This fusion construct was injected with and without the 
nrk2b MO cocktail. nrk2b MOs dramatically decreased translation of the Nrk2b:GFP 
fusion protein in all embryos observed (Fig. 2.1 panels K-K1, 3 experiments, 1 
representative experiment: 93% of nrk2b:gfp injected embryos expressed GFP (n=171 
out of 184 embryos) whereas only 5% of nrk2b:gfp + nrk2b MO-injected embryos 
expressed any GFP (n=1 out of 20 embryos, nrk2b MOs knocked down Nrk2b:GFP 
protein for at least 26 h, data not shown). These data indicate that two separate, non­
overlapping nrk2b MOs synergize and are sufficient to disrupt Nrk2b translation.
Because injection of MOs can activate the p53 pathway and cause non-specific effects
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(101), we co-injected the nrk2b MO cocktail 1:1 withp53 MO (101). Co-injection ofp53 
MO rescued necrosis in the head, but not U-shaped myotomes and shorter body axes 
(Fig. 2.1 panels N-N3). Myotome boundary angles in nrk2b morphants are significantly 
wider than controls (Fig. 2.1 panel J, Student t-test, p<0.001). Myotome boundary angles 
in nrk2b:p53 double morphants are also significantly wider than controls (Fig. 2.1 panel 
J, Student t-test, p<0.001) and are not significantly different than boundary angles in 
nrk2b morphants (Fig. 2.1 panel J). Thus, co-injection ofp53 MO does not rescue the 
paraxial mesoderm phenotype of nrk2b morphants.
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Fig. 2.1. nrk2b Expression and MO Characterization. (A-A6) ISH with nrk2b probe. (A- 
A3) Dorsal mount, anterior top. (A4-A6) Side mount, anterior left, dorsal top. Black 
arrowheads denote nrk2b expression. (B) Cartoon of nrk2b and MO target sites. (C-H1) 
Side mount, anterior left, dorsal top, 26 hpf embryos, lettered panels are DIC images, 
numbered panels are phalloidin stained to visualize actin. (C, C1) Injection of a standard 
control MO did not elicit a phenotype. Myotomes are V-shaped (white arrows) and 
muscle fibers are normal (white arrowheads). Injection of the functional dose of MO1 
(D, D1) or MO2 (E, E1) resulted in U-shaped myotomes (red arrows) and wavy muscle 
fibers (red arrowheads). Injection of half the functional dose of MO1 (F, F1) or MO2 (G, 
G1) did not disrupt muscle development. (H, H1) Injection of both low doses of 
MO1+MO2 recapitulated the phenotype. (I) Dose response graph. Injection of low doses 
of MO1 + MO2 resulted in more embryos with the phenotype than injection of either low 
dose alone (n of embryos injected is listed on the x-axis). (J) Average myotome boundary 
angles of 26 hpf control, laminin gammal mutants, nrk2b morphant, and nrk2b + p53 
MO-injected embryos. laminin gammal mutants, nrk2b morphants, and nrk2b + p53 
morphants have myotome boundaries o f a similar angle and all have myotome boundary 
angles that are significantly wider than controls, p < 0.001 (n of MTJs measured is listed 
on the x-axis). (K-K1) Brightfield images of shield stage embryos. Animal pole to the 
top. (K) Embryo injected with the nrk2b:gfp plasmid that contains both MO target sites. 
(K1) Embryo injected with the nrk2b:gfp plasmid and nrk2b MOs. Note that expression 
of GFP-tagged Nrk2b is drastically decreased by injection of nrk2b MOs (3 experiments, 
1 representative experiment: 93% of nrk2b:gfp injected embryos expressed GFP (n = 171 
out of 184 embryos) whereas only 5% of nrk2b:gfp + nrk2b MO-injected embryos 
expressed any GFP (n = 1 out of 20 embryos)). (L-N) Brightfield images of a dish of 26 
hpf embryos. (L-L1) Control MO-injected embryos. (M-M1) nrk2b morphants. (N-N1) 
nrk2b + p53 morphants. (L1-N1) Side mount, anterior left, dorsal top, 26 hpf embryos, 
DIC imaging. Higher magnification images of one representative embryo from each of 
the corresponding dishes. Note that the control morphant (L1) has a longer body axis 
than both nrk2b morphants (M1) and nrk2b + p53 double morphants (N1). (L2-N3) Side 
mount, anterior left, dorsal top, 26 hpf embryos, phalloidin staining to visualize actin. 
Higher magnification views of embryos from the corresponding dishes. In panels 
numbered 3, myotome boundaries were pseudocolored fuchsia and the myotome 
boundary angle is given with the corresponding boundary. Note that while injection of 
p53 MO did rescue the cell death seen in the head of nrk2b morphants, it did not rescue 
the shorter body axis (compare M1 to N1) or the U-shaped myotomes (compare M3 to 
N3). Scale bars are 50 ^m, ***p < 0.001.
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Nrk2 was identified in a yeast two-hybrid screen for proteins that interact with the 
Laminin receptor Integrin alpha7beta1. It was subsequently shown that ectopic Nrk2 
expression in C2C12 myoblasts disrupts adhesion to Laminin, but not the ECM protein 
Fibronectin (69). The fact that the phenotype of the paraxial mesoderm in nrk2b 
morphants resembles that of laminin betal and gammal mutants (93), in that myotome 
boundary angles in laminin mutants and nrk2b morphants are not significantly different 
(Student t-test, p = 0.3) and both are significantly wider compared to controls (Fig. 2.1 
panel J, Student t-test, p<0.001), suggests that Nrk2 is involved in adhesion to Laminin in 
vivo as well as in vitro. These data, however, do not clarify whether Nrk2b also functions 
in other pathways operating during development. We thus conducted pseudo-genetic 
epistasis analysis. If the function(s) of Nrk2b is/are solely in adhesion to Laminin, then 
knock down of Nrk2b and Laminin in the same embryo will result in a laminin mutant 
phenotype. If Nrk2b additionally functions outside of Laminin adhesion, then knock 
down of Nrk2b in laminin mutants will result in a more severe phenotype, such as when 
Hedgehog signaling is inhibited in laminin mutants (102). Injection of nrk2b MOs into 
laminin mutants phenocopied laminin mutants (Fig. 2.2 panels A-D). This result suggests 
that Nrk2b participates in the Laminin signaling pathway during early development.
The preceding data provide evidence that nrk2b MOs are specific. First, two MOs
targeting nrk2b generate a similar phenotype, suggesting that they disrupt translation of
nrk2b. Second, the phenotype is recapitulated by co-injection of sub-functional doses of
both MOs. Third, nrk2b MOs block translation of a Nrk2b:GFP fusion protein containing
the target sequences for the MOs. Fourth, co-injection ofp53 MO with the nrk2b MO
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cocktail rescues the cell death seen in the head of nrk2b morphants, but does not rescue 
the disrupted muscle phenotype. Fifth, injection of nrk2b MOs into wild-type or laminin 
mutants phenocopies the laminin mutant phenotype. Taken together, these results suggest 
that nrk2b MOs disrupt translation of Nrk2b protein and do not cause significant “off- 
target” effects (100).
2.4.2. MTJs are Disrupted in nrk2b Morphants
MTJ development is disrupted by 48 hpf in laminin beta1 and gamma1 mutants 
(103). Given the above data suggesting that Nrk2b participates in Laminin signaling/ 
adhesion, we asked whether MTJ development is also disrupted in nrk2b morphants. 
Phalloidin staining, to visualize filamentous-actin, showed organized elongated muscle 
fibers in 48 hpf controls (Fig. 2.2 panel E). The MTJ is the dark region devoid of actin 
staining (pseudocolored purple in Fig. 2.2 panel E1). In contrast, about one third (71/212, 
33%) of MTJs in every 48 hpf nrk2b morphant contained foci where MTJs were 
disrupted and muscle fibers were abnormally long (pseudocolored yellow in Fig. 2.2 
panels F-F1). Approximately the same proportion of MTJs (19/67, 28%) were disrupted 
in all 96 hpf nrk2b morphants (Fig. 2.2 panel H). Similar proportions of disrupted MTJs 
in 48 and 96 hpf nrk2b morphants indicates that there is no age-dependent degeneration 
of the MTJ. This phenotype of disrupted MTJs is also observed in nrk2b:p53 double 
morphants (data not shown). These data show that Nrk2b is required for normal muscle 
development and raise the question of why nrk2b morphant MTJs are discontinuous.
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In teleosts, MTJs are derived from initial epithelial somite boundaries. Therefore, 
we asked if discontinuous MTJs at 48 hpf are a direct consequence of discontinuous 
initial somite boundary formation. Although somites are misshapen in nrk2b morphants, 
segmentally reiterated boundaries form (Fig. 2.2 panels I, K) and the expression of somite 
patterning genes appears normal (Fig. 2.2 panels J-J4, L-L4). Similar to laminin beta1 
and gamma1 mutants (103), initial somites are narrower in the anterior-posterior 
dimension (Fig. 2.2 panels N-N1). These abnormally shaped but continuous somite 
boundaries are clearly visible when phalloidin staining is used to outline cells (Fig. 2.2 
panels N-N1). In controls at 26 hpf, MTJs are clearly V-shaped and actin is slightly 
enriched at the terminal ends of muscle fibers attached to MTJs, (Fig. 2.2 panel O, white 
arrow). In contrast, actin is strikingly enriched at the terminal ends of muscle fibers at the 
MTJ and depleted within myotubes in 26 hpf laminin mutants (Fig. 2.2 panel P). Similar 
actin distribution is observed in both nrk2b morphants and nrk2b MO-injected laminin 
mutants (Fig. 2.2 panels Q-R). These differences in actin distribution are clear when 
normalized fluorescence intensity in the anterior-posterior dimension is graphed (Fig. 2.2 
panels O-R). Note that the peaks and valleys of fluorescence intensity in controls (Fig.
2.2 panel O) are less extreme than those in the other panels (Fig. 2.2 panels P-R). These 
data suggest that adhesion to Laminin may be required for normal cellular distribution of 
F-actin. In addition, this higher resolution analysis of nrk2b morphant-laminin mutants 
indicates that injection of nrk2b MOs into laminin mutants does slightly affect the 
laminin mutant phenotype. Boundaries are more U-shaped than laminin mutants injected 
with control MO (compare Fig. 2.2 panels P and R). Both laminin beta1 and laminin
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gamma1 are maternally expressed (93), and we have found that injection of laminin MOs 
into laminin mutants worsens the laminin mutant phenotype, resulting in early embryonic 
lethality (data not shown). We hypothesize that injection of nrk2b MOs into laminin 
mutants disrupts adhesion to maternally provided laminin and thus results in a slightly 
worse phenotype, as opposed to the alternate explanation of Laminin-independent 
functions for Nrk2b. Taken together, these data indicate that discontinuous MTJs at 48 
hpf in nrk2b morphants are not due to discontinuous somite boundary formation earlier in 
development. In addition, these data further show that the nrk2b morphant phenotype 
resembles that of laminin mutants, supporting the hypothesis that Nrk2b functions in 
Laminin-mediated adhesion/signaling.
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Fig. 2.2. Disrupted MTJs in nrk2b Morphants are Not Due to Discontinuous Initial 
Somite Boundaries. (A-D) Brightfield images of a dish of 26 hpf embryos. (A) Wild- 
types. (B) sly/laminin gammal mutants. (C) nrk2b morphants. (D) nrk2b MO-injected- 
laminin gammal mutants. Note that injection of nrk2b MOs into laminin mutants does 
not drastically worsen their phenotype or result in death. (E-H) Side mount, anterior left, 
dorsal top, phalloidin stained embryos, MTJ boundaries are pseudocolored fuchsia and 
abnormally long muscle fibers are pseudocolored yellow. (E-E1) 48 hpf control. (F-F1) 
48 hpf nrk2b morphant (71/212, 33% of MTJs are crossed by muscle fibers). (G) 96 hpf 
control. (H) 96 hpf nrk2b morphant (19/67, 28% of MTJs are crossed by muscle fibers). 
(I, K) Dorsal mount, anterior top, 16 S, brightfield images. Note that somite boundaries 
form (white arrows) in nrk2b morphants (K). (Panels J and L) Dorsal mount, anterior 
top, 10-12 S, ISH for known somite patterning and somite boundary formation genes. 
Note that the domains and patterns of expression are similar between controls (panel J) 
and nrk2b morphants (panel L). (M-N) Side mount, anterior left, dorsal top, 16 S, 
phalloidin staining. Note concentrated actin at the initial somite boundary (white arrows). 
These data show that discontinuous MTJs are not due to discontinuous initial somite 
boundaries. (O-R) Side view, anterior left, dorsal top, 26 hpf embryos, phalloidin stained 
to visualize actin. (O-P) Control MO-injected. (Q-R) nrk2b MO-injected. (O, Q) Wild- 
types. (P, R) sly/laminin gammal mutants. Note that in laminin mutants and nrk2b 
morphants, actin is enriched at the MTJ (white arrows) and lacking in the myotome. 
Green boxes correspond to normalized fluorescence intensity (see Section 2.3.11) plots. 
These graphs support the qualitative actin disruption seen in laminin mutants and nrk2b 
morphants. Scale bars are 50 p,m.
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2.4.3. Exogenous NAD+ Rescues MTJ Deterioration in nrk2b Morphants
Yeast and human Nrk2 phosphorylate Nicotinamide Riboside to generate NAD+ 
through an alternative salvage pathway (71). We hypothesized that addition of exogenous 
NAD+ would rescue the nrk2b morphant phenotype. We incubated control and nrk2b 
MO-injected embryos in 100 ^M or 1 mM exogenous NAD+ beginning at shield stage. 
Addition of NAD+ to control MO-injected embryos did not affect muscle development 
(Fig. 2.3 panels A-A2). Body axes are again shorter, somites are U-shaped, and MTJs are 
discontinuous in nrk2b morphants (Fig. 2.3 panels B-B2). Exogenous NAD+ rescued the 
nrk2b morphant paraxial mesoderm phenotype. Morphants incubated in 100 ^M or 1 mM 
NAD+ had longer body axes and greatly decreased boundary angles that were 
significantly different from angles in nrk2b morphants (Fig. 2.3 panels C-C2, D-D2, 
p<0.001 for both concentrations). Approximately 7% of MTJs were discontinuous in 
morphants treated with 100 ^M NAD+ (Fig. 2.3 panel C2). Discontinuous MTJs in NAD 
+-treated nrk2b morphants with normal boundary angles indicate that MTJ disruption is 
not a non-specific side effect of wider MTJs. Although myotome boundary angles were 
not significantly different in nrk2b morphants grown in 100 ^M and 1 mM NAD+, there 
was a difference in MTJ integrity. Far fewer MTJs were discontinuous in morphants 
treated with 1 mM NAD+ than treated with 100 ^M NAD+ (Fig. 2.3 panel F). Thus, there 
is a dose dependent rescue of MTJ integrity when nrk2b morphants are supplemented 
with NAD+. Treatment of laminin morphants with exogenous NAD+ did not rescue 
wider myotome boundary angles or MTJ crossings (Fig. 2.3 panels E, F, H-H3, I-I3).
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Taken together, these data suggest NAD+ is functionally upstream of Laminin adhesion/ 
signaling.
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Fig. 2.3. Exogenous NAD+ Treatment Rescues the nrk2b Morphant Muscle Phenotype. 
(A-D) Brightfield images, side mount, anterior left, dorsal top, 26 hpf embryos. 
(Numbered panels A-D) Side mount, anterior left, dorsal top, 48 hpf embryos, phalloidin 
stained to visualize actin. In panels numbered 2, MTJs are pseudocolored fuchsia. (Panel 
A) Control MO-injected. (Panel B) nrk2b MO-injected. (Panel C) nrk2b MO-injected 
embryos incubated in 0.1 mM NAD+. (Panel D) nrk2b MO-injected embryos incubated 
in 1 mM NAD+. (E) Graph of average myotome boundary angles in controls, NAD+- 
treated controls, nrk2b morphants, NAD+-treated nrk2b morphants, laminin morphants, 
and NAD+-treated laminin morphants. The average myotome boundary angle of nrk2b 
morphants is significantly different than controls (Student t-test, p<0.001) and the 
average myotome boundary angle of NAD+-treated nrk2b morphants is significantly 
different than untreated nrk2b morphants and controls (Student t-test, p<0.001, n of 
myotome boundaries measured on x-axis). (F) Graph of the percent of MTJs crossed by 
muscle fibers in nrk2b morphants, NAD+-treated nrk2b morphants, laminin morphants, 
and NAD+-treated laminin morphants. NAD+ treatment rescues boundary crossings in a 
dose dependent manner in nrk2b morphants, but not laminin morphants (n of MTJs 
crossed over total MTJs analyzed is listed on the x-axis). (Panel G) Controls. (Panel H) 
laminin morphants. (Panel I) 1 mM NAD+-treated laminin morphants. (Lettered panels) 
Brightfield images of a dish of embryos. (Panels numbered 1) Side mount, brightfield 
images, 26 hpf embryos, anterior left, dorsal top. (Panels numbered 2) Side mount, 48 
hpf embryos, anterior left, dorsal top, phalloidin stained to visualize actin. (Panels 
numbered 3) MTJs are pseudocolored fuchsia. Scale bars are 50 p,m, ***p<0.001.
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2.4.4. Nrk2b is Required Non-Cell Autonomously for Basement Membrane 
Polymerization at the MTJ
We showed that discontinuous MTJs in nrk2b morphants at 48 hpf are not due to 
discontinuous somite boundaries. Somite boundary morphogenesis into nascent MTJs 
occurs around 24 hpf (96) and polymerized Laminin-111, indicative of basement 
membrane assembly, robustly concentrates throughout the MTJ at this time (58,60). We 
asked if Nrk2b is required for basement membrane formation because Nrk2b interacts 
specifically with the Laminin receptor, Integrin alpha7beta1, in vitro (69). In controls, 
Laminin-111 at the basement membrane is clear as a distinct line between adjacent 
myotomes (Fig. 2.4 panels A1-3, small square panels). In 3D projections, the 
organization and continuous nature of Laminin-111 in the medial-lateral dimension is 
clear (Fig. 2.4 panels A1-3, large square panels). When the 3D projections are rotated to 
generate a transverse view, high levels of Laminin-111 are observed throughout the 
medial-lateral extent of the MTJ except for the horizontal myoseptum (dark vertical line, 
Fig. 2.4 A1-3, tall rectangular panels, Laminin is observed at the MTJ adjacent to slow- 
twitch fibers in blue, but also medially in the fast-twitch muscle domain). In contrast, the 
MTJ basement membrane in nrk2b morphants is disorganized and discontinuous. At a 
lower magnification view, Laminin-111 at the MTJ in nrk2b morphants appears similar to 
controls (compare Fig. 2.4 panels A to B). Upon closer inspection, however, it is clear 
that Laminin-111 is not laid down in a straight and organized line (Fig. 2.4 panels B1-3, 
small square panels). The basement membrane is not always continuous, i.e. there are
holes in Laminin-111 at the MTJ (Fig. 2.4 panel B3, white arrow in large square panel,
39
note gap in Laminin-111 staining in the top left small square panel, this gap appears as a 
hole in Laminin-111 staining when 3D projected). These holes do not represent gaps 
within muscle tissue because staining for phalloidin, which outlines cells, showed that 
muscle fibers terminated adjacent to the gaps/holes (Fig. 2.4 panel B3, white arrow in 
small square panel). This disorganization of the basement membrane is especially clear in 
3D projections (Fig. 2.4 panels B1-3, large square panels). The transverse view shows 
that levels of Laminin-111 are not uniform throughout the medial-lateral extent of the 
MTJ (Fig. 2.4 panels B1-3, tall rectangular panels). Interestingly, Laminin-111 deposition 
appears to be particularly poor in the MTJ adjacent to the medial fast-twitch muscle 
domain (Fig. 2.4 panels B1-3, tall rectangular panels).
The above data indicate that basement membrane assembly at the MTJ is
disrupted in nrk2b morphants. To test whether this disruption is a common phenotype
when adhesion to Laminin-111 is disrupted, we assayed basement membrane assembly in
dystroglycan morphants. Dystroglycan is a component of the Dystrophin-Glycoprotein
Complex (DGC), a transmembrane receptor for Laminin, and is crucial for maintenance
of muscle fiber attachment to the ECM. It has previously been shown that dystroglycan
morphants have muscular dystrophy (92), but the age of onset has not been closely
investigated. We find that MTJs in dystroglycan morphants at 26 hpf are fairly normal
(Fig. 2.4 panel C). Very few MTJs are discontinuous and crossed by abnormally long
muscle fibers (2 experiments, 13 embryos, 4/110 MTJs crossed). Careful inspection of
the basement membrane in dystroglycan morphants corroborates this conclusion. 3D and
transverse projections show robust basement membrane polymerization (Fig. 2.4, panel
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C). Even when the MTJ is discontinuous and there is a hole in the basement membrane 
that is crossed by muscle fibers, the adjacent basement membrane is robust (Fig. 2.4 
panel C1, square panels, red arrowhead). Importantly, transverse views show that 
basement membrane assembly in the fast-twitch muscle domain is robust adjacent to the 
gap in the MTJ that is crossed by muscle fibers (Fig. 2.4 panel C, tall rectangular panel, 
red arrowhead).
By applying the 2D Wavelet Transform Modulus Maxima (WTMM) method 
(6°,97,98,i°3) we performed a structural, multi-scale anisotropy analysis to rigorously and 
objectively assess CMAC components at the MTJ in nrk2b morphants. The 2D WTMM 
method can be used to quantify the amount of structure (order) of objects that do not have 
a well-defined boundary by calculating the angle of steep gradients in pixel intensity, at 
different size scales. This is perhaps most apparent in controls, where most of the arrows 
plotting this angle are parallel to each other (Fig. 2.4 panel E). Angles are also mostly 
parallel in dystroglyan morphants (Fig. 2.4 panel F). However, arrows are far less 
organized in nrk2b morphants (Fig. 2.4 panel G). This organization is quantified by 
calculating the probability density function of the angles, from which we obtain the 
anisotropy factor. The anisotropy factor is the departure from isotropy or randomness. A 
higher anisotropy factor indicates a more ordered structure. We found that control and 
dystroglycan morphants have similar anisotropy factors (Fig. 2.4 panel D). The 
anisotropy factor of Laminin-111 staining in nrk2b morphants is significantly lower, 
indicating a more random structure (Student t-test, p<0.01, Fig. 2.4 panel D). These data
indicate that Nrk2b is required for normal basement membrane assembly.
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Fig. 2.4. Nrk2b is Required for Normal Basement Membrane Development. (A, B, C) 26 
hpf embryos, side mount, anterior left, dorsal top, F59 antibody stained to visualize slow- 
twitch muscle, phalloidin stained to visualize actin and Laminin-111 antibody stained to 
visualize the basement membrane of the MTJ. (A) Control. (B) nrk2b morphant. (C) 
dystroglycan morphant. Numbered panels 1-3 are examples of different MTJs within an 
embryo from each treatment (*, ** or *** indicates the location of the MTJ). Small 
square panels are focal planes of each antibody/stain used as well as a merged view.
Large square panels are 3D reconstructed Laminin-111 antibody staining (in black and 
white) or F59 and Laminin-111 antibody staining (in color). Tall rectangular panels are 
transverse views of the 3D reconstructed antibody staining with lateral to the left and 
medial to the right. Note in the MTJ examples in nrk2b morphants (panel B) that 
Laminin-111 is not laid down in a straight line and is not always continuous (white 
arrows). In the transverse views, note that Laminin-111 is especially disrupted in the 
medial fast-twitch fiber domain. In dystroglycan morphants, MTJs can still be 
discontinuous (red arrowheads), but Laminin-111 is robust in the lateral and medial 
domains. (D) Graph of the anisotrophy factor (see Section 2.3.12) in Laminin-111 
stained images. A lower anisotrophy value in nrk2b morphant images indicates that there 
is less order/ structure in Laminin-111 staining in these morphants. (E-G) Side mount, 
anterior left, dorsal top, 26 hpf embryos, Laminin-111 antibody staining. Numbered 
panels are higher magnification views of corresponding panels. Images were analyzed 
with the 2D Wavelet Transform Modulus Maxima (2DWTMM) method. (Panel E) 
Controls. (Panel F) dystroglycan morphants. (Panel G) nrk2b morphants. In controls and 
dystroglycan morphants, the vectors are more parallel indicating more order than in 
nrk2b morphants. Scale bars are labeled on the figure, **p<0.01.
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Possible explanations for the apparent decrease in Laminin-111 at nrk2b morphant 
MTJs are: (1) reduced laminin transcription, (2) increased Laminin-111 degradation or 
(3) less efficient assembly/polymerization of Laminin-111. We used multiple 
experimental approaches to distinguish between these possible mechanisms. We first 
analyzed laminin transcription at 24 hpf because this is the earliest time that basement
membranes at the MTJ are reliably robust in controls and disrupted in nrk2b morphants.
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Neither of these laminin chains is highly expressed in controls at 24 hpf (Fig. 2.5 panels 
B, C). Expression of both chains appears increased in 24 hpf nrk2b morphants (Fig. 2.5 
panels B1, C1). Because expression levels are somewhat low, we also quantitatively 
analyzed transcription of the three laminin chains that make up Laminin-111. 
Comparative quantitative Reverse Transcriptase-Polymerase Chain Reaction (qRT-PCR) 
of controls and nrk2b morphants indicated that these three laminin chains are not down 
regulated in nrk2b morphants (Fig. 2.5 panel A, Table 2.2). If anything, transcription of 
these laminin chains is increased. Transcription of laminin alpha1 is upregulated 
approximately 2.5 fold compared to controls. Because all three chains are required for 
Laminin-111 assembly, it is not clear whether dramatically increased transcription of one 
chain affects levels of Laminin-111 protein (we have been unsuccessful at using Westerns 
to detect Laminin-111 with the above antibody, this is probably due to the fact that the 
antibody recognizes assembled and polymerized Laminin-111). However, these data 
allow us to conclude that the disruption in Laminin-111 at the MTJ basement membrane 
is not due to decreased laminin transcription.
Another mechanism that could account for the holes in the MTJ basement
membrane in nrk2b morphants is increased degradation of Laminin-111. We used genetic
mosaic analysis to ask whether nrk2b morphant cells are sufficient for Laminin-111
degradation. Nrk2b-deficient cells were transplanted into wild-type hosts and the MTJ
basement membrane was assessed at 48 hpf. No holes in the MTJ basement membrane
were observed adjacent to Nrk2b-deficient cells in control hosts (Fig. 2.5 panels D-D3, n
= 68 cells). We also asked whether Nrk2b-deficient cells were able to elongate across
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MTJ boundaries. Only 9/485 (2%) cells crossed control MTJ boundaries (Fig. 2.5 panel 
E). Genetic mosaic analysis of myotubes is complicated by their multinucleate nature. 
However, we can conclude that Nrk2b-deficient cells are not sufficient, even in large 
quantities, to frequently induce Laminin degradation. Taken together, the above data 
suggest that Nrk2b is non-cell autonomously required for basement membrane 
polymerization and that basement membrane polymerization is a phenomenon mediated 
by communities of cells. To our knowledge, this is the first example of an intracellular 
protein critical for basement membrane assembly during muscle development in vivo.
The percentage of holes in Laminin-111 at 24 hpf is similar to the percentage of 
MTJs crossed at 48 hpf (Fig. 2.5 panel E). Muscle integrity does not degenerate through 
time in nrk2b morphants: the percentage of MTJs crossed at 96 hpf is similar to the 
percentage crossed at 48 hpf (Fig. 2.5 panel E). These results suggest that initial defects 
in basement membrane assembly precede muscle fibers crossing through the defective 
basement membrane later in development, resulting in discontinuous MTJs (Fig. 2.5 
panel F).
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Fig. 2.5. Nrk2b is Non-Cell Autonomously Required for Normal Basement Membrane 
Polymerization. (A) qRT-PCR for relative transcript abundance of the three laminin 
chains that comprise Laminin-111 in 24 hpf embryos. (B-C) Side mount, anterior left, 
dorsal top, 24 hpf. ISH for laminin transcripts in controls (lettered panels) and nrk2b 
morphants (numbered panels), (panel B) laminin alphal, (panel C) laminin gammal. 
ISH and qRT-PCR suggest that Laminin-111 defects in nrk2b morphants are not due to a 
laminin transcription deficiency. (D) Model of dextran labeled nrk2b morphant cells 
being transplanted into a wild-type host at blastula stage. (D1-D3) Side mount, anterior 
left, dorsal top, 48 hpf, red cells are dextran labeled Nrk2b-deficient cells. Laminin-111 
antibody staining (in green) is normal adjacent to Nrk2b-deficient cells (red) in a wild- 
type background. This suggests that basement membrane polymerization is a 
phenomenon mediated by communities of cells and that Nrk2b is non-cell autonomously 
required for basement membrane polymerization. (E) Graph of the percentage of MTJs 
with holes in Laminin-111 or with boundary crossings over time. The observation that 
the percentage of MTJs with defects does not steadily increase over time suggests that 
boundary crossings are not due to age-dependent degeneration of the MTJ. Note that a 
very small percentage of Nrk2b-deficient cells cross MTJs in wild-type hosts suggesting 
that these cells do not actively degrade Laminin-111 and that Nrk2b functions non-cell 
autonomously in basement membrane development. (F) Model of MTJ basement 
membrane defects in nrk2b morphants leading to fibers crossing MTJs as time 
progresses.
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2.4.5. CMAC Assembly is Aberrant in nrk2b Morphants
The above data show that Laminin-111 is not efficiently polymerized at the MTJ
basement membrane in nrk2b morphants. Recruitment of intracellular scaffolding and
signaling proteins, like Focal Adhesion Kinase (FAK), Paxillin and beta-Dystroglycan, to
CMACs is critical for the assembly and maintenance of the ECM (74,i°4,io5). Thus, we
assessed CMAC assembly at the MTJ both qualitatively and quantitatively, with the
WTMM formalism. The WTMM formalism was applied to images for beta-
Dystroglycan, pY861 FAK, pY397 FAK, and Paxillin. In order to best assess structure at
the MTJ, we analyzed wavelets between 1.88 and 3.75 p,m. Beta-Dystroglycan robustly
concentrates at the MTJ in controls at 26 hpf (Fig. 2.6 panel A, white arrows). This
organized staining is reflected in a relatively high anisotropy factor, approximately 1.3,
across all size scales analyzed (Fig. 2.6 panel M, dark blue bars). Beta-Dystroglycan
concentrates at nrk2b morphant MTJs, but is slightly less robust than in controls (Fig. 2.6
panel B, ct n=31 MTJs, nrk2b MOs n = 44 MTJs). This difference is clear when the
anisotropy factor is calculated (Fig. 2.6 panel M, light blue bars): beta-Dystroglycan is
significantly less organized in nrk2b morphants for all size scales examined (p<0.001).
Both FAK (data not shown, ct n = 48 MTJs; nrk2b MOs n = 43 MTJs) and tyrosine
phosphorylated FAK concentrated at the MTJ in controls and nrk2b morphants (Fig. 2.6
panels C-F, white arrows, pY861 FAK ct n = 52 MTJs, nrk2b MOs n=75 MTJs; pY397
FAK ct n=55 MTJs, nrk2b MOs n=83 MTJs). Gaps in FAK staining in nrk2b morphants
correlated with gaps in MTJs and abnormally long muscle fibers (Fig. 2.6 panels D, F, red
arrows). Anisotropy factors reflecting organization of pY FAK between control and nrk2b
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morphants were more similar to each other, but still significantly different (Fig. 2.6 panel 
N, O, p values ranged from 0.02 to 0.05, there was no correlation of size scale with p 
value). These results indicate that although concentration of beta-Dystroglycan and pY 
FAK appear qualitatively similar to controls, subcellular localization of these proteins at 
the MTJ is less organized in nrk2b morphants than in controls.
Strikingly, the localization of a different CMAC component, Paxillin, was 
disrupted in all nrk2b morphants analyzed (Fig. 2.6 panels G-H, imaging parameters were 
the same for controls and morphants, ct n = 200 MTJs; nrk2b MOs n = 181 MTJs). Note 
that Paxillin is concentrated at MTJs in controls, but is not highly concentrated at the 
MTJ in nrk2b morphants. Interestingly, similar to Laminin-111 staining, Paxillin staining 
at the MTJ within slow-twitch muscle fibers was not affected (data not shown), but was 
disrupted in the more medial fast-twitch fiber domain. The anisotropy factor was 
strikingly lower for nrk2b morphants than controls over all size scales (Fig. 2.6 panel P, 
p<0.001). In controls, the anisotropy factors for pY FAK and Paxillin are not significantly 
different (Fig. 2.6 panel Q). In contrast, the anisotropy factor for Paxillin in nrk2b 
morphants was significantly different than pY FAK (p<0.01). Addition of exogenous 
NAD+ rescues Paxillin concentration at the MTJ in the medial fast-twitch muscle domain 
in nrk2b morphants (Fig. 2.6 panels U-W). Taken together, the qualitative and 
quantitative assessments of CMAC formation in nrk2b morphants indicate that Paxillin 
concentration at MTJ CMACs is dramatically disrupted in nrk2b morphants.
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The lack of robust Paxillin concentration at MTJs in nrk2b morphants could be 
due to: (1) decreased paxillin transcription, (2) less Paxillin protein or (3) reduced 
recruitment/retention of Paxillin to MTJ CMACs. qRT-PCR for paxillin transcript levels 
show that paxillin transcription is normal in nrk2b morphants (Fig. 2.6 panel R, Table
2.2). Densitometry measurements of Paxillin antibody staining and Western analysis 
suggested that there is not a reduction in Paxillin protein in nrk2b morphants (Fig. 2.6 
panels S, T). One caveat, however, is that densitometry is qualitative and qRT-PCR and 
Westerns represent levels within entire embryos. Thus, although it does not appear to be 
the case, there could be a physiologically significant reduction of Paxillin levels in 
muscle tissue. These data suggest the hypothesis that Nrk2b is required for recruitment 
and/or retention of cytoplasmic Paxillin to MTJ CMACs.
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Fig. 2.6. Nrk2b is Required for Normal Subcellular Localization of Paxillin, but Not 
Beta-Dystroglycan or FAK. (A-H) Side mount, anterior left, dorsal top, 26 hpf. Panels 
A, C, E, and G are controls. Panels B, D, F, and H are nrk2b morphants. Panels 
numbered 1 are magnifications of the corresponding lettered panels. (A-B1) - 
Dystroglycan antibody staining. (C-D1) pY861 FAK antibody staining. (E-F1) pY397 
FAK antibody staining. (G-H1) Paxillin antibody staining. White arrows indicate normal 
localization of proteins to MTJs. Red arrows in nrk2b morphants (B, D, F) indicate 
discontinuous MTJs crossed by muscle fibers. Note that in nrk2b morphants (H, H1), 
Paxillin does not robustly concentrate to MTJs. (I-L) Side mount, anterior left, dorsal 
top, 26 hpf controls (lettered panels) and nrk2b morphants (numbered panels). 
Application of 2D WTMM method showing maxima chains (dark green), nodes (red), 
and vectors (light green) for CMAC component antibody staining. (M-Q) Graphs of 
anisotropy or the amount of order in a structure over a range of applicable size scales.
(R) qRT-PCR, (S) average densitometric mean of Paxillin antibody-stained images and 
(T) Western analysis suggest that Paxillin levels are not decreased in nrk2b morphants. 
(U-W) Side mount, anterior left, dorsal top, 26 hpf embryos, phalloidin staining in red, 
Paxillin antibody staining in green. Lettered panels are controls and numbered panels are 
nrk2b morphants. (Panel U) No exogenous NAD+. (Panel V) 0.1 mM exogenous NAD+. 
(Panel W) 1 mM exogenous NAD+. Note that exogenous NAD+ treatment rescues 
medial Paxillin concentration at the MTJ in nrk2b morphants in a dose dependent 
manner. Scale bars are 50 p,m.
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The above data indicate a specific requirement for Nrk2b in Paxillin localization 
at MTJ CMACs. This represents a novel model system with which to ask important 
questions about CMAC assembly in vivo. We used genetic mosaic analysis to ask 
whether Paxillin localization to MTJ CMACs was restored in wild-type cells transplanted 
into nrk2b morphants. Normal beta-Dystroglycan localization indicated that cells are not 
appreciably perturbed by transplantation (Fig. 2.7 panel B). Similar results were obtained 
when pY397 FAK concentration at the MTJ was analyzed (Fig. 2.7 panel C). Strikingly, 
Paxillin localization to MTJs was rescued in wild-type cells, but not in the Nrk2b- 
deficient cells surrounding them (Fig. 2.7 panel D) The multinucleate nature of fast- 
twitch muscle fibers and the possibility that wild-type cells fused with Nrk2b-deficient 
cells implies that even reduced amounts of Nrk2b are sufficient for Paxillin concentration 
at the MTJ. This result indicates that the protein composition of CMACs can be 
modulated cell autonomously in vivo.
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Fig. 2.7. Nrk2b is Cell Autonomously Required for Paxillin Localization to MTJs. (A) 
Cartoon showing dextran labeled wild-type cells being transplanted into a nrk2b 
morphant host at blastula stage. (B-D) Side mount, anterior left, 26 hpf nrk2b morphant 
hosts with transplanted wild-type cells (red), beta-Dystroglycan antibody staining (light 
blue, panel B), pY397 FAK antibody staining (dark blue, panel C), and Paxillin antibody 
staining (green, panel D). Note that beta-Dystroglycan and pY397 FAK robustly localize 
to MTJs in nrk2b morphants in the presence and the absence of transplanted wild-type 
cells. Note that robust Paxillin localization to the MTJ in nrk2b morphants is rescued in 
the transplanted wild-type cells, but not in the Nrk2b-deficient cells surrounding them. 
Numbered panels are merged images showing both antibody staining and transplanted, 
dextran-labeled cells.
A
Fix, stain, image
24 hpf
B—«* V * \  .
\  \
■ \  \  R-Dystroglycan
C
pY397 FAK
D
’ ; \
- J t t -  ’ ■
I
A.* \
Paxillin
B1 .
' \  V '
\  \
■ V . X.* .* • V
C1 D1
2.4.6. Paxillin is Sufficient for Boundary Capture in nrk2b Morphants
The data thus far suggest multiple hypotheses, including: (1) Paxillin 
concentration at the MTJ promotes normal basement membrane assembly and boundary 
capture, (2) Paxillin concentration at the MTJ is a read-out of robust CMAC assembly, 
(3) adhesion to Laminin-111 is critical for Paxillin concentration at the MTJ, or (4) 
Paxillin concentration at the MTJ and basement membrane assembly are linked through
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inside-out and outside-in signaling. Unfortunately we do not currently possess the tools 
for dynamic, in vivo analysis of basement membrane assembly and are unable to 
definitively discriminate between these hypotheses. However, analysis of Paxillin 
subcellular localization in laminin mutants could be informative. If Paxillin concentrates 
at the MTJ in laminin mutants, hypotheses (2) and (3) could be eliminated. Beta- 
Dystroglycan concentrates at the MTJ in laminin mutants as previously reported (Fig. 2.8 
panel B, 93). We find that Paxillin concentration at the MTJ is nearly abrogated in laminin 
mutants (Fig. 2.8 panel D). This result suggests that Paxillin concentration to the MTJ 
requires Laminin for its stability and is thus functionally downstream of Laminin.
We asked whether overexpression of Paxillin was sufficient to rescue the nrk2b 
morphant phenotype using a transgenic line that ubiquitously over expresses 
Paxillin:GFP. Paxillin:GFP concentrates robustly at MTJs in control transgenic embryos 
and Paxillin overexpression does not disrupt early development (data not shown). 
Interestingly, Paxillin:GFP also robustly concentrates at MTJs in transgenic embryos 
injected with nrk2b MOs. Overexpression of Paxillin:GFP did not significantly decrease 
wider MTJ angles in nrk2b morphants (Fig. 2.8 panel G, Student t-test, p = 0.17). 
However, overexpression of Paxillin:GFP did significantly reduce the percentage of 
MTJs crossed by muscle fibers in nrk2b morphants (Fig. 2.8 panel H, Student t-test, 
p<0.01). These data indicate that MTJ angle and MTJ integrity can be uncoupled. 
Furthermore, these data implicate Paxillin as a major regulator of boundary capture in 
vivo. Whether rescue of the nrk2b morphant phenotype by Paxillin overexpression is
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dependent on or independent of changes in NAD+ concentration remains to be 
determined.
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Fig. 2.8. Paxillin Overexpression Rescues MTJ Integrity in nrk2b Morphants. (A-D) Side 
mount, anterior left, dorsal top, 32 hpf controls (panels A and C) gup/laminin betal 
mutants (panels B and D) stained with phalloidin (red), beta-Dystroglycan (blue) and 
Paxillin (green). Note that the Paxillin is severely disrupted in gup/laminin betal 
mutants, suggesting that adhesion to Laminin plays a role in Paxillin localization. (E-F) 
Side mount, anterior left, dorsal top, 48 hpf embryos. (E) nrk2b morphant. Note that 
approximately 1/3 of MTJs are crossed by muscle fibers. (F) nrk2b-MO-injected 
Paxillin:GFP transgenic zebrafish. Note that overexpression of Paxillin:GFP greatly 
reduces the frequency of boundary crossings in nrk2b morphants. (G) Graph of myotome 
boundary angles. Note that overexpression of Paxillin:GFP does not rescue the wider 
myotome boundary angles observed in nrk2b morphants (n of myotome boundary angles 
measured is on the x-axis). (H) Graph of percentage of MTJs crossed by muscle fibers. 
Note that overexpression of Paxillin:GFP does significantly rescue boundary crossings in 
nrk2b morphants (n of crossed MTJs over total MTJs analyzed is on the x-axis). Scale 
bar is 50 ^m, **p<0.01.
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2.5. Discussion
Signaling through cell adhesion complexes not only mediates cell migration and 
cell shape changes, but also influences all other major cellular functions. Thus, these 
complexes are best thought of as flexible and dynamic information handling machines 
(74). Elucidating how adhesion complexes mediate the cellular and molecular 
mechanisms underlying myotube formation and tendon attachment is critical to 
understanding musculoskeletal development and the transition to disease states. We show 
that a novel protein, Nrk2b, is required for muscle development in vivo. Importantly, we 
identify Nrk2b functions at the tissue and cellular levels (Fig. 2.9). Nrk2b is required for 
normal basement membrane assembly at the MTJ. In the absence of Nrk2b, MTJs are 
discontinuous, resulting in abnormally long muscle fibers. Nrk2b also regulates the 
molecular composition of CMACs. Nrk2b is required for normal FAK and beta- 
Dystroglycan organization at the MTJ and localization of Paxillin to the MTJ is nearly 
abolished in nrk2b morphants. Finally, we show that addition of exogenous NAD+ 
rescues the nrk2b morphant phenotype. Multiple lines of evidence suggest that Nrk2, 
although little studied, is a highly significant protein with important functions in muscle 
growth and disease. Microarray analysis of “double muscled” myostatin - / -  cows found 
that itgb1bp3/nrk2 is the second most upregulated muscle transcript, second only to 
troponin T type 1 (85). nrk2 transcription is also highly upregulated in alveolar soft-part 
sarcoma (86), a rare and highly metastatic cancer with poor prognosis. These data do not 
determine whether nrk2 upregulation is a cause or an effect of increased muscle growth/
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proliferation. However, they do suggest that in vivo functional analysis may identify 
conserved functions of Nrk2 with therapeutic relevance.
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Fig. 2.9. Roles for Cell-Matrix Adhesion during Muscle Morphogenesis. (A) Cartoon of 
steps involved in muscle morphogenesis between 17 hpf and 24 hpf at the tissue level. 
During this time, myotube shape becomes more regular, fusion occurs, Fn is degraded, 
and Laminin polymerization increases. (B) Cartoon of CMAC formation and the 
modulation of the specificity of CMACs between 17 hpf and 24 hpf. Note the increase in 
cell-matrix adhesion complex formation. (C) Cartoon of hypothesized molecular level 
events during muscle morphogenesis involving Nrk2b and NAD+. Speculative 
interactions are in green lettering. NAD+ is an obligatory substrate for enzymes such as 
poly-ADP-ribose polymerases (PARPs), and Sirtuins. Ecto-mono-ADP- 
ribosyltransferases (ARTs) are hypothesized to ADP-ribosylate Integrins, increasing their 
binding affinity for Laminin in an irreversible reaction. NAD+ is also believed to 
modulate gene transcription via regulation of Sirtuin activity. Increased adhesion to 
Laminin can promote Paxillin recruitment to CMACs. Paxillin, in turn, mediates 
boundary capture and termination of muscle cell elongation.
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2.5.1. A Novel Morphogenetic Role for NAD+
NAD+ is a ubiquitous coenzyme best known for its role in metabolic electron
transfer reactions, but is also a critical coenzyme for many different reactions. For
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example, NAD+ is an obligatory substrate in ADP-ribosylation reactions that influence 
processes ranging from DNA repair to cell signaling and adhesion (106-112). Although 
recent data have identified a novel NAD(H) binding protein that links metabolic cues 
with cell cycle regulation, roles for NAD+ during morphogenesis have not been 
identified. We show that NAD+ regulates muscle morphogenesis. It was traditionally 
thought that the only mechanism for NAD+ synthesis was de novo synthesis from amino 
acids. Within the last decade, however, an alternative salvage pathway that generates 
NAD+ has been identified (71). This pathway involves salvage of Nicotinic acid, 
Nicotinamide, or Nicotinamide Riboside (72,88). Nicotinamide riboside kinases, Nrks, 
phosphorylate Nicotinamide Riboside, a critical step towards NAD+ synthesis. The 
question that remains, however, is how NAD+ regulates morphogenesis. Because a role 
for NAD+ during morphogenesis has not previously been shown, we can only speculate. 
We hypothesize that Nrk2b post-translationally promotes basement membrane assembly 
by providing a local source of NAD+ used to ADP-ribosylate Integrins (for discussion of 
the alternative hypothesis that Nrk2b regulates basement membranes through its Integrin 
binding function, see Section 4.1). ART1 is an ecto-mono-ADP-ribosyltransferase that 
ADP-ribosylates Integrin alpha7 at multiple sites, depending upon NAD+ concentration 
(113,114). This ADP-ribosylation by ART1 is not readily reversible and leads to an 
increased Laminin-binding affinity of Integrin alpha7beta1 in differentiated myotubes. 
Given that NAD+ is an obligatory substrate in ADP-ribosylation reactions, the authors 
hypothesized that Integrin alpha7 ADP-ribosylation might be a protective mechanism that 
increases Integrin alpha7beta1 adhesion to Laminin when the sarcolemma has been
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compromised and intracellular NAD+ leaks into the extracellular space. However, it is 
also possible that Integrin ADP-ribosylation and the subsequent increased affinity for 
Laminin is a morphogenetic mechanism that promotes basement membrane 
polymerization. We have identified two ART1 orthologs expressed in developing 
zebrafish skeletal muscle (unpublished data). Preliminary data indicate that expression of 
these ARTs is Nrk2b dependent, they are required for basement membrane assembly, and 
act within the same pathway as Nrk2b (Peterson and Henry, unpublished data). Thus, one 
interesting avenue of research is development of fluorescent tools that would allow 
visualization of ADP-ribosylation and basement membrane assembly in vivo. This model 
is clearly very speculative. However, two recent findings establish some precedent for 
compartmentalized NAD+ usage and NAD+-dependent enzymes in morphogenesis. 
Transgenic Arabidopsis expressing reporter constructs for three NAD+ kinases, or 
NADKs, show tissue-specific expression (115). Expression of GFP-tagged versions of the 
NADKs in suspension cultures showed that one of the three localized to the peroxisomal 
matrix (115). These data suggest that localized NAD+ usage may play roles in plant 
development and/or physiology. Data that potentially implicate NAD+ in morphogenesis 
were obtained by identifying a potential locus underlying isolated congenital nail 
clubbing (ICNC). ICNC is a rare autosomal recessive disorder characterized by abnormal 
connective tissue growth and matrix that lead to enlargement of digit terminal segments 
(116). In one large Pakistani family, a nonsense mutation in the gene encoding NAD+- 
dependent 15-hydroxyprostoglandin dehydrogenase is thought to underlie ICNC (116). 
Taken together, our findings implicating NAD+ in morphogenesis, as well as clear roles
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for NAD+ in modulating Integrin affinity for Laminin in cell culture, localized usage of 
NAD+ in Arabidopsis, and roles for a NAD+-dependent enzyme in a connective tissue 
disease all suggest that NAD+ may be a little recognized yet important morphogenetic 
mediator.
2.5.2. Dynamic Reciprocity and Musculoskeletal Homeostasis
Adhesion of muscle cells to the surrounding basement membrane is one of the 
most important aspects of musculoskeletal structure. When genes whose protein products 
are involved in muscle cell-basement membrane adhesion are mutated, myopathies can 
occur. Zebrafish models of muscular dystrophies have both validated the model and 
provided novel insights into pathogenesis (59,65,92,117-121). One important insight is that the 
MTJ is a major site of failure in sapje/dystrophin mutants (65). It has also recently been 
shown that muscle fibers detach from the basement membrane at the MTJ prior to 
membrane disruption and apoptosis in laminin alpha2 mutants (59), laminin beta2 
mutants (21), and dystroglycan mutants (122). One less appreciated but critically important 
aspect of musculoskeletal homeostasis is initial MTJ morphogenesis. Multiple studies 
have shown that disruption of ECM at the MTJ can result in the formation of aberrant and 
discontinuous MTJs (60,103,123,124). In this study, we elucidate some of the underlying 
mechanisms that govern ECM remodeling and allow cells to integrate signaling and 
differentiation with the structure of their local microenvironment. This dynamic, 
bidirectional relationship between cells and their local ECM environment mediate 
basement membrane assembly at the MTJ and reinforces muscle fiber-MTJ adhesion. We
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show that Nrk2b plays a critical role in basement membrane assembly. This is a novel 
mechanism of “inside-out” signaling. We also show that Laminin itself is critical for 
recruitment of Paxillin to cell-matrix adhesion complexes at the MTJ — “outside-in” 
signaling. Overexpression of Paxillin:GFP promotes boundary capture and termination of 
muscle fiber elongation, representing another example of “inside-out” signaling. These 
results provide a mechanistic framework for future studies investigating the positive 
feedback loop between cells and their matrix that reinforces and stabilizes muscle fiber- 
MTJ adhesion.
2.5.3. Nrk2b and Specificity of Cell Adhesion Function
Although it is not known how CMACs regulate disparate cellular processes such 
as motility, stable adhesion, proliferation, survival and invasion, it is likely that changes 
in their size, localization, stability and molecular composition mediate different cellular 
outputs. Recent advances in imaging technology (fluorescent speckle microscopy, spatio- 
temporal image correlation spectroscopy) have allowed new insights into the CMAC to 
F-actin linkage in vitro (74). However, analysis of the molecular composition and size of 
CMACs during development is difficult, if not impossible. Analysis of the phenotypes of 
mice, Xenopus and zebrafish deficient for different CMAC components has increased 
understanding of CMAC function during development. These studies show that one 
mechanism contributing to CMAC functional specificity is tissue-restricted expression of 
CMAC components. But what about a CMAC component such as Paxillin, which is 
ubiquitously expressed during zebrafish development (58)? How is Paxillin function
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within CMACs modulated in different contexts? Here, we provide one paradigm by 
which specificity can be achieved. We show that nrk2b is expressed in axial skeletal 
muscle and is required for Paxillin localization to MTJ CMACs. Interestingly, we also 
provide evidence that Nrk2b-mediated Paxillin concentration is modulated in a cell 
autonomous fashion. To our knowledge, this is the first mechanistic understanding of cell 
autonomous CMAC molecular composition regulation in vivo. Our data do not indicate 
whether Nrk2b is required for Paxillin recruitment or retention/stabilization of Paxillin at 
MTJs. Given the absolutely critical role of Paxillin in mediating cell adhesion and 
migration in vitro (125), it is perhaps not surprising that Paxillin localization to the MTJ 
can be modulated in a tissue-specific manner. Importantly, the fact that Nrk2b was shown 
to regulate the protein level and tyrosine phosphorylation of Paxillin in C2C12 myoblasts 
(69) suggests some conservation of Nrk2b function. Thus, an in vivo model of Nrk2b 
function may provide relevant insights into human health and disease.
Basement membranes, primarily composed of Laminin, are specialized 
compartments within the ECM that provide mechanical support and regulate multiple 
cellular activities. Laminins are heterotrimeric proteins composed of an alpha, beta and 
gamma chain. It is thought that once assembled, most Laminins polymerize via 
interactions between the three N-terminal short arms (126). The mechanisms that regulate 
Laminin polymerization in vivo are not well understood. We show that despite normal/ 
increased levels of laminin chain transcription, the MTJ basement membrane is 
significantly disorganized in nrk2b morphants. The fact that nrk2b morphant cells in
control hosts are unable to induce basement membrane defects indicates that basement
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membrane assembly at the MTJ is a community-mediated phenomenon. This result 
suggests that the basement membrane is not disorganized because of unusually high 
degradation in nrk2b morphants. If Nrk2b deficiency results in increased matrix 
proteolysis, one would predict that large cohorts of Nrk2b-deficient cells in control hosts 
would be sufficient to induce basement membrane disruption. Thus, taken together, these 
data suggest that Nrk2b is a novel regulator of basement membrane assembly during 
early MTJ morphogenesis.
2.5.4. Paxillin at the MTJ is Not Required for Subcellular Localization of FAK to the 
MTJ
Paxillin and FAK were among the first identified focal adhesion proteins and, as 
such, the focus of thousands of studies elucidating their molecular structure and function. 
FAK has a central kinase domain and a C-terminal domain that targets FAK to focal 
adhesions. Paxillin is a scaffolding protein replete with protein-protein binding domains: 
SH2 and SH3 domain binding sites, four C-terminal LIM domains, and five N-terminal 
LD motifs (125). Paxillin and FAK directly interact and FAK phosphorylation and 
localization to focal adhesions are reduced in paxillin - / -  cells (127,128). LD motifs 2 and 
4 of Paxillin bind to the alpha-helix 1/4 and alpha-helix 2/3 Paxillin-binding sites within 
the Focal Adhesion Targeting (FAT) domain of FAK (129-131). A recent in vitro study 
analyzed the function of these two Paxillin-binding sites within FAK. In the absence of 
both sites, only about 10% of FAK localizes to focal adhesions. The presence of either 
Paxillin-binding site is sufficient for FAK targeting to focal adhesions. However, both
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Paxillin-binding sites are necessary for maximal FAK activation and phosphorylation of 
downstream substrates (132). Given these in vitro data, it is curious that FAK 
phosphorylation and concentration at the MTJ are not more disrupted in nrk2b morphants 
that show disrupted Paxillin. In this regard, there is evidence from in vitro studies that 
secondary mechanisms for FAK subcellular localization may exist. Notably, although 
glutamic acid 997 of FAK does not normally play a role in FAK localization to focal 
adhesions, this residue is required for FAK localization to focal adhesions when FAK 
binding to Paxillin is abrogated (132). Thus, it is possible that within the complex in vivo 
environment, there are multiple mechanisms mediating FAK concentration at CMACs. 
Alternatively, it is possible that FAK at the MTJ is primarily localized to the Dystrophin- 
Glycoprotein Complex (DGC) that also anchors the intracellular cytoskeleton to Laminin 
in the ECM. Far less is known about dynamics of DGC assembly and it is not known if 
Paxillin is required for FAK recruitment to DGC based adhesions. Regardless, our data 
show that normal Paxillin localization is not required for robust concentration of FAK to 
CMACs at the MTJ in vivo.
2.5.5. Quantitative Analysis of Morphogenesis
The ability to quantify phenotypes is critical when investigating development or 
disease. A mathematical approach facilitates both an understanding of experimental/ 
developmental variability and also aids in identifying subtle differences that could 
otherwise be construed as noise (133). For example, morphometric analyses determined 
that adult zebrafish haploinsufficient for Fgf8 have craniofacial defects (134). The authors
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posit that one approach to identifying later developmental roles for homozygous lethal 
mutations is to quantitatively analyze morphogenesis in heterozygous embryos. 
Quantification is also important for comparing the efficacy of different treatments in 
animal models of disease. Towards this end, the minimal “Feret's diameter” has been 
identified as an excellent tool for reliable measure of fiber size in mdx - / -  mice (135). 
Multiple laboratories have developed excellent methodologies for quantification of 
morphogenesis (136,137). In this manuscript, we used the 2D WTMM method (60,97,98,103) to 
characterize the anisotropic signature (order/structure) of muscle architecture. Use of the 
2D WTMM formalism showed that the basement membrane at the MTJ is significantly 
less organized in nrk2b morphants than in control or dystroglycan morphants.
Importantly, however, we also showed that the 2D WTMM can be invaluable in parsing 
out subtle differences in CMAC organization. Although recruitment of both pY FAK and 
beta-Dystroglycan to the MTJ appears normal in nrk2b morphants, there is a significant 
difference in CMAC organization.
2.6. Chapter Conclusions
Zebrafish axial muscle development is an ideal paradigm for quantitatively 
integrating functions for cell adhesion in morphogenesis. We show that Nrk2b and NAD+ 
regulate basement membrane assembly and boundary capture at the MTJ, regulate 
Paxillin concentration at the MTJ, and exogenous Paxillin expression is sufficient to 
rescue boundary capture in nrk2b morphants. Thus, we have identified novel roles for 
NAD+ during morphogenesis and for Paxillin during boundary capture in vivo. Taken
70
together, these data provide novel insight into contributions of cell adhesion to 
morphogenesis.
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CHAPTER 3
NAD+ AMELIORATES MUSCULAR DYSTROPHY IN ZEBRAFISH
3.1. Chapter Abstract
Muscular dystrophies are common, currently incurable diseases. A subset of
dystrophies result from genetic disruptions in complexes that attach muscle fibers to their
surrounding extracellular matrix microenvironment. Cell-matrix adhesions are exquisite
sensors of physiological conditions and mediate responses that allow cells to adapt to
changing conditions. Thus, one approach towards finding targets for future therapeutic
applications is to identify cell adhesion pathways that mediate these dynamic, adaptive
responses in vivo. We find that NAD+, which functions as a small molecule agonist of
muscle fiber-extracellular matrix adhesion, corrects dystrophic phenotypes in zebrafish
lacking either a primary component of the Dystrophin-glycoprotein complex or Integrin
alpha7. Exogenous NAD+ or a vitamin precursor to NAD+ reduce muscle fiber
degeneration and result in significantly faster escape responses in dystrophic embryos.
Overexpression of Paxillin, an intracellular, Integrin-associated protein, reduces muscle
degeneration in zebrafish with intact Integrin receptors but does not improve motility.
NAD+ and Paxillin significantly increase organization of Laminin, a major component of
the extracellular matrix basement membrane. Our results indicate that the primary
protective effects of NAD+ result from changes to the basement membrane, as a wild-
type basement membrane is sufficient to increase resilience of dystrophic muscle fibers to
damage. The surprising result that NAD+ supplementation ameliorates dystrophy in
Dystrophin-glycoprotein complex- or Integrin alpha7-deficient zebrafish suggests the
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existence of an additional Laminin receptor complex that anchors muscle fibers to the 
basement membrane. We identify this receptor as Integrin alpha6, but show that either 
Integrin alpha7 or the Dystrophin-glycoprotein complex are required in conjunction with 
Integrin alpha6 to reduce muscle degeneration. Taken together, these results define a 
novel cell adhesion pathway that may have future therapeutic relevance for a broad 
spectrum of muscular dystrophies.
3.2. Introduction
The extracellular matrix (ECM) connects to the intracellular actin cytoskeleton via 
transmembrane receptor complexes. These adhesion complexes not only serve as 
scaffolds for tissue architecture, but also function as sensors of physiological change and 
signal transduction hubs. Thus, adhesion complexes facilitate cell adaptation to changing 
conditions during development, aging, injury response, and disease. Perhaps not 
surprisingly, the onset and progression of many diseases is affected by disrupted cell- 
ECM interactions. Despite the fact that modulating cell-ECM adhesion could be 
exploited for therapeutic purposes, the dynamic regulation of cell-ECM adhesion in vivo 
is not well understood.
Muscles and tendons function as an integrated unit to transduce force to the skeletal 
system and stabilize joints. Cell-ECM adhesions mechanically link muscles to tendons 
and are required for muscle physiology and homeostasis. Many muscle diseases, such as 
Duchenne, Becker, Merosin-deficient muscular dystrophies and congenital muscular 
dystrophy (CMD) with Integrin deficiency, result from mutations that disrupt adhesion of
muscle fibers to their surrounding basement membrane (BM), a substructure within the
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ECM. This weakened link between muscle fibers and the BM results in increased 
susceptibility to fiber damage and death during repeated cycles of contraction and 
relaxation. Due to the continuous bidirectional communication between cells and their 
surrounding BM, muscle atrophy is also accompanied by degeneration of the ECM 
microenvironment (13). As the BM also provides support for satellite cells that mediate 
muscle repair, augmenting the BM is a potential strategy to improve muscle structure and 
regenerative capacity (14,15,21).
Muscle fibers are known to utilize two receptor complexes to adhere to Laminin
in the BM, the Dystrophin-glycoprotein complex (DGC) and Integrin alpha7beta1
heterodimers. Disruption of components in either complex can lead to muscle disease.
Dystroglycan (UniProtKB accession number Q8JHU7_DANRE) is a major component of
the DGC and consists of two subunits (alpha and beta) transcribed from the same locus,
DAG1(138). Beta-Dystroglycan is a transmembrane subunit that indirectly links to the
intracellular cytoskeleton, and alpha-Dystroglycan binds to Laminin and again in the BM
(139-141). Humans with mutations in DAG1 have cognitive impairment and mild myopathy
(142,143). Alpha-Dystroglycan is heavily glycosylated and these post-translational
modifications are critical for binding of alpha-Dystroglycan to BM ligands and BM
deposition (139,144). Mutations in six genes required for normal glycosylation of alpha-
Dystroglycan have been identified thus far and the resultant diseases are commonly
referred to as the dystroglycanopathies (reviewed in 145). These diseases show a wide
clinical spectrum with only modest correlation between genotype and clinical phenotype
(145,146). Screening patient populations suggests that there are as yet unidentified genes
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involved in dystroglycanopathies (147). There are zebrafish orthologues of all six 
dystroglycanopathy genes (49,148). Morpholinos (MOs) against two of these genes have 
been characterized and both lead to muscle degeneration (Fukutin related protein 
Q0PIP5_DANRE, LARGE 2 LARG2_DANRE) (122148). Thus, the zebrafish system may 
provide a genetically and embryologically accessible model to complement investigations 
in mammalian model systems.
Both the DGC and Integrin alpha7beta1 heterodimers contribute to force 
production in mouse muscle, but only the DGC is required to maintain the attachment 
between the muscle cell membrane (sarcolemma) and the surrounding BM during 
lengthening contractions (149). Integrin alpha7 (E7FGC7_DANRE), in contrast, functions 
primarily at MTJs (150,151). Despite their differing roles in sarcolemma-BM attachment, 
these two receptor complexes can partially compensate for one another (41,43,44) and 
mutations in components of both receptor complexes greatly exacerbate the extent of 
muscle atrophy in mice (36,37). These data suggest that dynamic cell-ECM signaling 
mediates adaptive responses when normal muscle architecture is perturbed. Thus, one 
therapeutic approach is to enhance the intrinsic compensatory relationships between cell 
adhesion proteins and their ECM microenvironment by potentiating the adhesion of the 
alternate complex to the BM.
Vertebrate muscle is derived from somites, segmentally reiterated structures 
delineated by the formation of somite boundaries. As development proceeds, a subset of 
somitic cells generate muscle and the somite boundary gives rise to the myotendinous 
junction (MTJ), which is the major site of force transmission from muscle to the skeletal
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system. In zebrafish, elongation of fast-twitch muscle fibers and their subsequent 
attachment to the MTJ correlates with an increase in Laminin polymerization at the MTJ 
(60). We have identified a novel cell adhesion pathway required for Laminin 
polymerization at the MTJ in vivo. We found that Nicotinamide riboside kinase 2b 
(Nrk2b Q7ZUR6_DANRE) and NAD+ potentiate Laminin polymerization and 
subcellular localization of Paxillin (Q6R3L1_DANRE), an Integrin-associated adaptor 
protein (152). Yeast and human Nrks function in an alternative salvage pathway that 
generates Nicotinamide Adenine Dinucleotide (NAD+) (71,72). Exogenous NAD+ rescues 
MTJ morphogenesis in Nrk2b-deficient zebrafish embryos. Our previous results showing 
a requirement for Nrk2b and NAD+ in initial BM morphogenesis led us to hypothesize 
that activation of the Nrk2b pathway, either through chemical (NAD+ supplementation) 
or gene therapy (Paxillin overexpression) approaches, would be sufficient to activate the 
intrinsic compensation between cell-ECM adhesion proteins and result in a novel method 
of BM augmentation. Herein we will investigate whether the Nrk2b pathway can be 
exploited to augment Laminin polymerization and thus improve muscle tissue structure 
and function in dystrophic embryos.
Zebrafish deficient for Dagl display progressive muscle atrophy (92). Here, we 
show that muscle atrophy is preceded by degeneration of the MTJ BM. As we previously 
showed that Nrk2b is necessary for MTJ BM organization during development, we 
hypothesized that exogenous NAD+ would improve MTJ BM organization in dag1 
morphants. Indeed, supplementation of dag1 morphants with NAD+ or a vitamin 
precursor of NAD+ significantly improved muscle structure. Muscle function was also
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improved: NAD+- or Emergen-C-supplemented dag1 morphants swam faster after a 
touch stimulus. Nrk2 interacts with the cytoplasmic tail of Integrin beta1 in the Integrin 
alpha7beta1 complex (69). Surprisingly, exogenous NAD+ reduced muscle degeneration 
in integrin alpha7 (itga7) morphants, indicating that Itga7 is not the only Integrin in the 
Nrk2b pathway. We find that the mechanism of action of zebrafish Nrk2b involves a 
different Integrin receptor for Laminin, Integrin alpha6 (Itga6 A8WHQ8_DANRE). The 
intracellular cell-ECM adhesion protein Paxillin is downstream of NAD+ during MTJ 
development (152). Paxillin overexpression was sufficient to improve Laminin 
organization and significantly reduce muscle defects in dag1 morphants. Taken together, 
these results suggest manipulation of NAD+ precursors/biosynthetic enzymes and 
Paxillin as new potential therapeutic approaches for treatment of not only muscle 
diseases, but also diseases/syndromes that affect Laminin integrity.
3.3. Materials and Methods
3.3.1. Zebrafish Husbandry/Mutant/Transgenic Lines
Embryos were obtained from natural spawnings of zebrafish kept on a 16 hour 
light/8 hour dark cycle. Embryos were kept at 28.5°C in ERM and staged according to 
(90). Embryos stably overexpressing Paxillin fused to GFP were obtained from pairwise 
spawnings of carriers from the F1 generation of the Tg:paxillin:GFP line described in 
(152). wi390/laminin gamma1-/- embryos (153) were obtained from natural spawnings of 
identified heterozygotes.
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3.3.2. Morpholino Injection
Stable antisense MO oligonucleotides were obtained from Gene Tools, LLC and 
hydrated with sterile water to form 1 mM stocks. The dag1 translation-blocking MO 
sequence has been published (92) and 12.5 ng was injected per embryo. A splice blocking 
itga7 MO has been described (119) and 12.5 ng was injected per embryo. In our hands the 
phenotype was subtle and dystrophy varied between biological replicates. Two itga6 
translation-blocking MOs had the following sequences: MO1 5’- 
AGCTCCATTGCCTGAAATGAATG-3’ and MO2 5’-
CTGTTGTATGAAAAATATAGCCCTT-3’. These two MOs were co-injected so that 
embryos received 9 ng MO1 and 8 ng MO2. The Gene Tools standard control MO 
sequence is: 5’-CCTCTTACCTCAGTTACAAGGGATA-3’. 17 ng of control MO was 
injected as a control for itga6 MO injections. Thep53 MO sequence is: 5’- 
CCCTTGCGAACTTACATCAAATTCT-3’. p53 MO was co-injected 1:1 with itga6 
MOs. MOs were injected into the yolk of 1-2 cell stage embryos using a MPPI-2 pressure 
injector from ASI. For experiments where Paxillin:GFP transgenic and wild-type 
zebrafish were injected with dag1, itga7 or itga6 MOs, embryos from separate spawnings 
of each line were combined prior to injection and separated during imaging based on 
GFP fluorescence.
3.3.3. NAD+ and Emergen-C Treatment
Beta-NAD (10 mg aliquots, Sigma, stored at -20°C) were dissolved to 15 mM 
stocks in ERM. Twenty five embryos per 60 mm Petri dish were grown in 5 mL of ERM
with a final concentration of either 0 or 0.1 mM NAD. Embryos were treated from shield
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stage (6 hpf) through live imaging/fixation and the media were made fresh and changed 
every 24 hours. A new aliquot was used for each change of the NAD-containing media. 
Emergen-C (original formula, registered trademark of Alacer Corporation) 
supplementation followed the above protocol. Emergen-C powder was dissolved in ERM 
such that the final concentration of niacin that embryos were exposed to was 6.77 
micromolar. This concentration was chosen because it is roughly equivalent to what the 
concentration of niacin would be in an adult human bloodstream after consuming the 
contents of one Emergen-C packet (assuming 6 L of blood volume).
3.3.4. Phalloidin Staining and Immunohistochemistry
Embryos were fixed using 4% paraformaldehyde for four hours at room 
temperature or overnight at 4°C. Embryos were washed out of 4% paraformaldehyde at 
least three times with Phosphate Buffered Saline-0.1% Tween20 (PBS-0.1%Tw). Prior to 
phalloidin staining, embryos were permeabilized for 1.5 hours at room temperature with 
PBS-2%Trition. Embryos were incubated in Alexa fluor 488 or 546 phalloidin 
(Molecular Probes) at a 1:20 dilution overnight at 4°C. Antibody staining followed 
phalloidin staining or began with an incubation in block (5% w/v Bovine Serum Albumin 
in PBS-Tw) for at least one hour at room temperature. Embryos were incubated in 
primary antibody overnight at 4°C, washed in block for two to eight hours at room 
temperature, and then incubated in secondary antibody overnight at 4°C. Embryos were 
washed in PBS-0.1%Tw prior to imaging. Primary antibodies: polyclonal anti- 
Laminin-111 (Thermo Scientific, 1:50 dilution in block), monoclonal anti-Paxillin (BD
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Biosciences, 1:50 dilution in block). Secondary antibodies: GAM/GAR 488, 546, 633 
(Invitrogen, 1:200 dilution in block).
3.3.5. Genetic Mosaic Analysis
Embryos (1-2 cell stage) were injected with dag1 MOs and 10,000 MW dextrans 
(Molecular Probes). Morphant cells were removed at the sphere stage and transplanted 
into unlabeled control hosts. Hosts were grown to the appropriate stage, fixed and stained 
with phalloidin.
3.3.6. Westerns
Immunodetection of Paxillin was conducted using preparations from 2 dpf embryos 
as previously described (152). Protein concentration was quantified using a Nanodrop 
spectrophotometer and sample concentrations were normalized prior to loading. Band 
intensities were quantified in NIH Image J (http://lukemiller.org/journal/2007/08/ 
quantifying-western-blots-without.html).
3.3.7. In Situ Hybridization
ISHs were done as previously described (152) with serial washes into and out of 2X 
SSC occurring before incubation in anti-digoxygenin antibody.
3.3.8. Two-Dimensional Wavelet Transform Modulus Maxima
This rigorous and objective method of image quantification was applied as 
previously described in (103,152).
3.3.9. Motility Assay
Two concentric circles were drawn on an overhead projector transparency. The 
inner circle with a diameter of 5 mm and the outer circle with a diameter of 10 mm. A 60
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mm Petri dish containing ERM was placed on top of the concentric circles. An embryo 
was placed in the Petri dish and aligned to the middle of the inner circle. A video was 
recorded (see Imaging section below) of each embryo being poked with the end of fishing 
wire and the time that it took for the embryo to leave the field of view was documented. 
Embryos with abnormal escape responses were poked multiple times and the most robust 
escape response was recorded and used for analysis. For comparison of average escape 
response time between groups, embryos that were unable to exit the field of view were 
assigned a time value equal to that of the slowest embryo within an experiment that could 
exit the field of view (the value was determined after biological replicates of the same 
experiment had been combined).
3.3.10. Imaging
Images were collected and processed as described in (152). Videos were acquired on 
a Zeiss Discovery.V12 microscope with a high-speed digital camera.
3.3.11. Statistical Analyses
Error is reported as standard error of the mean and significance was calculated 
using two-tailed, paired, student t-tests with p<0.05 being considered significant.
3.3.12. Measuring Myotome Boundary Angles
Early MTJ morphogenesis was assayed through MTJ angle measurements as 
previously described in (152).
3.3.13. Electron Microscopy
Transmission electron microscopy was performed by Dr. Bryan D. Crawford, 
University of Fredericton, New Brunswick. Samples were fixed in Karnovsky’s fixative
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(2% paraformaldehyde from 16% stock, 2.5% glutaraldehyde from 25% stock, 5% 
sucrose, and 0.1% CaCl2 in 0.1 M cacodylate buffer (from 0.2 M cacodylate stock at pH
7.2)). Embryos in Karnovsky’s fixative were shipped to the University of Fredericton, 
New Brunswick where they were post-fixed in oxmium, dehydrated, embeded, sectioned 
(70 nm), stained and imaged.
3.4. Results
3.4.1. NAD+ Supplementation Reduces Muscle Degeneration in dystroglycan 
Morphants
Dystroglycan null mice die around the time of implantation (31). In contrast, 
zebrafish dag1 is maternally expressed, Dag1-deficient zebrafish gastrulate and initial 
muscle fiber development is normal (92). Staining for Laminin-111 in the ECM 
microenvironment of Dag1-deficient zebrafish muscle showed that initial BM 
development is also normal at 1 day post fertilization (dpf) (152). At this point in time, 
Laminin-111 is thought to be the major Laminin heterotrimer present (61). Given the 
critical role of the ECM microenvironment in maintaining fiber integrity, we asked 
whether the MTJ BM degenerates over time. Although Laminin concentrated at the MTJ 
BM in 2 dpf dag1 morphants, staining intensity was variable (white arrowhead, Fig. 3.1 
panel A). 3D reconstruction of Laminin-111 highlighted inconsistencies in the MTJ BM 
in dag1 morphants (Fig. 3.1 panels A1-A2, white arrowheads show holes in the MTJ 
BM). Because we have shown that Nrk2b is necessary for normal organization of the 
MTJ BM at 1 dpf, we asked whether exogenous NAD+ would be sufficient to improve 
MTJ BM structure at 2 dpf in dag1 morphants. Qualitatively, MTJ BM structure appeared
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to be better aligned in the medial-lateral dimension in dag1 morphants supplemented with 
NAD+ compared to untreated dag1 morphants (Fig. 3.1 panel B, Laminin-111 panels). To 
quantify these observations, we used a mathematical formalism, the 2DWTMM 
(97>98’103’152), to interrogate MTJ BM structure. The MTJ BM was significantly more 
organized in NAD+-supplemented dag1 morphants compared to untreated morphants. 
This increased organization is visually represented by the parallel alignment of vectors 
oriented in the direction of the maximal intensity gradient (Fig. 3.1 panels A3, B3). The 
anisotropy factor (a readout of organization) is derived from the sum of the vectors and is 
significantly higher in NAD+-supplemented dag1 morphants (Fig. 3.1 panel C, **p < 
0.01, *p<0.05). Therefore, NAD+ supplementation increases organization of the BM in 
dag1 morphants.
It is not known if detachment of muscle fibers from the MTJ BM contributes to 
human muscular dystrophies because biopsies are excised from the musculature to avoid 
injury to the tendon, but MRI studies do suggest that muscle damage is more severe 
closer to the MTJ (66,67). In dystrophic zebrafish, muscle fibers detach from the MTJ prior 
to apoptosis in laminin alpha2 (59), laminin beta2 (21), and dag1 mutants (122), implicating 
failure of muscle fiber-MTJ adhesion as the primary etiology in these models of muscular 
dystrophy. We hypothesized that the increased organization of the MTJ BM in NAD+- 
supplemented Dag1-deficient zebrafish would reduce the frequency of muscle fiber 
detachment. The ordered array of myofibers in wild-type skeletal muscle results in 
birefringence of polarized light (154). Muscle degeneration in dag1 morphants results in
gaps in birefringence (Fig. 3.2 panel A, white arrowheads). Birefringence was improved
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Figure 3.1. Exogenous NAD+ Improves the Structure of Muscle in dag1 Morphants. 
(A-B) Anterior left, dorsal top, side mounted 2 dpf embryos stained for actin (phalloidin, 
red) and Laminin-111 (green or white). Qualitatively, Laminin-111 antibody staining 
appears to be within myotomes and less well aligned at the MTJ BM in dag1 morphants 
(A) compared to dag1 morphants treated with 0.1 mM NAD+ (B). White boxes in A and 
B correspond to numbered panels below. White arrowheads indicate holes in the MTJ 
BM. (A3, B3) 2DWTMM analysis of Laminin-111 stained dag1 morphants (A3) and 
NAD+-supplemented dag1 morphants (B3). Maxima nodes are in red, maxima chains 
are in blue and vectors pointing in the direction of the maximum intensity gradient are in 
green. Parallel vectors reflect greater organization. (C) Quantification of the anisotropy 
factor. The anisotropy factor is the sum of the vector angles. A greater anisotropy factor 
denotes more organization. NAD+ treatment of dag1 morphants (blue bars) significantly 
increases organization of Laminin-111 compared to dag1 morphants (gray bars) over 
multiple size scales, *p<0.05, **p<0.01. (D) Model of the MTJ. Transmembrane 
receptors, Integrins and the DGC bind extracellular Laminin. In dag1 morphants, 
Laminin is less organized at the MTJ BM. Exogenous NAD+ improves Laminin 
organization in the MTJ BM in Dag1-deficient zebrafish. Scale bar is 50 micrometers.
A: 2 dpf dagl MOs B: 2 dpf dagl MOs+O.ImM NAD+
Focal plane 3D projection Focal plane 3D projection
1.88 3.27 5.69 9.90 17.24
micrometers
in NAD+-supplemented dag1 morphants (Fig. 3.2 panel A). We next used phalloidin 
staining to visualize detached muscle fibers and quantitatively assess muscle 
degeneration. The percent of muscle segments per embryo with detached muscle fibers
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was significantly reduced in dag1 morphants supplemented with NAD+ compared to 
untreated dag1 morphants (Fig. 3.2 panels B-D, white arrowheads indicate detached 
fibers, **p<0.01). These data show that NAD+ is sufficient to improve birefringence and 
reduce detachment of muscle fibers.
NAD+ is synthesized via multiple different pathways. Nrk2 is part of an 
alternative salvage pathway that mediates NAD+ biosynthesis (71,72). In addition, 
Tryptophan and vitamin B3 (niacin, niacinamide, nicotinamide or nicotinic acid) are 
NAD+ precursors. We next asked whether vitamin supplementation would result in an 
outcome similar to addition of exogenous NAD+. We choose Emergen-C packets for 
vitamin B3 supplementation because they: (1) are soluble in Embryo Rearing Medium 
(ERM) and do not disrupt development (data not shown), and (2) contain 5 mg niacin. As 
shown in Figure 3.2 panel D, addition of Emergen-C significantly reduced muscle 
degeneration in dag1 morphants compared to non-supplemented morphants. This result 
implicates the complex of B vitamins in Emergen-C as potent precursors of NAD+ in 
zebrafish and in promoting muscle health in genetic diseases.
In addition to using the 2DWTMM, polarized light and phalloidin staining assays to 
visualize and quantify changes in muscle tissue structure, we also utilized transmission 
electron microscopy. Electron microscopy showed that NAD+ supplementation did not 
affect muscle structure in control embryos (Fig. 3.2 panels E-F), but improved structure 
in dag1 morphants. Electron microscopy revealed deficiencies in the MTJ of dag1 
morphant muscle. Abnormal gaps in the MTJ BM were observed (Fig. 3.2 panel G, red
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arrows). In NAD+-supplemented dag1 morphants, BM structure was improved (Fig. 3.2 
panel H, white arrow).
3.4.2. A Normal MTJ BM Microenvironment is Sufficient to Rescue the Structure of 
Dystrophic Muscle
NAD+ supplementation significantly increases MTJ BM organization prior to the 
onset of dystrophy. This result suggests that the mechanism of action of NAD+ could be 
through BM augmentation. If NAD+ supplementation reduces the incidence of dystrophy 
via Laminin augmentation, NAD+ would not protect against muscle degeneration in 
laminin mutant zebrafish. We asked if Laminin is required for NAD+-mediated 
amelioration of dystrophy by utilizing laminin gamma1 mutant zebrafish, which display 
muscle degeneration starting at 3 dpf (Fig. 3.2 panel I, Laminin gamma1 UniProtKB
accession number Q1LVF0 LAMC1_DANRE). laminin gamma1 mutants supplemented
with exogenous NAD+ showed no improvement in the incidence of dystrophy compared 
to untreated mutants (Fig. 3.2 panels I-J). This result shows that Laminin is required for 
NAD+-mediated reduction of fiber detachment and supports our hypothesis that the 
protective effects of NAD+ occur through BM augmentation. This result also aligns with 
our previous finding that NAD+ reduces MTJ failure in 2 dpf nrk2b morphants, but not 
laminin beta1 morphants (152). Together, these results strongly suggest that the protective 
effects of NAD+ supplementation on MTJ failure and fiber detachment result from 
augmentation of Laminin in the BM.
We used genetic mosaic analysis to further test our hypothesis. If the DGC is
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required cell autonomously for maintenance of muscle fiber adhesion, we would predict 
that dag1 morphant cells in control hosts would degenerate as observed in dag1 
morphants. If, however, a normal BM provides a supportive environment for muscle 
fibers, we would predict that dag1 morphant cells would be less likely to degenerate in 
control embryos. To discriminate between these two outcomes, we transplanted 
fluorescent dextran-labeled dag1 morphant cells into control embryo hosts at the blastula 
stage, grew the embryos until 3 dpf, and asked whether dag1 morphant cells were viable 
(Fig. 3.2 panel K). The vast majority of dag1 morphant cells were viable (Fig. 3.2 panel 
L). Only 10 out of 523 transplanted dag1 morphant cells (1.9%) detached from the MTJ 
BM. The incidence of fiber detachment per embryo in transplant hosts was significantly 
less than in dag1 morphant embryos (p < 0.001). In addition, dag1 morphant cells fused 
with fluorescent dextran-labeled control cells (Fig. 3.2 panel L, fusion indicated by pink 
cells). A more rigorous test of our hypothesis would be to ask whether Dag1-deficient 
cells are more likely to detach in control hosts when muscle tissue is stressed. We 
repeatedly stimulated transplant host embryos to swim through a viscous medium as 
described previously (59). Of the 491 Dag1-deficient cells analyzed in 15 stressed host 
embryos, only 12 cells (2.4%) detached from the MTJ. Although a higher percentage of 
morphant cells detached in stressed hosts versus non-stressed hosts, the incidence of 
dystrophy per embryo did not significantly differ depending on stress (Fig. 3.2 panel M, 
p=0.81) and was still significantly different than in dag1 morphants (p<0.001). These 
data clearly indicate that local integrity of the ECM microenvironment is sufficient for
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muscle cell adhesion and that Dag1 is not required cell autonomously for maintenance of 
this adhesion.
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Figure 3.2. An Organized ECM Microenvironment Rescues Fiber Resiliency in Dagl- 
Deficient Cells. (A) Anterior left, dorsal top, side mounted, 3 dpf embryos. Polarized 
light microscopy shows loss of birefringence in dagl morphant myotomes (white 
arrowheads). Birefringence is rescued in NAD+-supplemented dagl morphants. (B, C, I, 
J, L) Anterior left, dorsal top, side mounted, 3 dpf embryos stained with phalloidin (white 
or green). Fiber detachment is readily observed in dagl morphants (B, white arrowheads) 
whereas dagl morphants supplemented with NAD+ display less fiber detachment (C).
(D) Compared to dagl morphants (gray bars), NAD+ supplementation (blue bar) and 
vitamin supplementation with Emergen-C (purple bar) significantly reduce fiber 
detachment, **p<0.01. (E-H) Transmission electron micrographs showing normal BMs 
(white arrows), normal sarcomeres (white arrowheads), disrupted BMs (red arrows) and 
disrupted sarcomeres (red arrowheads). Note that sarcomeres are disrupted adjacent to 
abnormal BMs in dagl morphants (G) and that NAD+ rescues these disruptions (H). (I) 
The dystrophic phenotype of 3 dpf sly/laminin gammal mutant zebrafish. White 
arrowhead points to detached fibers. (J) NAD+ does not rescue the dystrophic phenotype 
in sly mutants, suggesting that NAD+-mediated amelioration of dystrophy requires 
Laminin. (K) Genetic mosaic cartoon depicting transplantation of fluorescent dextran- 
labeled dagl morphant (red) and control (blue) cells into unlabeled, control hosts. Some 
embryos were stressed (frequently stimulated to swim in a viscous medium) and all hosts 
were reared to 3 dpf. (L) Transplanted control cells (blue) and dagl morphant cells (red) 
remain attached to MTJs, even when hosts are stressed. This suggests that a normal host 
ECM microenvironment is sufficient for resiliency of dagl morphant cells and supports 
that NAD+ functions via augmentation of the ECM microenvironment. (M) The vast 
majority of Dag1-deficient cells remain attached in unstressed (513/523 Dag1-deficient 
cells were attached) and stressed hosts (479/491 Dag1-deficient cells were attached),
N.S. = not significant. Scale bars are 50 micrometers in B and J and 5 micrometers in E­
H.
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3.4.3. Itga7 is Required for NAD+-Mediated Reduction of Dystrophy in dagl 
Morphants
The two ‘canonical’ Laminin receptors in muscle tissue are the DGC and Integrin 
alpha7beta1 receptor complexes. Itga7 is disrupted in CMD with Integrin deficiency (155). 
As the DGC is not required for NAD+-mediated reduction of dystrophy (Fig. 2), we 
asked if Itga7 is required for the amelioration of dystrophy in dag1 morphants by 
exogenous NAD+. A zebrafish model of CMD with Integrin deficiency has been 
generated (119,150). Muscle degeneration in itga7 morphants is apparent at approximately
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4.5 dpf. One critical axis to consider when evaluating muscle homeostasis is whether 
initial muscle morphogenesis is disrupted. It is not known if initial muscle development 
proceeds normally in itga7 morphants. We analyzed muscle morphogenesis at 26 hpf and 
found that both MTJ and muscle fiber development appeared normal (Fig. 3.3 panels A­
B). We next generated dag1;itga7 double morphant embryos by co-injecting half the 
functional doses of dag1 and itga7 MOs. Surprisingly, given that early MTJ 
morphogenesis appears grossly unaffected in single morphants, MTJ morphogenesis was 
disrupted in double morphants. MTJ angles were abnormally wide (Fig. 3.3 panels C, E), 
similar to laminin beta1 and gamma1 mutant embryos (93). This disruption in MTJ 
development is dramatically greater than would be predicted based upon the individual 
phenotypes and suggests Dag1 and Itga7-mediated adhesion to Laminin is synergistically 
required for MTJ morphogenesis. This was suprising given that MTJ morphogenesis 
appears normal in single morphants. We next asked whether exogenous NAD+ would 
rescue initial MTJ morphogenesis in dag1;itga7 morphants (Fig. 3.3 panel D). We found 
that MTJ angles in NAD+-supplemented dag1;itga7 morphants were significantly 
different from untreated double morphants (Fig. 3.3 panel E, 103.03 +/- 1.41 degrees vs. 
107.74 +/- 1.16 degrees respectively, **p < 0.01, *p < 0.05). Thus, NAD+ 
supplementation is sufficient to rescue early morphogenetic events that require adhesion 
to Laminin in a Dag1 and Itga7-independent manner.
The above data indicate that Itga7 and Dag1 are synergistic with regards to initial
muscle development but NAD+ supplementation is sufficient to improve MTJ
development in itga7;dag1 double morphant embryos. We next asked whether Itga7 is
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required for NAD+-mediated reduction of dystrophy in dag1 morphants. We found that 
NAD+ supplementation was not sufficient to significantly reduce the percent of muscle 
segments with fiber detachment in double morphants (Fig. 3.3 panel F, p=0.2). However, 
qualitatively, fewer fibers per myotome were detached (compare Fig. 3.3 panels C to D, 
we were unable to reliably count detached fibers in myotomes with severe degeneration 
and thus could not quantitate this observation). Taken together, these data indicate that 
Itga7 is required for NAD+-mediated reduction of dystrophy in dag1 morphants and that 
NAD+ supplementation is not sufficient to reduce the frequency of myotomes with 
muscle degeneration when both canonical Laminin receptors (Dag1, Itga7) are 
compromised.
The above data clearly show that Itga7 plays a role in NAD+-mediated reduction of 
dystrophy in dag1 morphants. Interestingly, two results suggest that an additional 
Laminin receptor participates in muscle development and homeostasis: (1) NAD+ 
supplementation rescues early MTJ morphogenesis in dag1;itga7 double morphants, and 
(2) overall muscle structure is qualitatively improved with NAD+ supplementation in 
dag1;itga7 double morphants. A key experiment to clarify whether an additional Laminin 
receptor also participates is to ask whether NAD+ supplementation is sufficient to reduce 
dystrophy in itga7 morphants. NAD+ supplementation significantly reduced the 
incidence of dystrophy in itga7 morphants (Fig. 3.3 panels G-I, ***p<0.001). This result 
indicates that there is an additional, “non-canonical” Laminin receptor that mediates 
Laminin signaling downstream of NAD+ during musculoskeletal homeostasis.
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Figure 3.3. Itga7 is Required for NAD+-Mediated Reduction of Fiber Degeneration in 
dagl Morphants. (A-D, G-H) Anterior left, dorsal top, side mounted embryos stained 
with phalloidin (red or white) or pY397 FAK (green). (A-B) Muscle morphogenesis 
proceeds normally in itga7 morphants. Phosphorylated FAK (green) outlines fibers and 
concentrates at the MTJ and actin distribution in slow- and fast-twitch muscle fibers 
(red) appears normal in 26 hpf itga7 morphants compared to wild-types. (C) 3 dpf 
dag1;itga7 double morphant. (D) 3 dpf NAD+-supplemented dag1;itga7 double 
morphant. MTJ morphogenesis is disrupted in dag1;itga7 double morphants as displayed 
by wider MTJ angles (C). MTJ morphogenetic defects were rescued by NAD+ in 
dag1;itga7 double morphants (D), suggesting that another Laminin receptor is sufficient 
for NAD+-mediated MTJ improvements. (E) Quantification of MTJ angles shows that 
dag1;itga7 double morphants have significantly wider MTJ angles than wild-types and 
NAD+ significantly reduces this defect, **p<0.01, *p<0.05. (F) Quantification of 
incidence of dystrophy per embryo shows no significant difference in dag1;itga7 double 
morphants upon addition of exogenous NAD+, suggesting that Itga7 is required for NAD 
+-mediated reduction of dystrophy in dag1 morphants, N.S. = not significant. However, 
fewer fibers appeared to detach in dag1;itga7 double morphants supplemented with 
NAD+ (D), again suggesting the involvement of another receptor for Laminin in NAD+ 
action. (G-H) Mild fiber detachment is readily observed in 4 dpf itga7 morphants (G) 
and reduced in NAD+-treated itga7 morphants (H). (I) NAD+ treatment significantly 
decreases fiber degeneration in itga7 morphants, ***p<0.001. (J) Model of cell adhesion 
at the MTJ. The transition from a somite boundary to a MTJ involves the downregulation 
of Fibronectin and the upregulation of Laminin and Laminin receptors. Our results 
suggest that Laminin receptors, Itga7 and Dag1, play a role in this transition, but the 
primary receptor involved is an unknown Integrin. In maintenance of fiber adhesion at 
the MTJ, our data show that either Itga7 or Dag1 is required, but also suggest the 
involvement of an additional Laminin receptor. Scale bar is 50 micrometers.
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3.4.4. Itga6 is Required for NAD+-Mediated Improvement of Muscle Tissue 
Structure
The above data indicate that the primary beneficial effect of NAD+ on muscle 
architecture is increased organization of Laminin in the BM. However, neither of the two 
Laminin receptors known to be required for muscle structure (Dag1, Itga7) are required 
individually for NAD+-mediated reduction of dystrophy (Figs. 3.2, 3.3). In order to 
identify mechanisms downstream of Laminin, we focused on identifying the relevant
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Laminin receptor. The Laminin-binding family of Integrin alpha chains that partner with 
Integrin beta1 includes alpha3, alpha6 , and alpha7 (156). Only two of these chains, itga6 
and itga7, are expressed during zebrafish muscle development (119, Thisse, B. and Thisse 
C., http://zfin.org, Fig. 3.4 panel A). Expression of itga6 is high during initial muscle 
development, and then declines. This correlates with the low level expression of itga6 in 
human muscle (157).
Interestingly, itga6 has recently been implicated in muscle development and 
regeneration in multiple mammalian species (158-161). We asked whether itga6 expression 
is upregulated in dag1 morphant zebrafish in dystrophic lesions where regeneration is 
occuring. As in other vertebrates, itga6 expression was low in zebrafish muscle, but 
clearly visible in dystrophic lesions (Fig. 3.4 panel B, red arrowheads). Given these 
recent results, combined with our data showing upregulation of itga6 in dag1 morphants, 
we hypothesized that Itga6  is involved in the Nrk2b-NAD+-Laminin pathway. We tested 
this hypothesis by using morpholino (MO)-mediated knockdown. We first characterized 
MOs against itga6. Injection of varying amounts/combinations of two different, non­
overlapping, translation-blocking MOs showed that both MOs generated the same 
phenotype and acted synergistically (Fig. 3.4 panels C-I). The itga6 morphant phenotype 
was nearly identical to that of laminin beta1 and gamma1 mutants and nrk2b morphants 
(103,152). This striking phenotypic similarity suggested that itga6 may function in the 
Nrk2b-NAD+-Laminin pathway. To confirm that Itga6  acts in Laminin signaling/ 
adhesion, we conducted pseudo-genetic epistasis analysis. The transcripts for laminin 
beta1 and gamma1 are maternally expressed. Thus injection of laminin beta1/gamma1
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MOs into laminin beta1/gamma1 mutants slightly worsens the phenotype (162). Injection 
of itga6 MOs into laminin gamma1 mutants also slightly worsened the phenotype (Fig. 
3.4 panels J-M), but average MTJ angles were not significantly different in itga6;lammm 
gamma1 morphant/mutants compared to laminin gamma1 mutants (Fig. 3.4 panel N). 
Together, these data indicate that these MOs are specific and do not cause off target 
effects (100). The above results also suggest that Itga6  does participate in Laminin 
signaling/adhesion.
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Figure 3.4. itga6 is Upregulated in Regenerating Muscle and Characterization of itga6 
MOs. (A) In situ hybridizations showing itga6 expression (purple). (A1-2) Dorsal view, 
anterior top. (A3-4, B) Side view, anterior left, dorsal top. (A1-4) Black arrowheads 
denote somitic expression. itga6 expression is high during early muscle development, 
then decreases. (B) itga6 is re-expressed in regenerating muscle. itga6, not normally 
expressed in muscle at 4 dpf, is observed in dystrophic lesions of 4 dpf dagl morphants 
(red arrowheads). (C) itga6 MO characterization. Dose response graph. MO1 and MO2 
generate the same phenotype and synergize when co-injected. (D-M) Brightfield images, 
side view, anterior left, dorsal top, 1 dpf embryos. (D-I) Phenotypic analysis of itga6 
MOs 1 and 2. Embryos injected with low doses of MO1 (E) or MO2 (F) are 
morphologically similar to controls (D). Combining the two lower doses of MOs 1 and 2 
results in a truncated body axis with myotomes that are narrower in the anterior-posterior 
dimension (G). The identical phenotype is obtained when higher doses of either MO1 
(H) or MO2 (I) are injected. (J-M) Pseudo-genetic epistasis analysis. (J) Siblings, (K) 
itga6 morphants, (L) wi390-/-/laminin gammal mutants, (M) itga6 MOs;wi390-/-. Note 
that injection of itga6 MOs into laminin mutants does not change their phenotype, 
suggesting Itga6 functions in Laminin signaling and adhesion. (N) Average MTJ angles 
of 1 dpf embryos. MTJ angles in morphants, mutants and morphant/mutants do not 
significantly differ from one another and are all significantly wider than in sibling 
controls, **p<0.01, N.S. = not significant.
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Although somite patterning was relatively normal and somite boundaries formed in 
these embryos (data not shown), by 2 dpf approximately 25% of the MTJs had failed 
(Fig. 3.5 panel B red arrows, 3.5 panel D). Abnormally long muscle fibers crossed the 
MTJ at sites of MTJ failure (Fig. 3.5 panel B1, MTJs pseudocolored blue and crossing 
fibers pseudocolored red). One possible side affect of MOs is that they can activate p53- 
dependent apoptosis and cause non-specific cell death (101). Co-injection withp53 MO 
did not alter the phenotype of itga6 morphants (Fig. 3.5 panels C, D). Co-injection of 
itga6 MOs with itga6 cDNA lacking the MO target sites rescued the morphant phenotype 
(Fig. 3.5 panels E, F), further suggesting that these itga6 MOs are specific (100).
NAD+ functions upstream of Laminin polymerization during MTJ development
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(152), thus, we hypothesized that itga6 morphants would not be rescued by NAD+ 
supplementation. Neither exogenous NAD+ nor Emergen-C (data not shown) were 
sufficient to rescue MTJ failure at 2 dpf in itga6 morphants, indicating that Itga6  
functions in this pathway downstream of NAD+ (Fig. 3.5 panel G, p=0.99 for NAD+). 
Although itga6 morphants were slightly dystrophic (data not shown), the frequency of 
dystrophy was too rare to readily ask whether NAD+ supplementation is sufficient to 
reduce dystrophy in itga6 morphants. Taken together, these data suggest that Itga6  
functions in this pathway downstream of NAD+.
Given the requirements for Itga6  in muscle development in mouse (158) and our data 
showing that Itga6  is required in zebrafish muscle development, we asked whether Itga6  
is required to mediate reduction of dystrophy in dag1 morphants. We co-injected itga6 
and dag1 MOs and assayed the incidence of dystrophy in response to NAD+ 
supplementation (Fig. 3.5 panels H-I). As with co-injection of itga7 and dag1 MOs, 
initial MTJ morphogenesis was disrupted: myotomes were narrower in the anterior- 
posterior dimension and wider in the medial-lateral dimension. In contrast to dag1;itga7 
double morphants, NAD+ supplementation was not sufficient to improve MTJ 
morphogenesis in dag1;itga6 double morphants (data not shown, average MTJ angle for 
dag1;itga6 morphants: 143.98 +/- 3.08 degrees, average MTJ angle for NAD+-treated 
dag1;itga6 morphants: 139.50 +/- 3.52 degrees, p=0.35). This result indicates that Itga6  
is the Laminin receptor required for the role of NAD+ in MTJ morphogenesis. NAD+ 
supplementation also did not ameliorate muscle degeneration in dag1;itga6 double
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morphants (Fig. 3.5 panel J, p=0.78). This result indicates that Itga6  is also required for 
NAD+-mediated amelioration of dystrophy in dag1 morphants.
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Figure 3.5. Itga6 is Required for NAD+-Mediated Rescue of MTJ Morphogenesis and 
Dystrophy. (A-C, E-F, H-I) Anterior left, dorsal top, side mounted, 2 dpf embryos stained 
with phalloidin (white) to visualize actin. In pseudocolored panels (A1, B1, C, E, F),
MTJ boundaries are blue and abnormally long muscle fibers are red. (A) MTJs are V- 
shaped and continuous in control embryos. (B) In itga6 morphants, MTJs are U-shaped, 
discontinuous and crossed by abnormally long muscle fibers (red arrows). (C) Co­
injection ofp53 MOs does not rescue MTJ failure in itga6 morphants. (D) Quantification 
of MTJ failure at 2 dpf in controls, itga6 morphants and itga6;p53 double morphants. (E- 
F) Co-injection of itga6 cDNA that does not contain the MO target sites with itga6 MOs 
rescues the itga6 morphant phenotype. (G) Quantification of MTJ failure shows that 
NAD+ treatment does not rescue MTJ failure in itga6 morphants, suggesting that NAD+ 
requires Itga6 for rescue of MTJ failure. (H) dag1;itga6 double morphants have U- 
shaped MTJs and dystrophy (white arrowheads). (I) NAD+ does not reduce MTJ angles 
(not shown) or dystrophy in dag1;itga6 double morphants, suggesting that Itga6 is also 
required for NAD+-mediated rescue of MTJ angles and dystrophy. (J) Quantification of 
dystrophy shows significant rescue by exogenous NAD+ in dagl morphants, but not 
dag1;itga6 double morphants, *p < 0.05, N.S. = not significant. Scale bars are 50 
micrometers.
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3.4.5. Paxillin Overexpression is Sufficient to Increase MTJ BM Structure and 
Decrease Fiber Detachment in dagl Morphants
We previously showed that the Integrin-associated adaptor protein Paxillin 
functions downstream of NAD+ during MTJ development: Paxillin overexpression is 
sufficient to rescue MTJ morphogenesis in nrk2b morphants (152). Thus, likely through 
“inside-out” signaling via Laminin receptors, Paxillin is sufficient to affect the ECM
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microenvironment. We asked whether overexpression of Paxillin would be sufficient to 
augment MTJ BM organization in dystrophic embryos. Paxillin concentration at the MTJ 
was slightly disrupted in dag1 morphants at 26 hpf (Fig. 3.6 panel B). NAD+ 
supplementation improved Paxillin concentration at the MTJ in 26 hpf dag1 morphants 
(Fig. 3.6 panel C). Next, we overexpressed Paxillin in dag1 morphants by injecting dag1 
MOs into Tg:paxillin:GFP embryos. Paxillin:GFP accounted for approximately 66.05 +/- 
8 % of total Paxillin expressed at 2 dpf in Tg:paxillin:GFP embryos (data not shown). 
Paxillin overexpression increased organization of Laminin-111 at the MTJ in 2 dpf dag1 
morphants (compare Fig. 3.6 panel E to D, 2DWTMM analysis not shown: *p < 0.05 for 
wavelets from 1.88 to 4.02 micrometers). Paxillin overexpression also significantly 
reduced the incidence of fiber detachment in 3 dpf Dag1-deficient embryos (Fig. 3.6 
panels F-H, *p<0.05).
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Figure 3.6. Paxillin Overexpression Increases Laminin Organization and Ameliorates 
Dystrophy in dagl Morphants. (A-C) Anterior left, dorsal top, side mounted, 1 dpf 
embryos antibody stained for Paxillin (white). (A) Paxillin concentrates at the MTJ in 
both untreated (not shown) and NAD+-treated controls (white arrows). (B) Paxillin is 
less concentrated at the MTJ in dagl morphants (white arrowheads). (C) NAD+ rescues 
the disrupted concentration of Paxillin at the MTJ in dagl morphants (white arrows). (D- 
E) Anterior left, dorsal top, side mounted, 2 dpf embryos stained with Laminin-111 
antibody (white). Numbered panels are 3D reconstructions. (D) dagl morphant. 
Laminin-111 appears within myotomes and the MTJ BM is poorly aligned medially- 
laterally and contains holes (white arrowheads). (E) In contrast, Paxillin overexpression 
(green) in dagl morphants reduces Laminin-111 within myotomes and enhances 
organization of Laminin-111 at the MTJ BM (white arrows). (F-G) Anterior left, dorsal 
top, side mounted, 3 dpf embryos stained for actin (phalloidin, white). (F) dagl 
morphant with detached fibers (white arrowhead). (G) Transgenic overexpression of 
Paxillin (green) in dagl morphants reduces fiber detachment. (H) Paxillin 
overexpression significantly reduces the frequency of fiber detachment in dagl 
morphants, *p<0.05. (I) Model of cell adhesion at the MTJ in response to Nrk2b pathway 
activation via exogenous NAD+ or Paxillin overexpression. Scale bars are 50 
micrometers.
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As Paxillin does not require Dag1 for BM augmentation-mediated reduction of 
dystrophy (Fig. 3.6), we asked whether Integrin receptors are required. We analyzed both 
the subcellular localization of Paxillin upon Itga6  or Itga7 knockdown as well as the 
ability of transgenic Paxillin overexpression to rescue the muscle defects observed in 
itga6 or itga7 morphants. In itga6 morphants, Paxillin concentrated at the MTJ as in
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control embryos (Fig. 3.7 panels A-B). Paxillin overexpression in itga6 morphants (Fig.
3.7 panel E) did not reduce the incidence of MTJ failure (Fig. 3.7 panel C, p=0.18). 
Paxillin also localized to the MTJ in itga7 morphants (Fig. 3.7 panel G) and Paxillin 
overexpression in itga7 morphants had no effect on the percent of myotomes per embryo 
with dystrophic lesions (Fig. 3.7 panels H-J, p=0.9). As Paxillin is an Integrin adaptor 
protein, it is perhaps not surprising that Paxillin-mediated BM augmentation requires 
functional Integrin receptors for Laminin. Our results suggest that Dag1, but not Itga6  or 
Itga7, is required for localization of Paxillin to the MTJ and that the beneficial effects of 
overexpressing Paxillin in Dag1-deficient muscle tissue may result from increasing the 
amount of MTJ-proximal Paxillin involved in inside-out signaling via Integrin receptors 
for Laminin.
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Figure 3.7. Paxillin Action, but Not Subcellular Localization, Requires Functional 
Integrin Receptors for Laminin. (A-B, D-E) Side mounted, anterior left, dorsal top, 2 dpf 
embryos stained with phalloidin (white). (A-B) Antibody staining shows that Paxillin 
(green) concentrates at the MTJ in itga6 morphants (B) as in controls (A). (C) 
Quantification of MTJ failure shows that Paxillin overexpression does not rescue itga6 
morphants. (D-E) Transgenic overexpression of Paxillin:GFP (green) does not affect 
MTJ development in controls (D) and is not sufficient to rescue MTJ failure in itga6 
morphants (E). (F-G) Anterior left, dorsal top, side mounted, 26 hpf embryos stained for 
Paxillin (white). Paxillin concentrates at the MTJ in itga7 morphants (G) as in controls 
(F). (H-I) Side mounted, anterior left, dorsal top, 4 dpf embryos stained with phalloidin 
(white). Fiber detachment is readily observed in itga7 morphants (H) and itga7 
morphants transgenically overexpressing Paxillin (I, white arrowheads). (J) Paxillin 
overexpression does not affect fiber detachment frequency in itga7 morphants. Together, 
these results suggest that Itga6 and Itga7 are required for Paxillin-mediated 
improvements in muscle tissue. N.S. = not significant. Scale bars are 50 micrometers.
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3.4.6. NAD+ Supplementation Improves the Mobility of Dystrophic Zebrafish
We next asked whether improvements in MTJ BM structure and maintenance of
fiber attachment in dystrophic zebrafish correlated with physiological improvements by
assaying the average time it takes for dystrophic embryos to swim a predetermined
distance following a touch stimulus. Whereas control, NAD+-treated, Emergen-C-
supplemented (not shown) or Tg:Paxillin:GFP control embryos always rapidly exited a
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10 mm diameter circle (Fig. 3.8 panel G), only approximately half of dag1 morphants 
swam out of the circle and were, on average, significantly slower than controls (Fig. 3.8 
panels B, G, ***p<0.001). Dag1 morphants supplemented with NAD+ (Fig. 3.8 panel C) 
or Emergen-C (not shown) were more likely to exit the circle compared to untreated dag1 
morphants and were, on average, significantly faster than untreated dag1 morphants (Fig.
3.8 panel G, *p<0.05 for NAD+, **p<0.01 for Emergen-C). Similarly, NAD+-treated or 
Emergen-C-supplemented (not shown) itga7 morphants were more likely to exit the 
circle (Fig. 3.8 panel E) and were, on average, significantly faster (Fig. 3.8 panel G, 
**p<0.01 for NAD+, *p<0.05 for Emergen-C) than unsupplemented itga7 morphants 
(Fig. 3.8 panel D). These data suggest that NAD+ or Emergen-C treatment is sufficient to 
improve mobility in Dag1 or Itga7-deficient zebrafish. Interestingly, however, 
Tg:paxillin:GFP embryos injected with dag1 MOs or itga7 MOs actually tended to be 
slower than dag1 or itga7 morphants, respectively (Fig. 3.8 panels F, G). These results 
indicate that improving basement membrane structure in dystrophic zebrafish by 
overexpressing Paxillin is not sufficient to improve mobility.
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Figure 3.8. NAD+ Supplementation, but Not Paxillin Overexpression, Improves Motility 
of Dystrophic Zebrafish. (A-F) Individual panels from videos of escape responses after a 
touch stimulus at 2 dpf, time in milliseconds is denoted on panels. The outer circle is 10 
mm in diameter. Red arrowheads point to the embryo’s location. (A) Control embryo.
(B) dagl morphant. (C) NAD+-supplemented dagl morphant. (D) itga7 morphant. (E) 
NAD+-supplemented itga7 morphant. (F) dagl MOs;Tg:paxillin:GFP embryo. (G) 
Average escape response times of 2 dpf dystrophic zebrafish after exogenous NAD+ 
treatment or overexpression of Paxillin. Exogenous NAD+ or Emergen-C (not shown) 
significantly reduced the escape times of both dagl and itga7 morphants.
Overexpression of Paxillin, however, did not reduce escape times of dagl or itga7 
morphants. * p<0.05, **p<0.01, ***p<0.001, N.S. = not significant. (H) Model of cell 
adhesion at the MTJ. Our data show that Laminin polymerization is necessary and 
sufficient for muscle fiber homeostasis and that NAD+ and Paxillin increase Laminin 
polymerization. We find that Dagl and Nrk2b are required for Paxillin localization to the 
MTJ. We hypothesize that NAD+, through mediating Paxillin concentration at MTJs, 
invokes ‘inside-out’ signaling through Laminin receptors that results in increased 
Laminin polymerization.
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3.5. Discussion
Tissue homeostasis, especially when tissue is stressed, requires cellular adaptations. 
Such adaptations are executed by a variety of mechanisms and lead to numerous potential 
outcomes such as hypertrophy, hyperplasia, and metaplasia, among others. Interactions 
between cells and their ECM microenvironment may play roles in skeletal muscle 
adaptation because cell-ECM adhesion complexes sense multiple types of physiological 
changes and interface with every major signaling pathway. Thus, cell-ECM adhesion
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complexes are in a prime position to facilitate appropriate responses to physiological 
change. However, in muscle disorders such as muscular dystrophies, sarcopenia, and 
denervation injuries, tissue structure is disrupted to such a degree that normal cellular 
adaptive responses are not sufficient to compensate. In zebrafish embryos deficient for 
Dag1 or Itga7, transmembrane receptor proteins involved in anchoring the sarcolemma of 
muscle cells to the BM, the consequence of disrupted cell adhesion is detachment and 
death of muscle fibers (92,119). Here, we show that addition of a small molecule, NAD+, is 
sufficient to increase the organization of the muscle cell microenvironment in dystrophic 
zebrafish. Exogenous NAD+ is sufficient to reduce dystrophy when either Itga7 or Dag1 
is compromised because this pathway also functions through a different Laminin 
receptor, Itga6 . Pseudo-genetic epistasis experiments show that either Dag1 or Itga7 is 
required with Itga6  for the effects of exogenous NAD+ on reduction of dystrophy.
Finally, we show that NAD+ plays a dual role in ameliorating dystrophy: NAD+- 
mediated Paxillin clustering improves muscle structure and adhesion, but NAD+ acts 
independently of Paxillin to improve motility. Taken together, these data provide 
fundamental new insights into the adaptability of cell adhesion mechanisms in vivo, and 
the phenotypic consequences of this adaptability.
3.5.1. The ECM Microenvironment: A Dynamic Structure Sufficient to Guide 
Morphological Change
A fundamental question is how tissue architecture is generated and maintained 
during development and homeostasis. The mechanical linkage of cells to BMs,
substructures in the ECM, is necessary for cell viability and physiological homeostasis.
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Laminins are heterotrimeric proteins necessary for BM assembly. laminin mutations lead 
to multiple diseases including myopathies, junctional epidermolysis bullosa, laryngo- 
oncho-cutaneous syndrome, and microcoria-congenital nephritic syndrome (126). Tissue 
specific function of Laminin isoforms arises not only through regulated expression, but 
also through the generation of splice variants and post-translational glycosylation and 
processing. Despite the apparent tissue specificity of Laminin function, multiple 
experiments indicate that, at least in the context of muscle biology, alternate BM 
components can partially compensate and restore cell-ECM adhesion when one Laminin 
chain is disrupted. Mutations in laminin alpha2 cause a severe congenital muscular 
dystrophy, MDC1A. Overexpression of either Laminin alpha1, Laminin-111 or mini- 
agrin, an ECM protein that can link with the DGC, slows the progression of dystrophy in 
laminin alpha2 mutant mice (14-16>23). Recent data indicate that Laminin-111 protein 
therapy can also reverse muscle disease even when the gene mutated encodes an 
intracellular protein. Injection of Laminin-111 protein directly into muscle of DMD mice 
dramatically improves muscle structure and function by increasing Itga7 expression (22).
Here, we show that disorganized Laminin-111 in the MTJ BM of Dag1-deficient
zebrafish muscle tissue can be significantly improved by exogenous NAD+. We implicate
Laminin-111 organization in prolonging cell-ECM adhesion and fiber viability by
showing that laminin gamma1 is required for NAD+-mediated reduction of fiber
detachment. Furthermore, we used genetic mosaic analysis to directly assess the role of a
normally organized MTJ BM microenvironment on cell-ECM adhesion and muscle fiber
viability in Dag1-deficient muscle cells. dag1 MO-injected cells were transplanted into
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control embryos. Dag1-deficient muscle cells developed normally, and sarcomeres 
formed in the viable Dag1-deficient fibers. Significantly, only 1.9% of Dag1-deficient 
fibers in control embryos detached from the wild-type ECM microenvironment. Our 
findings suggest that proper organization of the ECM microenvironment plays a crucial 
role in maintenance of cell-ECM adhesion and fiber viability and thus muscle tissue 
homeostasis. Another striking example of how the ECM microenvironment impacts 
muscle cells is seen in how sarcomere morphogenesis changes depending upon the elastic 
moduli of hydrogels. The highest percent of sarcomerogenesis (60%) was observed after 
culture on a relatively elastic hydrogel (15 kPa) (163). Taken together, these data not only 
suggest that the composition and physical properties of the ECM influence muscle 
structure, but that local organization of the ECM can be dynamic and organizational state 
plays a critical role in muscle cell health. In addition, these data raise the possibility that a 
better understanding of the effects of ECM dynamics on cell and tissue morphogenesis 
and homeostasis, and the use of supplements like NAD+ to increase ECM organization, 
could improve in vitro tissue synthesis and regenerative medicine.
3.5.2. Unique and Redundant Roles for the Laminin Receptor Proteins Integrin 
alpha7, Integrin alpha6, and Dystroglycan
Many studies have highlighted the complex, dynamic, and redundant interactions 
between Integrin alpha7beta1 and the DGC in muscle disease. Although both of these 
Laminin receptors have unique functions (149), they can partially compensate for each 
other in adhesion to Laminin. Expression of the uncompromised complex’s components 
can be upregulated in dystrophy, mutations in both complexes exacerbate dystrophy, and
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overexpression of alternate complex components can alleviate dystrophy (36,37,41,43,44). 
Because exogenous NAD+ ameliorates dystrophy in embryos deficient for the DGC, we 
predicted that Integrin alpha7beta1 would be required for reduction of dystrophy in dag1 
morphants. In support of this, we found that the frequency of myotomes with muscle 
degeneration in dag1;itga7 double morphants was not significantly improved by NAD+. 
Surprisingly, however, overall muscle structure improved in NAD+-supplemented 
dag1;itga7 double morphants. This result suggests: (1) the existence of an additional 
Laminin receptor downstream of NAD+ in the Nrk2b pathway, and (2) this receptor 
partially compensates when Dag1 and Itga7 are disrupted. We identified this receptor as 
Itga6 . Compared to Itga7 and Dag1, far less is known about Itga6  function. Mutations in 
human itga6 lead to epidermolysis bullosa with pyloric atresia (severe skin blistering 
with life threatening obstruction of the digestive tract). The mouse itga6 mutant is even 
more severe; mutant embryos die at birth with severe skin blistering (164). Thus, at first 
glance, our results implicating Itga6  in muscle development and homeostasis are 
surprising. However, Itga6  is downstream of Myf5 and required for Laminin assembly 
and normal myogenesis in mouse embryo explants (158). Itga6  expression is a biomarker 
for highly myogenic cell populations in muscle tissue and required for normal myogenic 
differentiation and myotube formation of a porcine muscle progenitor cell population 
(159,160). Itga6  and Laminin1 also play key roles in regeneration of CD117-positive cells 
in adult human pathological hearts (161). These studies, along with our data, suggest that 
Itga6  does play a role in muscle physiology, and may in fact be a key player in muscle 
tissue adaptation to stress.
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Adhesion to Laminin is required for initial MTJ development: MTJs in laminin 
beta1 and gamma1 mutant embryos are significantly wider than in wild-type embryos. 
The Laminin receptors that mediate initial MTJ morphogenesis were not known. Our data 
indicate that Itga6  is the main Laminin receptor mediating MTJ morphogenesis. MTJ 
angles are significantly wider in itga6 morphants or dag1;itga6 double morphant 
embryos compared to controls. MTJ development is not rescued when itga6 or 
dag1;itga6 morphants are supplemented with NAD+, indicating that Itga6  is necessary 
for the role of NAD+ in MTJ development. Although both dag1 and itga7 are expressed 
early in zebrafish development (92>119), MTJ angles are normal in dag1 or itga7 single 
morphants. However, we show that MTJ angles are wider than normal in dag1;itga7 
double morphants. This result suggests that these two Laminin receptors are required for 
normal MTJ development, but function redundantly. MTJ angles in dag1;itga7 double 
morphants are significantly narrower when incubated in NAD+, suggesting that Itga6  is 
sufficient to compensate for the decreased adhesion to Laminin in dag1;itga7 double 
morphants. Taken together, these results suggest that Itga6  is the major Laminin receptor 
necessary and sufficient for mediating early muscle and MTJ morphogenesis, but that 
Itga7 and Dag1 also contribute.
Muscle homeostasis also requires adhesion to Laminin. In this instance, however, 
Integrin alpha7beta1 and the DGC are the main Laminin receptors mediating muscle 
stability. Muscle degenerates in zebrafish embryos deficient for either dag1 or itga7 
(92,119). Exogenous NAD+ increases Laminin organization and reduces dystrophy in 
embryos deficient for either dag1 or itga7. Pseudo-genetic epistasis analysis indicates
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that both itga7 and itga6 are necessary for NAD+-mediated amelioration of dystrophy in 
dagl morphants. Our data suggest that all three Laminin receptors play unique roles in 
MTJ development and muscle homeostasis. However, when one receptor is 
compromised, the other receptors can partially compensate and NAD+ supplementation 
potentiates this compensatory response by facilitating increased Laminin organization in 
an Integrin-dependent manner.
3.5.3. Paxillin and Basement Membrane Organization
Paxillin overexpression is also sufficient to restore Laminin organization in
dystrophic zebrafish. Paxillin is an essential signaling nexus that regulates cell adhesion,
morphology, and migration (125). Depending upon context, Paxillin potentiates either the
assembly or disassembly of cell-ECM adhesion complexes. The robust concentration of
Paxillin at MTJs during muscle development suggested a role for Paxillin in maintaining
muscle structure (58). Here we show that overexpression of Paxillin in dagl morphants
increases organization of Laminin-111 at the MTJ and reduces dystrophy. These results
clearly implicate Paxillin in playing a fundamental role in muscle homeostasis. It is very
interesting that Paxillin overexpression does not rescue morphogenesis/reduce dystrophy
in itga6 or itga7 morphants. There are at least three possible explanations for why Itga6
and Itga7, but not Dag1, are required for Paxillin overexpression-mediated restoration of
muscle structure. One is that the subcellular localization of Paxillin to MTJs is critical for
Paxillin function: Paxillin localization is disrupted in dagl morphants, but not in itga6 or
itga7 morphants. Overexpression of Paxillin restores localization of Paxillin to MTJs in
dagl morphants and reduces dystrophy. Another scenario that would explain these results
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is that Paxillin modulates “inside-out” signaling via Itga6  and Itga7. Paxillin localization 
to Itga6  and Itga7 containing cell-ECM adhesions may directly or indirectly cause these 
Laminin receptors to adopt their high-affinity conformation, thus increasing adhesion to 
Laminin. Finally, Paxillin could be required to recruit the exocyst to the MTJ. The 
exocyst traffics vesicles to subdomains within the membrane and is critical for efficient 
exocytosis of Integrins. Paxillin binding to an exocyst component, Sec5, mediates proper 
subcellular localization of exocyst complexes (165). Thus, one mechanism by which 
Paxillin could function upstream of Itga6  and Itga7 is modulation of exocyst localization. 
Intriguingly, another component of the exocyst is Arf6 , which would require NAD+ as a 
cofactor for ADP-ribosylation of its targets. Our results clearly show that MTJ-localized 
Paxillin is sufficient to impact local organization of the ECM microenvironment. It will 
be very interesting to determine the mechanism(s) of action, and elucidate why Paxillin -  
one of a thousand focal adhesion proteins -  plays such a critical role. As Paxillin is 
ubiquitously expressed and necessary for early development (127,166), understanding how 
Paxillin improves Laminin organization in dag1 morphants may provide insight into 
Paxillin function in other tissues as well.
3.5.4. Moving Toward Viable Therapeutic Options for Myopathies
Congenital muscular dystrophies are a heterogeneous group of early-onset 
progressive muscle wasting diseases. In animal models of CMDs where sarcolemma 
integrity remains intact prior to fiber detachment, BM augmentation has been proposed 
and implemented as a successful approach to maintain muscle fiber viability. 
Interestingly, multiple different methods of BM augmentation have proved beneficial. In
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laminin beta2 mutant zebrafish, initial failure between muscle fibers and the MTJ BM is 
compensated for by newly formed ectopic BMs at the detached ends of fibers (21). Gene 
therapy approaches involving the expression of synthetic BM components are sufficient 
to reduce myopathy in mouse models (14,15). We show that modulation of the ECM 
microenvironment by the small molecule NAD+ also ameliorates muscle degeneration. In 
Dystrophin-deficient zebrafish, where sarcolemma integrity is compromised prior to fiber 
detachment, a screen of chemicals approved for human use revealed that the nonselective 
phosphodiesterase inhibitor aminophylline best restored muscle structure by activating 
cAMP-dependent PKA signaling (68). These reports highlight the importance of 
classifying the etiology of fiber degeneration, as different myopathies may respond better 
to certain treatment approaches. In addition, investigation of combinatorial therapeutic 
approaches may prove most useful.
Along with muscle degeneration, CMDs can also present with joint and skeletal 
deformities and mental retardation. In dystrophic zebrafish, we find that NAD+ 
supplementation improves both muscle structure and mobility, but Paxillin 
overexpression only improves muscle structure. Thus, in this system, structure does not 
beget function. It is perhaps not surprising that NAD+ contributes to the development and 
functioning of tissues other than muscle. Neurodegenerative disorders such as 
Parkinson’s and Alzheimer’s are associated with reduced NAD+ levels and increasing 
NAD+ metabolism slows neuronal degeneration in vitro. Although the exact mechanisms 
are not known, the neuroprotective effects of NAD+ are thought to be mediated by poly 
ADP-ribose polymerases (PARPs), which play critical roles in genome stability, DNA
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repair, and telomere maintenance. In the case of ischemia, it is thought that the oxidative 
stress brought on by reperfusion with oxygen can cause DNA damage. This damage then 
activates the PARP-1 cascade and results in rapid depletion of NAD+. Energy within the 
cell quickly becomes limiting and may cause cell death. Evidence for this hypothesis 
comes from the fact that PARP-/- mice show reduced tissue damage and protected NAD+ 
metabolism in cerebral ischemia (167). In a similar vein, nicotinamide treatment has been 
shown to allay the effects of fetal alcohol syndrome in mice (168). This may be an 
important intervention for early neuronal damage during fetal development. Given these 
data, it is tempting to speculate that NAD+ may contribute to neuromuscular junction 
development or prolong/enhance signaling through neuromuscular junctions, thus 
contributing to improved motility in dystrophic zebrafish. As many NAD+ biosynthetic 
enzymes and precursors/metabolites are both required and cytoprotective in muscle and 
neural tissues, downstream targets of NAD+ signaling are promising potential therapies 
for multiple symptoms of muscle degeneration, including fiber atrophy, reduced motor 
function and mental retardation.
The experiments shown here were undertaken because we had previously shown
that Nrk2b is necessary for Laminin organization during myotendinous junction
development. An alternate method to NAD+ supplementation in vivo is vitamin
supplementation with a precursor to NAD+, such as niacin. Water-soluble Emergen-C
packets that contain niacin were added to ERM and were sufficient to reduce muscle
degeneration in dagl morphants. This result suggests the hypothesis that maternal and
fetal nutrition may partly explain the variable progression and age of onset of some
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dystrophies. Clearly, vitamins other than niacin in the packets could contribute to the 
reduction of dystrophy. However, given that the reduction in muscle degeneration is 
similar in NAD+-supplemented, Emergen-C-supplemented, and Paxillin overexpressing 
dag1 morphants, it seems unlikely that other vitamins are causing this effect.
Niacin has been used clinically for decades to manage dyslipidemia (169). Although 
the mechanism of action is not well understood, it is known that niacin increases high- 
density lipoprotein (HDL) independently of NAD+ synthesis. An extended release form 
of niacin, Niaspan, has been used in combination with statins that lower LDL levels to 
treat cardiovascular disease (170). However, NIH recently aborted a clinical trial 
combining niacin and statin therapy because the combination therapy did not decrease 
cardiovascular events in patients with heart and vascular disease and the risk of stroke 
was slightly increased (http://www.nih.gov/news/health/may2011/nhlbi-26.htm). Thus, it 
is not clear whether niacin will continue to be prescribed for cardiovascular disease. 
However, recent experiments in rats suggest other possible therapeutic uses for niacin. 
Niaspan is neuroprotective after stroke (171) and slows the progression of chronic kidney 
disease (172). Our data suggest that the currently tractable approach of vitamin 
supplementation may warrant continued investigation.
3.6. Chapter Conclusions
One of the advantages of using a “4D” system such as muscle development in vivo 
is the depth of dynamic range that cells exhibit in response to changes in cell signaling, 
cell adhesion, and the biophysics of the surrounding microenvironment. These processes 
allow cells to adapt to changing conditions during development, aging, injury response
121
and repair. We show that one such adaptive response -  an increase in ECM organization 
mediated by the Nrk2b pathway -  is sufficient to improve the resilience of muscle in 
dystrophic zebrafish. There are three Laminin receptors expressed in muscle. The 
“canonical” receptors, Dag1 and Itga7, are highly expressed and, when mutated, lead to 
congenital muscular dystrophies. Here we implicate a "non-canonical” Laminin receptor, 
Itga6 , in the Nrk2b pathway. Recent findings from mouse, pig and human cells, along 
with our data utilizing zebrafish embryos, suggest a conserved and previously 
unrecognized role for Itga6  in promoting muscle regeneration and homeostasis. Genetic 
mosaic analysis shows that the main effect of the Nrk2b pathway is an increase in 
structure of the ECM. A series of psuedo-genetic epistasis experiments with these three 
Laminin receptors indicate that Dag1 or Itga7 is required along with Itga6  for NAD+ to 
reduce dystrophy. Taken together, these data suggest that two out of three receptors are 
required in order to sufficiently bind Laminin and increase ECM organization. Our data 
highlight the contribution of the Nrk2b-NAD+-Laminin-Paxillin-Itga6/Itga7 to cellular 
adaptive responses and suggest that this pathway may have therapeutic potential.
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CHAPTER 4 
FUTURE DIRECTIONS
The best kind of answers to scientific questions are ones that beget more 
questions. What we have learned about the Nrk2b pathway in muscle development and 
disease over the course of my graduate research project has certainly resulted in the 
formulation of new questions to answer and future directions to pursue. The future 
directions that will be discussed in this chapter are by no means an exhaustive list.
Equally interesting and worthy future avenues of investigation that will not described in 
this chapter include larger size scale, integrative studies, such as compensation for loss of 
cell-matrix adhesion by upregulation of cell-cell adhesion proteins through adhesive 
crosstalk, roles for NAD+ in neuromuscular junction development and function, and 
clinical epidemiological studies correlating pregnant mother’s intake of NAD+ precursors 
with the timing of onset, rate of progression and severity of disease in children that were 
diagnosed with a congenital muscular dystrophy. The future directions that will be 
detailed in this chapter can be categorized into two broad areas of investigation: ( 1) the 
vertical depth of the mechanisms through which Nrk2b, NAD+ and Paxillin regulate 
Laminin organization at different size scales and (2) the horizontal breadth of the efficacy 
of Nrk2b pathway manipulation in animal models of diseases associated with basement 
membrane disruptions. This chapter will describe potential future experiments to address 
questions related to these two areas of investigation, hopefully resulting in even more 
questions to pursue.
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4.1. Molecular Functions of Zebrafish Nrk2b
Nrk2 (aka MIBP2, ITGB1BP3) is a little studied protein that has been implicated 
in regulation of muscle tissue development and function: it is upregulated in double 
muscled cattle (85) and ASPS, a rare, highly metastatic cancer (86); and its overexpression 
disrupts muscle differentiation in cultured mouse myoblasts (84). MIBP2 was first 
identified in a yeast two-hybrid screen for proteins that directly interact with the 
cytoplasmic tail of human Integrin beta1 (residues 749-801(84)). The authors of the study 
proposed that MIBP2 overexpression likely inhibits terminal muscle differentiation via 
changes in Integrin beta1 signaling, as enhanced expression of Integrin beta1 causes 
similar results in cell culture (173,174). Interestingly, MIBP2 is a splice-variant of Nrk2, an 
enzyme involved in NAD+ biosynthesis in multiple species (71). Therefore, MIBP2/Nrk2 
action in muscle development may occur through its role in Integrin beta1 binding, NAD 
+ biosynthesis, both, or as of yet unknown molecular functions.
This dissertation describes the first in vivo study of MIBP2/Nrk2 in muscle
development using a zebrafish ortholog, Nrk2b. A reverse genetics approach and
morpholino-mediated knock down of Nrk2b protein levels revealed a role for Nrk2b in
development of the myotendinous junction basement membrane and maintenance of MTJ
integrity. Provision of exogenous NAD+ rescued MTJ failure in nrk2b morphants,
providing evidence that the NAD+ biosynthetic function of Nrk2 enzymes may be
conserved in zebrafish Nrk2b. However, our data do not discriminate whether the role of
Nrk2b in MTJ BM development requires the catalytic function of Nrk2b, Integrin beta1
binding or both. Experiments to address whether the enzymatic or Integrin beta1 binding
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function of Nrk2b is required for normal MTJ BM development and MTJ integrity would
involve generating Nrk2b mutant constructs incapable of enzymatic activity or unable to
bind Integrin beta1. Aspartic acid residue 35 was identified as essential for Nrk2
enzymatic function in yeast (72) and this residue is conserved in zebrafish Nrk2b and
human Nrk2 (data not shown). Generation and then transgenic expression of a nrk2b
D35A mutant construct in nrk2b morphant zebrafish could be used to determine how well
catalytically dead Nrk2b rescued MTJ failure in comparison to wild-type Nrk2b. If the
Nrk2b mutant construct rescued MTJ failure in nrk2b morphant zebrafish as well as wild-
type Nrk2b, then the NAD+ biosynthetic function of zebrafish Nrk2b would not be
required for MTJ integrity. However, if the mutant construct did not rescue boundary
crossings as well as wild-type Nrk2b, it would be concluded that Nrk2b-mediated NAD+
biosynthesis is essential for Nrk2b’s role in MTJ integrity. Similar experiments involving
mutating or deleting the Integrin beta1 binding residues of Nrk2b could be done to
determine whether Nrk2b-Integrin beta1 binding is required for the role of Nrk2b in MTJ
integrity. However, the authors of Li et al., 1999 only determined the residues of Integrin
beta1 that are involved in binding MIBP2/Nrk2, not the MIBP2/Nrk2 residues that bind
Integrin beta1. These residues would have to be identified before these experiments could
be conducted. Results from these experiments could show that the requirement for Nrk2b
in zebrafish MTJ BM development is: (1) solely through ‘inside-out’ signaling via
Integrin beta1, (2) through NAD+ biosynthesis and that Integrin beta1 binding may only
function to localize this source of NAD+ or (3) through both or neither of these molecular
functions of Nrk2b. The data from these experiments could raise the interesting
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possibility that intracellular Nrk2b via Integrin beta1 signaling and provision of 
exogenous NAD+ may be two, completely independent ways of augmenting 
Laminin-111 organization or that the results we obtained supplementing zebrafish 
embryos with exogenous NAD+ is coupled to the NAD+ biosynthetic function of Nrk2b.
4.2. Molecular Functions and Regulation of NAD+
To begin to address how exogenous NAD+ affects extracellular Laminin-111 
organization, the many molecular functions of intracellular and extracellular NAD+ must 
be considered. NAD+ is a ubiquitous metabolic factor involved in electron transfer 
reactions and is also a substrate in mono- and poly-ADP-ribose transfer reactions, cyclic 
ADP-ribose reactions regulating calcium signaling and Sirtuin deacetylase reactions. As 
NAD+ is degraded in its role as a substrate, it must be continuously synthesized via the 
three pathways of NAD+ biosynthesis. NAD+ can be synthesized from tryptophan via the 
de novo pathway, from nicotinamide and nicotinic acid via the Preiss-Handler salvage 
pathway and from nicotinamide riboside and nicotinic acid riboside via an alternative 
salvage pathway. This alternative salvage pathway beginning with nicotinamide riboside 
and involving two enzymatic steps to NAD+ generation is of particular interest to my 
graduate studies because the first reaction, phosphorylation of nicotinamide riboside, is 
carried out by the Nrk family of enzymes. Alternative salvage is the only means of NAD+ 
biosynthesis in bacteria that lack enzymes required in the other two pathways and the 
function of alternative salvage pathway enzymes was found to be conserved in 
eukaryotes (71). Together, this evolutionary conservation along with the fact that 
tryptophan alone can not maintain adequate NAD+ levels in rats (175) or cultured cells
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(176) suggest that this alternative salvage pathway of NAD+ biosynthesis is critical for 
maintenance of adequate basal levels of NAD+.
Due to the involvement of NAD+ in a myriad of cellular reactions, NAD+ 
availability and subcellular compartmentalization must be strictly regulated in order for 
specificity of function. Compartmentalization of NAD+ to mitochondria severely restricts 
the NAD+ available for reactions utilizing NAD+ as a coenzyme: as much as 75% of 
intracellular NAD+ can be sequestered within the mitochondria of heart muscle (177). 
Providing NAD+ precursors or up regulating NAD+ biosynthetic enzymes can increase 
the availability of intracellular NAD+ for NAD+-dependent reactions through boosting 
overall levels NAD+, but can also, through as of yet unknown mechanisms, increase 
NAD+ availability without altering steady-state NAD+ levels (178). Recently, a valuable 
tool was developed allowing for indirect visualization and quantification of intracellular 
NAD+ localization and levels using constitutively active PARP enzymes to generate 
fluorescent products in a NAD+ concentration dependent manner (176). In this report, the 
authors found that extracellular nucleotides (NAD+, NAAD, NMN, NAMN) could not 
permeate the cell membrane, but that nucleosides (NA, Nam, NR, NAR) were cell 
permeable through nucleoside transporter-dependent or -independent routes (176). Also, 
the authors showed that particular NAD+ biosynthetic enzymes localize to specific 
subcellular compartments, such as mitochondria, nuclei or the cytosol (176). These 
subcellularly localized enzymes could generate localized sources of NAD+ that may play 
distinct cellular roles at different times. The study described above regarding NAD+ 
regulation in multiple cultured cell lines went a long way toward enhancing our
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understanding of NAD+ dynamics and regulation. All together, the many molecular 
functions of NAD+, the multiple and complex layers of NAD+ regulation and the 
interconnectivity of NAD+ biosynthetic pathways and NAD+-degrading reactions with 
other major cell signaling pathways make for a multitude of ways in which NAD+ could 
function in organization of Laminin-111.
Adaptation of the tool described above or the development of others allowing for 
visualization of NAD+ biosynthetic components and NAD+ localization and levels for in 
vivo studies would certainly be a worthy endeavor. As we do not know how much, if any, 
of the NAD+ that is added to zebrafish embryo rearing media actually enters muscle 
cells, how it enters muscle cells or in what form it enters muscle cells, the ability to 
visualize changes in NAD+ concentrations and localizations in vivo would shed light on 
this unknown. A hypothetical tool allowing for in vivo visualization of NAD+ could also 
be used to assess how depletion or overexpression of Nrk2b or other zebrafish Nrk 
orthologs, Nampt (the rate limiting enzyme in the Preiss-Handler branch of NAD+ 
biosynthesis (179)) or other NAD+ biosynthetic enzymes affects NAD+ levels and 
localization and whether two pathways of NAD+ biosynthesis can compensate for the 
loss of one in zebrafish. Interestingly, Nampt is predominately expressed in human 
skeletal muscle and regulates the expression of myogenic regulatory factors and thus 
myogenesis in cultured chick muscle cells (180). Expression of zebrafish Nampt is 
currently completely unknown (no data are available on ZFIN) and characterization of 
roles for Nampt in zebrafish muscle development would present an interesting line of 
investigation.
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4.3. Elucidating the Molecular Function of NAD+ in Basement Membrane 
Organization
Data presented in this dissertation show that exogenous NAD+ rescues MTJ break 
down in nrk2b morphants (Chapter 2) and muscle degeneration in dag1 or itga7 
morphants (Chapter 3). Exogenous NAD+, however, could not rescue MTJ break down 
in gup/laminin beta1 (Chapter 2) or itga6 morphants (Chapter 3) or muscle degeneration 
in sly/laminin gamma1 mutants, dag1;itga7 or dag1;itga6 double morphants (Chapter 3). 
Thus, we have not only shown a novel role for NAD+ in muscle development and 
homeostasis, but have also elucidated part of the mechanism of NAD+ action by showing 
specific requirements for Itga7, Itga6  and Laminin-111. Something our experiments did 
not address is the smaller size scale, molecular level mechanism of NAD+ action in 
muscle morphogenesis and homeostasis. Therefore, one future direction would be to 
elucidate how NAD+ affects Integrin receptors and how this results in organization of 
Laminin-111 in the MTJ BM.
We have provided a hypothesis and some preliminary data as to how we suspect
extracellular NAD+ may be affecting Laminin-111 organization via Integrins in Section
2.5.1. We hypothesize that extracellular, NAD+-dependent enzymes called mono-ADP-
ribosyltransferases utilize extracellular NAD+ to transfer ADP-ribose moieties to
Integrins. ADP-ribosylation is a post-translational modification that transfers a negatively
charged ADP-ribose from NAD+ onto target proteins. This addition frequently inactivates
proteins and was historically best known for its role in bacterial pathogenesis. Within the
last decade, it has become increasingly clear that ADP-ribosylation of multiple proteins is
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an evolutionarily ancient and important reaction that can activate proteins. ADP- 
ribosylation activates Integrins to increase cell-matrix adhesion (113). We predict this post- 
translational modification will increase binding affinity between Itga7b1 or Itga6b1 and 
Laminin-111 and, through dynamic reciprocity, receptor recruitment and clustering would 
result in increased organization of the 3D structure of Laminin-111. Evidence to support 
our hypothesis includes increased binding affinity between Integrin alpha7beta1 and 
Laminin-111 upon ADP-ribosylation in in vitro studies (113) and conservation of the ADP- 
ribosylated region of Itga7 (181) in Itga6 . This line of future investigation would be both 
innovative in that in vivo functions for mono-ADP-ribosylation in development and 
muscle tissue are not known as well as significant in that ecto-mono-ADP- 
ribosyltransferases could be novel therapeutic targets in diseases associated with 
disrupted BMs.
Questions and experiments to lend support to or discredit our hypothesis that 
extracellular NAD+ is utilized in mono-ADP-ribosyltransferase reactions to impact 
Laminin-111 organization in vivo are detailed below. The admittedly poorly characterized 
mono-ADP-ribosyltransferase genes in zebrafish include Art1 and Art4 (the Art1 gene 
information was recently removed from the Zebrafish Model Organism Database ZFIN 
for unknown reasons). We have generated preliminary data showing that artl and art4 
are expressed in developing zebrafish skeletal muscle in a Nrk2b-dependent manner 
(Peterson and Henry, personal communication of unpublished data). A question of 
interest to pursue is whether extracellular NAD+ acts only through Arts to impact 
Laminin-111 organization or also through alternative molecular functions of NAD+. To
130
answer this question, 3D reconstructions of Laminin-111 antibody staining and the 
frequency of boundary crossings per embryo would be compared between nrk2b;art 
double morphants and nrk2b;art double morphants incubated in exogenous NAD+. If 
there is no qualitative difference in Laminin-111 organization at the MTJ BM and no 
quantitative difference in the frequency of boundary crossings per double morphant 
embryo upon NAD+ supplementation, it would be concluded that Arts are required and 
that extracellular NAD+ functions in Laminin-111 organization solely through mono- 
ADP-ribosylation reactions. If nrk2b;art double morphants incubated in NAD+ show a 
partial or complete rescue in Laminin-111 organization and boundary crossings compared 
to their unsupplemented counterparts, then Arts may or may not be required and we 
would conclude that the extracellular NAD+ provided is used in NAD+-consuming 
reactions other than mono-ADP-ribosylation to impact MTJ BM integrity. Perhaps, the 
best test of our hypothesis would be to show that zebrafish Art1/4 ADP-ribosylate Itga7 
and Itga6  in vivo or in whole embryo lysates. This is currently not possible because, 
while antibodies for poly-ADP-ribosylation exist, antibodies to detect mono-ADP- 
ribosylations currently do not. Development of this tool, as well as tools to visualize 
Laminin-111 polymerization dynamics in vivo in real time, would greatly enhance 
rigorous testing of our hypothesis.
If it were the case that exogenous NAD+ could partially rescue Laminin-111
disorganization and boundary crossings in nrk2b;art morphants, which would not be all
that surprising given the many cellular roles for NAD+, even more future directions
would arise. This outcome could be due to mono-ADP-ribosyltransferase function of
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previously unknown zebrafish Art genes that were not accounted for, but it could also 
implicate poly-ADP-ribosyltransferase reactions, cyclic ADP-ribose reactions regulating 
Calcium signaling or Sirtuin deacetylase reactions in extracellular NAD+-mediated 
organization of Laminin-111 via Integrins.
4.4. Elucidating the Molecular Function of Paxillin in Basement Membrane 
Organization
As NAD+ is involved in multiple cellular reactions, one approach to narrowing
down the possibilities of the molecular function of NAD+ in Laminin-111 organization is
to investigate downstream of NAD+ in the Nrk2b pathway. Data presented in this
dissertation show that the intracellular, cell-matrix adhesion protein Paxillin functions
downstream of Nrk2b and NAD+ in zebrafish MTJ BM development. We found
transgenic overexpression of Paxillin to be sufficient to reduce boundary crossings in
nrk2b morphants (Chapter 2) and reduce dystrophic lesions in dag1 morphant zebrafish
(Chapter 3). Therefore, Paxillin likely impacts Laminin-111 organization through inside-
out signaling via cell-matrix adhesion complexes. In Chapter 3, we also show that
Paxillin function requires Integrin receptors for Laminin-111: Itga6  is required for
Paxillin-mediated rescue of boundary crossings and Itga7 is required for Paxillin-
mediated reduction of dystrophic lesions. Therefore, we have again elucidated the
relevant receptors in the mechanism of Paxillin function, but not the molecular level
intricacies, making another future direction to elucidate the molecular function of Paxillin
in Laminin-111 organization. We hypothesize that Paxillin signaling augments
Laminin-111 organization by regulating inside-out signaling via Integrins. The proposed
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experiments to follow are innovative in that exceedingly little is known about regulation 
of BM development in vivo by cell-matrix adhesion proteins and significant in that 
molecular dissection of Paxillin function and potential links to downstream signaling 
pathways could elucidate novel drug targets for currently incurable diseases affecting 
BMs.
Experiments to address this future direction would involve generation of Paxillin 
mutant constructs and then either their transient expression in zebrafish or the generation 
of stable transgenic zebrafish lines expressing these constructs. Data analysis would 
involve assaying Laminin-111 antibody staining and boundary crossings in nrk2b 
morphant embryos. Dissection of Paxillin function in vitro has been well studied and 
there is a large number of potential mutant constructs to try in vivo. One construct of 
interest is a tryosine phosphorylation-deficient variant of Paxillin, Y31F/Y118F (182).
This construct would be co-injected along with nrk2b MOs and Laminin-111 antibody 
staining and boundary crossings would be compared between nrk2b morphants, nrk2b 
morphants expressing wild-type Paxillin and nrk2b morphants expressing Y31F/Y118F 
Paxillin. If this phosphorylation-deficient mutant construct rescues boundary crossings to 
the same degree that wild-type Paxillin does, then phosphorylation of Paxillin at these 
sites is not required for Paxillin function in Laminin-111 organization. If this mutant 
construct results in no significant change in boundary crossings compared to nrk2b 
morphants, then tyrosine phosphorylation of Paxillin is required for Paxillin action in 
Laminin-111 organization. Expression of this Paxillin variant could also be found to only
partially rescue boundary crossings. Phosphorylation at these sites has been shown to
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indirectly promote Rac1 and inhibit Rho1, has been implicated in focal adhesion 
maturation and modulation of Calpain activity, enhances binding of FAK to the LD 
motifs, promotes invadopodia (actin-rich cell membrane extensions, similar to 
lamellipodia, but that extend into the ECM and involve proteolysis) formation, and has 
been implicated in sarcomere formation (46,183-188). Thus, if tyrosine phosphorylations at 
Y31 and Y118 are found to be required for the molecular function of Paxillin in 
Laminin-111 organization, the aforementioned downstream signaling pathways and 
proteins will be implicated and provide additional future directions to explore.
Another Paxillin variant to test is D146A/D268A, which disrupts the LD2 and LD4 
domains of Paxillin and completely abrogates FAK binding (131). Binding of FAK to both 
LD2 and LD4 of Paxillin is necessary for maximal activation of FAK (132). If the Paxillin 
D146A/D268A construct is unable to rescue boundary crossings in nrk2b morphants, 
FAK activation would be implicated in Paxillin-mediated Laminin-111 organization. This 
would open up additional future avenues of investigation into whether constitutively 
activated FAK is sufficient to rescue and which domains of FAK are required. Other 
Paxillin variants to test include phosphorylation mimics and mutated versions that affect 
ubiquitination, nuclear export and protein-protein interactions. It would not be surprising 
if multiple constructs contributed to the increased organization of Laminin-111 by 
Paxillin and the efficacy of rescue by certain Paxillin constructs could be prioritized.
Another line of investigation regarding Paxillin-mediated Laminin-111 organization
is to ask where (in what tissues) Paxillin functions. In Chapters 2 and 3, it is shown that
overexpression of Paxillin in all tissues rescues boundary crossings in nrk2b morphant
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embryos and ameliorates dystrophy in dagl morphant embryos, but perhaps ubiquitous 
Paxillin overexpression is not necessary for this effect. It is not known if Laminin-111 
polymerization at the MTJ is affected by adjacent tissues that also express Laminin 
(neural plate, notochord (93)), if Paxillin is required within tenocytes, or if Paxillin 
expression in muscle cells is sufficient in order to impact Laminin-111 organization. 
Experiments elucidating the tissue level functions of Paxillin will provide critical 
information for future therapeutic applications of Paxillin in diseases with BM 
disruptions.
Comparison of Laminin-111 antibody staining and boundary crossings in nrk2b 
morphants either transiently or stably expressing Paxillin under the control of zebrafish 
muscle tissue-specific promoters (189-191) vs. ubiquitous promoters (Section 2.3.1.) will 
elucidate whether Paxillin overexpression in muscle tissue is sufficient or whether 
Paxillin overexpression in other cell types is necessary for Paxillin-mediated 
Laminin-111 organization. Other tissue types that might be involved in Laminin-111 
organization via Paxillin could include tendon progenitors or adjacent tissues, such as the 
notochord, that could impact the ECM of muscle. If ubiquitously expressed Paxillin 
provided a better rescue of the nrk2b morphant boundary crossings than muscle-specific 
Paxillin expression, investigation into the roles of these other tissues in Laminin-111 
organization could be pursued. This information is critical for potential translation of 
Paxillin gene therapy to human applications in order to balance optimal treatment 
efficacy with the fewest side effects possible.
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4.5. Potential of the Nrk2b Pathway in Therapeutics
laminin mutations lead to multiple diseases including myopathies, junctional 
epidermolysis bullosa, laryngo-oncho-cutaneous syndrome, and microcoria-congenital 
nephritic syndrome (126). Due to our limited knowledge of mechanisms regulating in vivo 
Laminin assembly and polymerization and lack of tools with which to visualize this 
process, effective treatments for these diseases have not yet been discovered. This 
dissertation describes a study elucidating a novel cell-matrix adhesion pathway that is 
required for normal organization of Laminin-111 in zebrafish MTJ BMs and a follow-up 
study beginning to test the therapeutic potential of this pathway in augmenting disrupted 
BMs in animal models of disease. Potential therapeutics discovered using the zebrafish 
model system have been successfully translated into human therapies and entered into 
clinical trials for the treatment of Duchenne muscular dystrophy and cancer (192-194). 
Manipulation of the Nrk2b pathway has the potential to translate into treatments for 
human diseases, but many more studies still need to be conducted first and thus, another 
future area of investigation arises.
Data are provided in this dissertation that exogenous NAD+ or Paxillin 
overexpression rescue MTJ failure and ameliorate dystrophy in zebrafish. However, these 
interventions occurred around the beginning of gastrulation, approximately 40 hours 
before boundary crossings or fiber detachment are evident. Understanding the 
developmental time windows when abnormal MTJ BMs can be repaired is critical 
information for regenerative studies and therapies for diseases affecting BM integrity.
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Important questions to resolve include when exogenous NAD+ or Paxillin are 
required for normal Laminin-111 organization, whether exogenous NAD+ or Paxillin are 
sufficient to augment Laminin-111 organization after the initial MTJ BM has formed in 
nrk2b morphants, whether exogenous NAD+ or Paxillin are protective at all times prior 
to the onset of dystrophy, and whether exogenous NAD+ or Paxillin can exert a 
protective effect subsequent to the onset of dystrophy in dag1 morphants. In order to 
activate the Nrk2b pathway during different developmental windows, NAD+ could be 
added to embryo rearing media at different developmental stages and a transgenic line 
expressing Paxillin under control of a heat shock inducible promoter (195) could be 
generated and embryos heat shocked at different times during development. One concern 
with adding exogenous NAD+ at later developmental time points is that it may not be 
able to permeate through the skin. However, changes in fat metabolism were seen in 
zebrafish incubated in exogenous NAD+ starting at 3 days post fertilization (94), 
suggesting that later supplementation can cause an effect. Quantification of boundary 
crossings in nrk2b morphants and dystrophic lesions in dag1 morphants would elucidate 
during which developmental windows exogenous NAD+ or Paxillin are able to rescue 
MTJ failure and dystrophy. NAD+ could also be injected into the skeletal muscle of older 
zebrafish embryos if necessary. Potential outcomes include that these interventions are 
protective both before and after phenotypic onset or that these interventions are only 
protective prior to MTJ failure or muscle fiber detachment. Regardless of the outcomes, 
these findings will have translational science implications. These experiments could also
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uncover subtle protective roles of NAD+ and Paxillin after disease onset and small 
improvements, while not cures, could improve quality of life for patients.
Although NAD+ and Paxillin are sufficient to reduce MTJ failure and dystrophy 
in zebrafish, neither treatment is tissue-specific. Attributes that make Nrk2 an attractive 
therapeutic option are: ( 1) kinases are recognized as accessible pharmacological targets, 
and (2) Nrk2 is specifically expressed in human adult heart and skeletal muscle (84), thus 
potentially limiting side effects of systemic drug delivery. Asking whether overexpression 
of Nrk2b is sufficient to ameliorate myopathy in dystrophic zebrafish is a worthy future 
direction to explore. A stable transgenic line expressing Nrk2b:GFP would have to be 
generated in order to pursue this line of investigation. Injection of dag1 MOs into Nrk2b 
transgenic embryos and quantification of dystrophic lesions would elucidate whether 
Nrk2b overexpression is sufficient to reduce dystrophy. If Nrk2b overexpression were 
found to be sufficient to reduce dystrophy, experiments as described above for Paxillin 
overexpression to discover when during development and in which tissues Nrk2b 
overexpression is required would inform the therapeutic potential of Nrk2b gene therapy 
as a treatment for diseases where skeletal muscle BMs are compromised. There may be a 
dose-dependent response to Nrk2b expression. If this were the case, the relationship 
between Nrk2b expression levels and the degree of rescue could be analyzed and the 
optimum dose determined.
The Nrk2b pathway represents an exciting new approach to BM augmentation.
Testing the breadth of efficacy of Nrk2b pathway activation to treat muscular dystrophies
with diverse etiologies could be easily and quickly completed using the zebrafish system
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relative to other animal models. It is shown in this dissertation that activation of the 
Nrk2b pathway ameliorates muscle degeneration in zebrafish lacking Dag1. We predict 
that this pathway will also be beneficial when other DGC components, or post- 
translational modification of Dag1, are disrupted. This could be tested by activating the 
Nrk2b pathway via exogenous NAD+ or Paxillin in sapje/dystrophin, fukutin related 
protein and large2/glycosyltransferase-like 1b morphant or mutant zebrafish and assaying 
dystrophic lesions per embryo.
Mutations in subunits of Collagen VI result in Bethlem myopathy or the more 
severe Ullrich CMD (196). Mouse models of Bethlem myopathy and patients with 
Collagen VI myopathies have swollen mitochondria and treatment with cyclosporine A to 
alter mitochondrial permeability improves mitochondria structure and reduces atrophy 
(197-199). However, the mouse mutant resembles Bethlem myopathy and does not model 
the severity of Ullrich CMD. Recent data showed that although treatment with 
cyclosporine A reduced mitochondrial defects and cell death in zebrafish modeling 
Ullrich CMD, it did not improve muscle structure or restore sarcolemma integrity (200). 
Asking whether a multifaceted approach, involving addition of both cyclosporin A and 
NAD+ to the media of Collagen VI-deficient zebrafish, improves mitochondrial and 
muscle structure defects would further test the breadth of Nrk2b pathway efficacy in 
therapeutics and potentially improve current therapeutic options being researched for 
treatment of Collagen VI-related myopathies.
Another multifaceted approach that could be undertaken is combining Paxillin
overexpression with NAD+ supplementation in dystrophic zebrafish. We do not know if
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either of these interventions alone maximally activates the Nrk2b pathway. If these 
interventions only partially activate the Nrk2b pathway, they might be more effective in 
combination. Alternatively, these treatments in combination could turn out to be toxic. 
This information would be valuable in considering the therapeutic potential of the Nrk2b 
pathway. A further test of the breadth of the applicability of NAD+ and Paxillin-mediated 
augmentation of Laminin-111 organization would be to look at the efficacy of these 
interventions in diseases associated with BM disruptions other than myopathies, such as 
junctional epidermolysis bullosa, laryngo-oncho-cutaneous syndrome, and microcoria- 
congenital nephritic syndrome.
4.6. Concluding Remarks
The future directions discussed in this chapter are only a few of the possible areas 
of investigation that stem from the data presented in this dissertation. The sets of 
experiments proposed can be conducted independently of each other with regards to 
space and time. However, studies at individual size scales will only elucidate pieces of 
the whole mechanism through which the Nrk2b pathway functions in muscle 
development and disease. Thus, studies at all size scales and collaboration between 
researchers in multiple scientific disciplines will result in the most complete 
understanding of the Nrk2b pathway and its implications in the basic and translational 
sciences.
140
REFERENCES
1. Lu P, Takai K, Weaver VM, Werb Z. Extracellular Matrix Degradation and Remodeling 
in Development and Disease. Cold Spring Harbor Perspectives in Biology. 2011 
December 1;3(12):5058.
2. Nelson C. Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates 
development, homeostasis, and cancer. Annual Review of Cell and Developmental 
Biology. 2006 November;22(1):287-309.
3. Rozario T. The extracellular matrix in development and morphogenesis: A dynamic 
view 10.1016/j.ydbio.2009.10.026 : Developmental Biology | ScienceDirect.com. 
Developmental biology. 2010.
4. Cox TR, Erler JT. Remodeling and homeostasis of the extracellular matrix: 
implications for fibrotic diseases and cancer. Disease models & mechanisms. 2011 March 
1;4(2):165-178.
5. Daley WP, Peters SB, Larsen M. Extracellular matrix dynamics in development and 
regenerative medicine. Journal of Cell Science. 2008 February 1;121(3):255-264.
6. Goody MF, Henry CA. Dynamic interactions between cells and their extracellular 
matrix mediate embryonic development. Molecular reproduction and development. 2010 
June;77(6):475-488.
7. Bissell MJ, Hall HG, Parry G. How does the extracellular matrix direct gene 
expression? Journal of theoretical biology. 1982 November;99(1):31-68.
8. Pedrosa-Domellof F, Tiger CF, Virtanen I, Thornell L-E, Gullberg D. Laminin Chains 
in Developing and Adult Human Myotendinous Junctions. Journal of Histochemistry & 
Cytochemistry. 2000 February 1;48(2):201-209.
9. Ishii H, Hayashi YK, Nonaka I, Arahata K. Electron microscopic examination of basal 
lamina in Fukuyama congenital muscular dystrophy. Neuromuscular disorders : NMD. 
1997 May;7(3):191-197.
10. Osari S, Kobayashi O, Nonaka I, 8. Basement membrane abnormality in merosin- 
negative congenital muscular dystrophy. Acta Neuropathologica. 1996 January 1;91(4): 
332-336.
11. Vajsar J, Ackerley C, Chitayat D, Becker LE. Basal lamina abnormality in the skeletal 
muscle of Walker-Warburg syndrome. Pediatric neurology. 2000 February;22(2):139-
143.
141
12. Sabatelli P, Columbaro M, Mura I, Capanni C, Lattanzi G, Maraldi NM, Beltran- 
Valero de Barnabe D, van Bokoven H, Squarzoni S, Merlini L. Extracellular matrix and 
nuclear abnormalities in skeletal muscle of a patient with Walker-Warburg syndrome 
caused by POMT1 mutation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of 
Disease. 2003 May;1638(1):57-62.
13. Morgan JE, Zammit PS. Direct effects of the pathogenic mutation on satellite cell 
function in muscular dystrophy. Experimental Cell Research. 2010 November 1;316(18): 
3100-3108.
14. Moll J, Barzaghi P, Lin S, Bezakova G, Lochmuller H, Engvall E, Muller U, Ruegg 
MA. An agrin minigene rescues dystrophic symptoms in a mouse model for congenital 
muscular dystrophy. Nature. 2001 September 20;413(6853):302-307.
15. Bentzinger CF, Barzaghi P, Lin S, Ruegg MA. Overexpression of mini-agrin in 
skeletal muscle increases muscle integrity and regenerative capacity in laminin-{alpha}2- 
deficient mice. The FASEB Journal. 2005 June 1;19(8):934-942.
16. Gawlik K, Miyagoe-Suzuki Y, Ekblom P, Takeda S, Durbeej M. Laminin {alpha}1 
chain reduces muscular dystrophy in laminin {alpha}2 chain deficient mice. Human 
Molecular Genetics. 2004 August 15;13(16):1775-1784.
17. Gawlik KI, Akerlund M, Carmignac V, Elamaa H, Durbeej M. Distinct roles for 
laminin globular domains in laminin alpha1 chain mediated rescue of murine laminin 
alpha2 chain deficiency. PLoS One. 2010;5(7):e11549.
18. Gawlik KI, Oliveira BM, Durbeej M. Transgenic expression of Laminin a1 chain 
does not prevent muscle disease in the mdx mouse model for Duchenne muscular 
dystrophy. The American journal of pathology. 2011 April;178(4):1728-1737.
19. Goudenege S, Lamarre Y, Dumont N, Rousseau J, Frenette J, Skuk D, Tremblay JP. 
Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. Molecular 
therapy : the journal of the American Society of Gene Therapy. 2010 December;18(12): 
2155-2163.
20. Meinen S, Barzaghi P, Lin S, Lochmuller H, Ruegg MA. Linker molecules between 
laminins and dystroglycan ameliorate laminin- 2-deficient muscular dystrophy at all 
disease stages. Journal of Cell Biology. 2007 March 19;176(7):979-993.
21. Jacoby AS, Busch-Nentwich E, Bryson-Richardson RJ, Hall TE, Berger J, Berger S, 
Sonntag C, Sachs C, Geisler R, Stemple DL, et al. The zebrafish dystrophic mutant softy 
maintains muscle fibre viability despite basement membrane rupture and muscle 
detachment. Development (Cambridge, England). 2009 October 1;136(19):3367-3376.
142
22. Rooney JE, Gurpur PB, Burkin DJ. Laminin-111 protein therapy prevents muscle 
disease in the mdx mouse model for Duchenne muscular dystrophy. Proceedings of the 
National Academy of Sciences. 2009 May 12;106(19):7991-7996.
23. Rooney JE, Knapp JR, Hodges BL, Wuebbles RD, Burkin DJ. Laminin-111 protein 
therapy reduces muscle pathology and improves viability of a mouse model of merosin- 
deficient congenital muscular dystrophy. The American journal of pathology. 2012 April; 
180(4):1593-1602.
24. Rooney J, Gurpur P. Laminin-111 Restores Regenerative Capacity in a Mouse Model 
for {alpha} 7 Integrin Congenital Myopathy. American Journal of Pathology. 2009 Jan; 
174Q):256-64.
25. Yurchenco PD, Tsilibary EC, Charonis AS, Furthmayr H. Laminin polymerization in 
vitro. Evidence for a two-step assembly with domain specificity. Journal of Biological 
Chemistry. 1985 June 25;260(12):7636-7644.
26. Yurchenco PD, Furthmayr H. Self-assembly of basement membrane collagen. 
Biochemistry. 1984 April 10;23(8):1839-1850.
27. Schwarzbauer J. Basement membrane: Putting up the barriers. Current Biology. 1999 
April;9(7):R242-R244.
28. Henry MD, Campbell KP. A Role for Dystroglycan in Basement Membrane 
Assembly. Cell. 1998 December 11;95(6):859-870.
29. Sasaki T, Forsberg E, Bloch W, Addicks K, Fassler R, Timpl R. Deficiency of beta 1 
integrins in teratoma interferes with basement membrane assembly and laminin-1 
expression. Experimental Cell Research. 1998 January 10;238(1):70-81.
30. Aumailley M, Pesch M, Tunggal L. Altered synthesis of laminin 1 and absence of 
basement membrane component deposition in (beta) 1 integrin-deficient embryoid 
bodies. Journal of Cell Science. 2000;113:259-268.
31. Williamson R, Henry M, Daniels K. Dystroglycan is essential for early embryonic 
development: disruption of Reichert's membrane in Dag1-null mice. Human molecular 
genetics. 1997;6(6):831-841.
32. Stephens LEL, Sutherland AEA, Damsky CHC, 7. Deletion of beta 1 integrins in 
mice results in inner cell mass failure and peri-implantation lethality. Genes & 
Development. 1995 August 1;9(15):1883-1895.
143
33. Henry M, Satz J, Brakebusch C, Costell M, Gustafsson E, Fassler R, Campbell K. 
Distinct roles for dystroglycan, (&bgr;)1 integrin and perlecan in cell surface laminin 
organization. Journal of Cell Science. 2001 March 15;114(6):1137-1144.
34. Carmignac V, Durbeej M. Cell-matrix interactions in muscle disease. The Journal of 
Pathology. 2012 January;226(2):200-218.
35. Colognato H, Winkelmann D. Laminin polymerization induces a receptor- 
cytoskeleton network. The Journal of Cell Biology. 1999 May 3;145(3):619-631.
36. Rooney JE, Welser JV, Dechert MA, Flintoff-Dye NL, Kaufman SJ, Burkin DJ.
Severe muscular dystrophy in mice that lack dystrophin and alpha7 integrin. Journal of 
Cell Science. 2006 June 1;119(Pt 11):2185-2195.
37. Guo C. Absence of 7 integrin in dystrophin-deficient mice causes a myopathy similar 
to Duchenne muscular dystrophy. Human Molecular Genetics. 2006 January 26;15(6): 
989-998.
38. Allikian MJ, Hack AA, Mewborn S, Mayer U, McNally EM. Genetic compensation 
for sarcoglycan loss by integrin {alpha}7{beta}1 in muscle. Journal of Cell Science.
2004 August 1;117(17):3821-3830.
39. Ringelmann B. Expression of Laminin a1, a2, a4, and a5 Chains, Fibronectin, and 
Tenascin-C in Skeletal Muscle of Dystrophic 129ReJdy/dyMice. Experimental Cell 
Research. 1999 January 10;246(1):165-182.
40. Cote PD. Dystroglycan Is Not Required for Localization of Dystrophin, Syntrophin, 
and Neuronal Nitric-oxide Synthase at the Sarcolemma but Regulates Integrin alpha 7B 
Expression and Caveolin-3 Distribution. Journal of Biological Chemistry. 2001 
December 6;277(7):4672-4679.
41. Banks GB, Combs AC, Chamberlain JR, Chamberlain JS. Molecular and cellular 
adaptations to chronic myotendinous strain injury in mdx mice expressing a truncated 
dystrophin. Human Molecular Genetics. 2008 December 15;17(24):3975-3986.
42. Burkin DJ, Wallace GQ, Nicol KJ, Kaufman DJ, Kaufman SJ. Enhanced expression 
of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in 
dystrophic mice. The Journal of Cell Biology. 2001 March 19;152(6):1207-1218.
43. Burkin DJ, Wallace GQ, Milner DJ, Chaney EJ, Mulligan JA, Kaufman SJ.
Transgenic expression of {alpha}7{beta}1 integrin maintains muscle integrity, increases 
regenerative capacity, promotes hypertrophy, and reduces cardiomyopathy in dystrophic 
mice. The American journal of pathology. 2005 January;166(1):253-263.
144
44. Doe JA, Wuebbles RD, Allred ET, Rooney JE, Elorza M, Burkin DJ. Transgenic 
overexpression of the {alpha}7 integrin reduces muscle pathology and improves viability 
in the dyW mouse model of merosin-deficient congenital muscular dystrophy type 1A. 
Journal of Cell Science. 2011 July 1;124(13):2287-2297.
45. Liu J, Milner DJ, Boppart MD, Ross RS, Kaufman SJ. P1D chain increases a7p1 
integrin and laminin and protects against sarcolemmal damage in mdx mice. Human 
Molecular Genetics. 2011 December 30.
46. Sen S, Tewari M, Zajac A, Barton E, Sweeney HL, Discher DE. Upregulation of 
paxillin and focal adhesion signaling follows Dystroglycan Complex deletions and 
promotes a hypertensive state of differentiation. European journal of cell biology. 2011 
January;90(2-3):249-260.
47. Durbeej M, Campbell KP. Muscular dystrophies involving the dystrophin- 
glycoprotein complex: an overview of current mouse models. Current opinion in genetics 
& development. 2002 June;12(3):349-361.
48. Guyon JR, Steffen LS, Howell MH, Pusack TJ, Lawrence C, Kunkel LM. Modeling 
human muscle disease in zebrafish. Biochimica et biophysica acta. 2007 February; 
1772(2):205-215.
49. Steffen LS, Guyon JR, Vogel ED, Beltre R, Pusack TJ, Zhou Y, Zon LI, Kunkel LM. 
Zebrafish orthologs of human muscular dystrophy genes. BMC genomics. 2007;8:79-.
50. Bassett DI. The zebrafish as a model for muscular dystrophy and congenital 
myopathy. Human Molecular Genetics. 2003 August 19;12(90002):265R-270.
51. Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. 
Nature Reviews Genetics. 2007 May;8(5):353-367.
52. Devoto S, Stoiber W, Hammond C. Generality of vertebrate developmental patterns: 
evidence for a dermomyotome in fish. Evol. Dev. 2006. 8(1):101-110.
53. Devoto S. The teleost dermomyotome. Developmental Dynamics. 2007.
54. Blochz W. METHODS IN CELL BIOLOGY THE ZEBRAFISH: DISEASE 
MODELS AND CHEMICAL SCREENS - H William Detrich, III, Monte Westerfield, 
Leonard I. Zon - vol. 105, Third edition, Chapter 8. 2011.
55. Charvet B, Malbouyres M, Pagnon-Minot A, Ruggiero F, Le Guellec D. Development 
of the zebrafish myoseptum with emphasis on the myotendinous junction. Cell and tissue 
research. 2011 December;346(3):439-449.
145
56. Summers AP, Koob TJ. The evolution of tendon--morphology and material properties. 
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology. 
2002 December;133(4):1159-1170.
57. Hynes RO. The Evolution of Cell Adhesion. The Journal of Cell Biology. 2000 July 
24;150(2):89F-96.
58. Crawford BD, Henry CA, Clason TA, Becker AL, Hille MB. Activity and distribution 
of paxillin, focal adhesion kinase, and cadherin indicate cooperative roles during 
zebrafish morphogenesis. Molecular biology of the cell. 2003 August;14(8):3065-3081.
59. Hall TE, Bryson-Richardson RJ, Berger S, Jacoby AS, Cole NJ, Hollway GE, Berger 
J, Currie PD. The zebrafish candyfloss mutant implicates extracellular matrix adhesion 
failure in laminin alpha2-deficient congenital muscular dystrophy. Proceedings of the 
National Academy of Sciences of the United States of America. 2007 April 24;104(17): 
7092-7097.
60. Snow CJ, Henry CA. Dynamic formation of microenvironments at the myotendinous 
junction correlates with muscle fiber morphogenesis in zebrafish. Gene expression 
patterns : GEP. 2009 January;9(1):37-42.
61. Sztal T, Berger S, Currie PD, Hall TE. Characterization of the laminin gene family 
and evolution in zebrafish. Developmental dynamics : an official publication of the 
American Association of Anatomists. 2011 February;240(2):422-431.
62. Ochi H. Signaling networks that regulate muscle development: lessons from 
zebrafish. Development (Cambridge, England). 2007.
63. Bryson-Richardson RJ, Currie PD. The genetics of vertebrate myogenesis. Nature 
Reviews Genetics. 2008 August;9(8):632-646.
64. Berger J, Berger S, Hall TE, Lieschke GJ, Currie PD. Dystrophin-deficient zebrafish 
feature aspects of the Duchenne muscular dystrophy pathology. Neuromuscular 
disorders : NMD. 2010 December;20(12):826-832.
65. Bassett D, Bryson-Richardson R, Daggett D. Dystrophin is required for the formation 
of stable muscle attachments in the zebrafish embryo. Development (Cambridge, 
England). 2003 December 1;130(23):5851-5860.
66. Hasegawa T, Matsumura K, Hashimoto T, Ikehira H, Fukuda H, Tateno Y. 
[Intramuscular degeneration process in Duchenne muscular dystrophy--investigation by 
longitudinal MR imaging of the skeletal muscles]. Rinsho shinkeigaku = Clinical 
neurology. 1992 March;32(3):333-335.
146
67. Nagao H, Morimoto T, Sano N. Magnetic resonance imaging of skeletal muscle in 
patients with Duchenne muscular dystrophy--serial axial and sagittal section studies]. No 
to hattatsu. 1991 January;23(1):39-43.
68. Kawahara G, Karpf JA, Myers JA, Alexander MS, Guyon JR, Kunkel LM. Drug 
screening in a zebrafish model of Duchenne muscular dystrophy. Proceedings of the 
National Academy of Sciences of the United States of America. 2011 March 29;108(13): 
5331-5336.
69. Li J, Rao H, Burkin D, Kaufman SJ, Wu C. The muscle integrin binding protein 
(MIBP) interacts with a7p1 integrin and regulates cell adhesion and laminin matrix 
deposition. Developmental biology. 2003 September 1;261(1):209-219.
70. Belenky P, Racette FG, Bogan KL, McClure JM, Smith JS, Brenner C. Nicotinamide 
riboside promotes Sir2 silencing and extends lifespan via Nrk and Urh1/Pnp1/Meu1 
pathways to NAD+. Cell. 2007 May 4;129(3):473-484.
71. Bieganowski P, Brenner C. Discoveries of nicotinamide riboside as a nutrient and 
conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi 
and humans. Cell. 2004 May 14;117(4):495-502.
72. Tempel W, Rabeh WM, Bogan KL, Belenky P, Wojcik M, Seidle HF, Nedyalkova L, 
Yang T, Sauve AA, Park H-W, et al. Nicotinamide Riboside Kinase Structures Reveal 
New Pathways to NAD. Plos Biology. 2007;5(10):e263.
73. Geiger B, Bershadsky A, Pankov R, Yamada KM. Transmembrane crosstalk between 
the extracellular matrix--cytoskeleton crosstalk. Nature Reviews Molecular Cell Biology. 
2001 November;2(11):793-805.
74. Lock J, Wehrle-Haller B. Cell-matrix adhesion complexes: master control machinery 
of cell migration. Seminars in cancer biology. 2008.
75. Schaller M, Borgman C. pp125FAK a structurally distinctive protein-tyrosine kinase 
associated with focal adhesions. PNAS. 1992 June; 89(11):5192-5196.
76. Chatzizacharias NA, Kouraklis GP, Theocharis SE. Clinical significance of FAK 
expression in human neoplasia. Histology and histopathology. 2008 May;23(5):629-650.
77. Ilic D, Furuta Y, Kanazawa S, Takeda N, Sobue K, Nakatsuji N, Nomura S, Fujimoto 
J, Okada M, Yamamoto T. Reduced cell motility and enhanced focal adhesion contact 
formation in cells from FAK-deficient mice. Nature. 1995 October 12;377(6549):539- 
544.
147
78. Quach NL, Rando TA. Focal adhesion kinase is essential for costamerogenesis in 
cultured skeletal muscle cells. Developmental biology. 2006 May 1;293(1):38-52.
79. Gordon SE, Fluck M, Booth FW. Selected Contribution: Skeletal muscle focal 
adhesion kinase, paxillin, and serum response factor are loading dependent. Journal of 
Applied Physiology. 2001 March;90(3):1174-83; discussion 1165.
80. Digman MA, Brown CM, Horwitz AR, Mantulin WW, Gratton E. Paxillin dynamics 
measured during adhesion assembly and disassembly by correlation spectroscopy. 
Biophysical journal. 2008 April 1;94(7):2819-2831.
81. Webb DJ, Donais K, Whitmore LA, Thomas SM, Turner CE, Parsons JT, Horwitz AF. 
FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. 
Nature Cell Biology. 2004 February;6(2):154-161.
82. Kanagawa M, Toda T. The genetic and molecular basis of muscular dystrophy: roles 
of cell-matrix linkage in the pathogenesis. Journal of human genetics. 2006;51(11):915- 
926.
83. Schessl J, Zou Y, Bonnemann CG. Congenital muscular dystrophies and the 
extracellular matrix. Seminars in pediatric neurology. 2006 June;13(2):80-89.
84. Li J, Mayne R, Wu C. A novel muscle-specific beta 1 integrin binding protein (MIBP) 
that modulates myogenic differentiation. The Journal of Cell Biology. 1999 December 
27;147(7):1391-1398.
85. Sadkowski T, Jank M, Zwierzchowski L, Siadkowska E, Oprzadek J, Motyl T. Gene 
expression profiling in skeletal muscle of Holstein-Friesian bulls with single-nucleotide 
polymorphism in the myostatin gene 5'-flanking region. Journal of applied genetics. 
2008;49(3):237-250.
86. Stockwin LH, Vistica DT, Kenney S, Schrump DS, Butcher DO, Raffeld M, 
Shoemaker RH. Gene expression profiling of alveolar soft-part sarcoma (ASPS). BMC 
cancer. 2009;9:22.
87. Belenky P, Bogan KL, Brenner C. NAD+ metabolism in health and disease. Trends in 
biochemical sciences. 2007 January;32(1):12-19.
88. Belenky P, Christensen KC, Gazzaniga F, Pletnev AA, Brenner C. Nicotinamide 
riboside and nicotinic acid riboside salvage in fungi and mammals. Quantitative basis for 
Urh1 and purine nucleoside phosphorylase function in NAD+ metabolism. Journal of 
Biological Chemistry. 2009 January 2;284(1):158-164.
148
89. Bogan KL, Brenner C. Nicotinic acid, nicotinamide, and nicotinamide riboside: a 
molecular evaluation of NAD+ precursor vitamins in human nutrition. Annual review of 
nutrition. 2008;28:115-130.
90. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of 
embryonic development of the zebrafish. Developmental dynamics : an official 
publication of the American Association of Anatomists. 2005 February 3;203(3):253- 
310.
91. Kwan KM, Fujimoto E, Grabher C, Mangum BD, Hardy ME, Campbell DS, Parant 
JM, Yost HJ, Kanki JP, Chien C-B. The Tol2kit: a multisite gateway-based construction 
kit for Tol2 transposon transgenesis constructs. Developmental dynamics : an official 
publication of the American Association of Anatomists. 2007 November;236(11):3088- 
3099.
92. Parsons M, Campos I, Hirst E, Stemple D. Removal of dystroglycan causes severe 
muscular dystrophy in zebrafish embryos. Development (Cambridge, England). 
2002;129(14):3505-3512.
93. Parsons MJ, Pollard SM, Saude L, Feldman B, Coutinho P, Hirst EMA, Stemple DL. 
Zebrafish mutants identify an essential role for laminins in notochord formation. 
Development (Cambridge, England). 2002 July;129(13):3137-3146.
94. Jones KS, Alimov AP, Rilo HL, Jandacek RJ, Woollett LA, Penberthy WT. A high 
throughput live transparent animal bioassay to identify non-toxic small molecules or 
genes that regulate vertebrate fat metabolism for obesity drug development. Nutrition & 
Metabolism. 2008;5:23.
95. Link V, Shevchenko A, Heisenberg C-P. Proteomics of early zebrafish embryos. BMC 
developmental biology. 2006;6:1.
96. Henry CA, McNulty IM, Durst WA, Munchel SE, Amacher SL. Interactions between 
muscle fibers and segment boundaries in zebrafish. Developmental biology. 2005 
November 15;287(2):346-360.
97. Arnedo A, Decoster N, Roux S. A wavelet-based method for multifractal image 
analysis. I. Methodology and test applications on isotropic and anisotropic random rough 
surfaces. European Physical Journal B. 2000;15(3):567-600.
98. Khalil A, Joncas G, Nekka F, Kestener P, Arneodo A. Morphological Analysis of H 
iFeatures. II. Wavelet-based Multifractal Formalism. The Astrophysical Journal 
Supplement Series. 2006 August;165(2):512-550.
149
99. Thisse B, Heyer V, Lux A, Alunni V, Degrave A, Seiliez I, Kirchner J, Parkhill J-P, 
Thisse C. Spatial and temporal expression of the zebrafish genome by large-scale in situ 
hybridization screening. Methods in cell biology. 2004;77:505-519.
100. Eisen JS, Smith JC. Controlling morpholino experiments: don't stop making 
antisense. Development (Cambridge, England). 2008 May;135(10):1735-1743.
101. Robu ME, Larson JD, Nasevicius A, Beiraghi S, Brenner C, Farber SA, Ekker SC. 
p53 activation by knockdown technologies. PLoS genetics. 2007 May 25;3(5):e78.
102. Peterson MT, Henry CA. Hedgehog signaling and laminin play unique and 
synergistic roles in muscle development. Developmental dynamics : an official 
publication of the American Association of Anatomists. 2010 March;239(3):905-913.
103. Snow CJ, Goody M, Kelly MW, Oster EC, Jones R, Khalil A, Henry CA. Time-lapse 
analysis and mathematical characterization elucidate novel mechanisms underlying 
muscle morphogenesis. PLoS genetics. 2008;4(10):e1000219.
104. Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. 
Clinical & experimental metastasis. 2009;26(1):19-34.
105. White ES, Baralle FE, Muro AF. New insights into form and function of fibronectin 
splice variants. The Journal of Pathology. 2008 September;216(1):1-14.
106. Hassa PO, Hottiger MO. The diverse biological roles of mammalian PARPS, a small 
but powerful family of poly-ADP-ribose polymerases. Frontiers in bioscience : a journal 
and virtual library. 2008;13:3046-3082.
107. Kahn RA. Toward a model for Arf GTPases as regulators of traffic at the Golgi. 
FEBS letters. 2009 December 3;583(23):3872-3879.
108. Keppler BR, Archer TK. Chromatin-modifying enzymes as therapeutic targets--Part 
1. Expert opinion on therapeutic targets. 2008 October;12(10):1301-1312.
109. Koch-Nolte F, Kernstock S, Mueller-Dieckmann C, Weiss MS, Haag F. Mammalian 
ADP-ribosyltransferases and ADP-ribosylhydrolases. Frontiers in bioscience : a journal 
and virtual library. 2008;13:6716-6729.
110. Myers KR, Casanova JE. Regulation of actin cytoskeleton dynamics by Arf-family 
GTPases. Trends in cell biology. 2008 April;18(4):184-192.
111. Sabe H, Onodera Y, Mazaki Y, Hashimoto S. ArfGAP family proteins in cell 
adhesion, migration and tumor invasion. Current opinion in cell biology. 2006 October; 
18(5):558-564.
150
112. Saporita AJ, Maggi LB, Apicelli AJ, Weber JD. Therapeutic targets in the ARF 
tumor suppressor pathway. Current medicinal chemistry. 2007;14(17):1815-1827.
113. Zhao Z, Gruszczynska-Biegala J, Zolkiewska A. ADP-ribosylation of integrin 
alpha7 modulates the binding of integrin alpha7beta1 to laminin. Biochem J. 2005 
January 1;385(Pt 1):309-317.
114. Zolkiewska A, Moss J. The alpha 7 integrin as a target protein for cell surface mono- 
ADP-ribosylation in muscle cells. Muscle Biophysics: From Molecules to Cells. 
1997;419:297-303.
115. Waller JC, Dhanoa PK, Schumann U, Mullen RT, Snedden WA. Subcellular and 
tissue localization of NAD kinases from Arabidopsis: compartmentalization of de novo 
NADP biosynthesis. Planta. 2010 January;231(2):305-317.
116. Tariq M, Azeem Z, Ali G, Chishti MS, Ahmad W. Mutation in the HPGD gene 
encoding NAD+ dependent 15-hydroxyprostaglandin dehydrogenase underlies isolated 
congenital nail clubbing (ICNC). Journal of medical genetics. 2009 January;46(1):14-20.
117. Bassett D, Currie P. Identification of a zebrafish model of muscular dystrophy. In: 
Vol. 31. 2004. pp. 537-540.
118. Nixon S, Wegner J, Ferguson C, Mery P, Hancock J, Currie P, Key B, Westerfield M, 
Parton R. Zebrafish as a model for caveolin-associated muscle disease; caveolin-3 is 
required for myofibril organization and muscle cell patterning. Human Molecular 
Genetics. 2005;14(13):1727-1743.
119. Postel R, Vakeel P, Topczewski J, Knoll R, Bakkers J. Zebrafish integrin-linked 
kinase is required in skeletal muscles for strengthening the integrin-ECM adhesion 
complex. Developmental biology. 2008 June 1;318(1):92-101.
120. Steffen LS, Guyon JR, Vogel ED, Howell MH, Zhou Y, Weber GJ, Zon LI, Kunkel 
LM. The zebrafish runzel muscular dystrophy is linked to the titin gene. Developmental 
biology. 2007 September 15;309(2):180-192.
121. Thornhill P, Bassett D, Lochmuller H, Bushby K, Straub V. Developmental defects 
in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related 
protein (FKRP). Brain : a journal of neurology. 2008 June;131(Pt 6):1551-1561.
122. Lin Y-Y, White RJ, Torelli S, Cirak S, Muntoni F, Stemple DL. Zebrafish Fukutin 
family proteins link the unfolded protein response with dystroglycanopathies. Human 
Molecular Genetics. 2011 May 1;20(9):1763-1775.
151
123. Kudo H, Amizuka N, Araki K, Inohaya K, Kudo A. Zebrafish periostin is required 
for the adhesion of muscle fiber bundles to the myoseptum and for the differentiation of 
muscle fibers. Developmental biology. 2004 March 15;267(2):473-487.
124. Pagnon-Minot A, Malbouyres M, Haftek-Terreau Z, Kim HR, Sasaki T, Thisse C, 
Thisse B, Ingham PW, Ruggiero F, Le Guellec D. Collagen XV, a novel factor in 
zebrafish notochord differentiation and muscle development. Developmental biology. 
2008 April 1;316(1):21-35.
125. Deakin NO, Turner CE. Paxillin comes of age. Journal of Cell Science. 2008 August 
1;121(Pt 15):2435-2444.
126. Tzu J, Marinkovich MP. Bridging structure with function: Structural, regulatory, and 
developmental role of laminins. The International Journal of Biochemistry & Cell 
Biology. 2008 January;40(2):199-214.
127. Hagel M, George EL, Kim A, Tamimi R, Opitz SL, Turner CE, Imamoto A, Thomas 
SM. The adaptor protein paxillin is essential for normal development in the mouse and is 
a critical transducer of fibronectin signaling. Molecular and Cellular Biology. 2002 
February;22(3):901-915.
128. Wade R, Bohl J, Vande Pol S. Paxillin null embryonic stem cells are impaired in cell 
spreading and tyrosine phosphorylation of focal adhesion kinase. Oncogene. 2002 
January 3;21(1):96-107.
129. Bertolucci CM, Guibao CD, Zheng J. Structural features of the focal adhesion 
kinase-paxillin complex give insight into the dynamics of focal adhesion assembly. 
Protein science : a publication of the Protein Society. 2005 March;14(3):644-652.
130. Gao G, Prutzman KC, King ML, Scheswohl DM, DeRose EF, London RE, Schaller 
MD, Campbell SL. NMR solution structure of the focal adhesion targeting domain of 
focal adhesion kinase in complex with a paxillin LD peptide: evidence for a two-site 
binding model. Journal of Biological Chemistry. 2004 February 27;279(9):8441-8451.
131. Thomas JW. The Role of Focal Adhesion Kinase Binding in the Regulation of 
Tyrosine Phosphorylation of Paxillin. Journal of Biological Chemistry. 1999 December 
17;274(51):36684-36692.
132. Scheswohl DM, Harrell JR, Rajfur Z, Gao G, Campbell SL, Schaller MD. Multiple 
paxillin binding sites regulate FAK function. Journal of molecular signaling. 2008;3:1.
133. Cooper WJ, Albertson RC. Quantification and variation in experimental studies of 
morphogenesis. Developmental biology. 2008 September 15;321(2):295-302.
152
134. Albertson RC, Yelick PC. Fgf8 haploinsufficiency results in distinct craniofacial 
defects in adult zebrafish. Developmental biology. 2007 June 15;306(2):505-515.
135. Briguet A, Courdier-Fruh I, Foster M, Meier T, Magyar JP. Histological parameters 
for the quantitative assessment of muscular dystrophy in the mdx-mouse. Neuromuscular 
Disorders. 2004 October;14(10):675-682.
136. Park TJ, Mitchell BJ, Abitua PB, Kintner C, Wallingford JB. Dishevelled controls 
apical docking and planar polarization of basal bodies in ciliated epithelial cells. Nature 
genetics. 2008 July;40(7):871-879.
137. Yin C, Kiskowski M, Pouille P-A, Farge E, Solnica-Krezel L. Cooperation of 
polarized cell intercalations drives convergence and extension of presomitic mesoderm 
during zebrafish gastrulation. Journal of Cell Biology. 2008 January 14;180(1):221-232.
138. Ibraghimov-Beskrovnaya OO, Ervasti JMJ, Leveille CJC, Slaughter CAC, Sernett 
SWS, Campbell KPK. Primary structure of dystrophin-associated glycoproteins linking 
dystrophin to the extracellular matrix. Nature. 1992 February 20;355(6362):696-702.
139. Gee SHS, Montanaro FF, Lindenbaum MHM, Carbonetto SS. Dystroglycan-alpha, a 
dystrophin-associated glycoprotein, is a functional agrin receptor. Cell. 1994 June 
3;77(5):675-686.
140. Yamada HH, Shimizu TT, Tanaka TT, Campbell KPK, Matsumura KK.
Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS 
letters. 1994 September 19;352(1):49-53.
141. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a 
transmembrane linker between laminin and actin. The Journal of Cell Biology. 1993 
August;122(4):809-823.
142. Frost AR, Bohm SV, Sewduth RN, Josifova D, Ogilvie CM, Izatt L, Roberts RG. 
Heterozygous deletion of a 2-Mb region including the dystroglycan gene in a patient with 
mild myopathy, facial hypotonia, oral-motor dyspraxia and white matter abnormalities. 
European journal of human genetics : EJHG. 2010 March 17;18(7):852-855.
143. Hara Y, Balci-Hayta B, Yoshida-Moriguchi T, Kanagawa M, Beltran-Valero de 
Bernabe D, Gunde§li H, Willer T, Satz JS, Crawford RW, Burden SJ, et al. A dystroglycan 
mutation associated with limb-girdle muscular dystrophy. The New England journal of 
medicine. 2011 March 10;364(10):939-946.
144. Inamori K-I, Yoshida-Moriguchi T, Hara Y, Anderson ME, Yu L, Campbell KP. 
Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. 
Science. 2012 January 6;335(6064):93-96.
153
145. Godfrey C, Foley AR, Clement E, Muntoni F. Dystroglycanopathies: coming into 
focus. Current opinion in genetics & development. 2011 June 1;21(3):278-285.
146. Mercuri E, Messina S, Bruno C, Mora M, Pegoraro E, Comi GP, D'Amico A, Aiello 
C, Biancheri R, Berardinelli A, et al. Congenital muscular dystrophies with defective 
glycosylation of dystroglycan: a population study. Neurology. 2009 May 26;72(21): 
1802-1809.
147. Jimenez-Mallebrera C, Torelli S, Feng L, Kim J, Godfrey C, Clement E, Mein R, 
Abbs S, Brown SC, Campbell KP, et al. A comparative study of alpha-dystroglycan 
glycosylation in dystroglycanopathies suggests that the hypoglycosylation of alpha- 
dystroglycan does not consistently correlate with clinical severity. Brain pathology 
(Zurich, Switzerland). 2009 October;19(4):596-611.
148. Moore CJ, Goh HT, Hewitt JE. Genes required for functional glycosylation of 
dystroglycan are conserved in zebrafish. Genomics. 2008 September;92(3):159-167.
149. Han R, Kanagawa M, Yoshida-Moriguchi T, Rader EP, Ng RA, Michele DE, 
Muirhead DE, Kunz S, Moore SA, Iannaccone ST, et al. Inaugural Article: Basal lamina 
strengthens cell membrane integrity via the laminin G domain-binding motif of - 
dystroglycan. Proceedings of the National Academy of Sciences. 2009 August 4;106(31): 
12573-12579.
150. Mayer U, Saher G, Fassler R, Bornemann A, Echtermeyer F, Mark HVD, Miosge N, 
Posch E, Mark KVD. Absence of integrin a7 causes a novel form of muscular dystrophy. 
Nature genetics. 1997 November;17(3):318-323.
151. Van Der Flier A, Gaspar A. Spatial and temporal expression of the P1D integrin 
during mouse development. Dev Dyn. 1997 Dec;210(4):472-86.
152. Goody MF, Kelly MW, Lessard KN, Khalil A, Henry CA. Nrk2b-mediated NAD+ 
production regulates cell adhesion and is required for muscle morphogenesis in vivo: 
Nrk2b and NAD+ in muscle morphogenesis. Developmental biology. 2010 August 
15;344(2):809-826.
153. Wiellette E, Grinblat Y, Austen M, Hirsinger E. Combined haploid and insertional 
mutation screen in the zebrafish. genesis. 2004.
154. Granato M, Van Eeden F, Schach U, Trowe T. Genes controlling and mediating 
locomotion behavior of the zebrafish embryo and larva. Development. 1996 123; 
399-413.
154
155. Hayashi YK, Chou F-L, Engvall E, Ogawa M, Matsuda C, Hirabayashi S, Yokochi 
K, Ziober BL, Kramer RH, Kaufman SJ, et al. Mutations in the integrin a7 gene cause 
congenital myopathy. Nature genetics. 1998 May;19(1):94-97.
156. Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. Journal of Cell 
Science. 2006 October 1;119(19):3901-3903.
157. Terpe HJ, Stark H, Ruiz P, Imhof BA. Alpha 6 integrin distribution in human 
embryonic and adult tissues. Histochemistry and Cell Biology. 1994 January;101(1):41-
49.
158. Bajanca F, Luz M, Raymond K, Martins GG, Sonnenberg A, Tajbakhsh S, 
Buckingham M, Thorsteinsdottir S. Integrin alpha6beta1-laminin interactions regulate 
early myotome formation in the mouse embryo. Development (Cambridge, England). 
2006 May;133(9):1635-1644.
159. Wilschut KJ, van Tol HTA, Arkesteijn GJA, Haagsman HP, Roelen BAJ. Alpha 6 
integrin is important for myogenic stem cell differentiation. Stem cell research. 2011 
September;7(2):112-123.
160. Wilschut KJ, Haagsman HP, Roelen BAJ. Extracellular matrix components direct 
porcine muscle stem cell behavior. Experimental Cell Research. 2010 February 1;316(3): 
341-352.
161. Castaldo C, Di Meglio F, Nurzynska D, Romano G, Maiello C, Bancone C, Muller 
P, Bohm M, Cotrufo M, Montagnani S. CD117-positive cells in adult human heart are 
localized in the subepicardium, and their activation is associated with laminin-1 and 
alpha6 integrin expression. Stem cells (Dayton, Ohio). 2008 July;26(7):1723-1731.
162. Dolez M, Nicolas J-F, Hirsinger E. Laminins, via heparan sulfate proteoglycans, 
participate in zebrafish myotome morphogenesis by modulating the pattern of Bmp 
responsiveness. Development (Cambridge, England). 2011 January;138(1):97-106.
163. Serena E, Zatti S, Reghelin E, Pasut A, Cimetta E, Elvassore N. Soft substrates drive 
optimal differentiation of human healthy and dystrophic myotubes. Integrative biology : 
quantitative biosciences from nano to macro. 2010 April 7;2(4):193-201.
164. Georges-Labouesse E, Messaddeq N, Yehia G. Absence of integrin a6 leads to 
epidermolysis bullosa and neonatal death in mice. Nature genetics. 1996.
165. Spiczka KS, Yeaman C. Ral-regulated interaction between Sec5 and paxillin targets 
Exocyst to focal complexes during cell migration. Journal of Cell Science. 2008 
September 1;121(Pt 17):2880-2891.
155
166. Mazaki Y. Paxillin Isoforms in Mouse. LACK OF THE gamma ISOFORM AND 
DEVELOPMENTALLY SPECIFIC beta ISOFORM EXPRESSION. Journal of 
Biological Chemistry. 1998 August 28;273(35):22435-22441.
167. Eliasson M, Sampei K, Mandir A. Poly (ADP-ribose) polymerase gene disruption 
renders mice resistant to cerebral ischemia. Nature. 1997.
168. Ieraci A, Herrera DG. Nicotinamide protects against ethanol-induced apoptotic 
neurodegeneration in the developing mouse brain. PLoS medicine. 2006 April;3(4):e101.
169. ALTSCHUL R, HOFFER A, STEPHEN JD. Influence of nicotinic acid on serum 
cholesterol in man. Archives of Biochemistry and Biophysics. 1955 February;54(2):558- 
559.
170. Hausenloy DJ, Yellon DM. Enhancing cardiovascular disease risk reduction: raising 
high-density lipoprotein levels. Current opinion in cardiology. 2009 September;24(5): 
473-482.
171. Shehadah A, Chen J, Zacharek A, Cui Y, Ion M, Roberts C, Kapke A, Chopp M. 
Niaspan treatment induces neuroprotection after stroke. Neurobiology of disease. 2010 
October;40(1):277-283.
172. Cho K-H, Kim H-J, Kamanna VS, Vaziri ND. Niacin improves renal lipid 
metabolism and slows progression in chronic kidney disease. Biochimica et biophysica 
acta. 2010 January;1800(1):6-15.
173. Sastry SK, Lakonishok M, Thomas DA, Muschler J, Horwitz AF. Integrin alpha 
subunit ratios, cytoplasmic domains, and growth factor synergy regulate muscle 
proliferation and differentiation. Journal of Cell Biology. 1996 April;133(1):169-184.
174. Sastry SK. Quantitative Changes in Integrin and Focal Adhesion Signaling Regulate 
Myoblast Cell Cycle Withdrawal. The Journal of Cell Biology. 1999 March 22;144(6): 
1295-1309.
175. Henderson L, Deodhar T, Krehl W. FACTORS AFFECTING THE GROWTH OF 
RATS RECEIVING NIACIN-TRYPTOPHAN-DEFICIENT DIETS. Journal of 
Biological Chemistry. 1947.
176. Nikiforov A, Dolle C, Niere M, Ziegler M. Pathways and subcellular 
compartmentation of NAD biosynthesis in human cells: from entry of extracellular 
precursors to mitochondrial NAD generation. Journal of Biological Chemistry. 2011 June 
17;286(24):21767-21778.
156
177. Di Lisa F, Ziegler M. Pathophysiological relevance of mitochondria in NAD(+) 
metabolism. FEBS letters. 2001 March 9;492(1-2):4-8.
178. Anderson RM, Bitterman KJ, Wood JG, Medvedik O, Cohen H, Lin SS, Manchester 
JK, Gordon JI, Sinclair DA. Manipulation of a nuclear NAD+ salvage pathway delays 
aging without altering steady-state NAD+ levels. Journal of Biological Chemistry. 2002 
May 24;277(21):18881-18890.
179. Revollo JR, Grimm AA, Imai S-I. The NAD biosynthesis pathway mediated by 
nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. 
Journal of Biological Chemistry. 2004 December 3;279(49):50754-50763.
180. Krzysik-Walker SM, Hadley JA, Pesall JE, McFarland DC, Vasilatos-Younken R, 
Ramachandran R. Nampt/visfatin/PBEF affects expression of myogenic regulatory 
factors and is regulated by interleukin-6 in chicken skeletal muscle cells. Comparative 
biochemistry and physiology. Part A, Molecular & integrative physiology. 2011 April 22.
181. Zolkiewska A. Ecto-ADP-ribose transferases: cell-surface response to local tissue 
injury. Physiology (Bethesda, Md.). 2005 December;20:374-381.
182. Petit V, Boyer B, Lentz D, Turner CE, Thiery JP, Valles AM. Phosphorylation of 
tyrosine residues 31 and 118 on paxillin regulates cell migration through an association 
with CRK in NBT-II cells. Journal of Cell Biology. 2000 March 6;148(5):957-970.
183. Brown MC, Turner CE. Paxillin: adapting to change. Physiological Reviews. 2004 
October;84(4):1315-1339.
184. Pasapera AM, Schneider IC, Rericha E, Schlaepfer DD, Waterman CM. Myosin II 
activity regulates vinculin recruitment to focal adhesions through FAK-mediated paxillin 
phosphorylation. Journal of Cell Biology. 2010 March 22;188(6):877-890.
185. Cortesio CL, Boateng LR, Piazza TM, Bennin DA, Huttenlocher A. Calpain- 
mediated proteolysis of paxillin negatively regulates focal adhesion dynamics and cell 
migration. Journal of Biological Chemistry. 2011 March 25;286(12):9998-10006.
186. Vindis C, Teli T, Cerretti DP, Turner CE, Huynh-Do U. EphB1-mediated cell 
migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118. Journal of 
Biological Chemistry. 2004 July 2;279(27):27965-27970.
187. Badowski C, Pawlak G, Grichine A, Chabadel A, Oddou C, Jurdic P, Pfaff M, 
Albiges-Rizo C, Block MR. Paxillin phosphorylation controls invadopodia/podosomes 
spatiotemporal organization. Molecular biology of the cell. 2008 February;19(2):633- 
645.
157
188. Tsubouchi A, Sakakura J, Yagi R, Mazaki Y, Schaefer E, Yano H, Sabe H. Localized 
suppression of RhoA activity by Tyr31/118-phosphorylated paxillin in cell adhesion and 
migration. The Journal of Cell Biology. 2002 November 25;159(4):673-683.
189. Chen Y-H, Wang Y-H, Chang M-Y, Lin C-Y, Weng C-W, Westerfield M, Tsai H-J. 
Multiple upstream modules regulate zebrafish myf5 expression. BMC developmental 
biology. 2007;7:1.
190. Higashijima S, Okamoto H, Ueno N, Hotta Y, Eguchi G. High-frequency generation 
of transgenic zebrafish which reliably express GFP in whole muscles or the whole body 
by using promoters of zebrafish origin. Developmental biology. 1997 December 
15;192(2):289-299.
191. Ju B, Chong SW, He J, Wang X, Xu Y, Wan H, Tong Y, Yan T, Korzh V, Gong Z. 
Recapitulation of fast skeletal muscle development in zebrafish by transgenic expression 
of GFP under the mylz2 promoter. Developmental dynamics : an official publication of 
the American Association of Anatomists. 2003 May;227(1):14-26.
192. Kinali M, Arechavala-Gomeza V, Feng L, Cirak S, Hunt D, Adkin C, Guglieri M, 
Ashton E, Abbs S, Nihoyannopoulos P, et al. Local restoration of dystrophin expression 
with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, 
placebo-controlled, dose-escalation, proof-of-concept study. Lancet neurology. 2009 
October;8(10):918-928.
193. Cirak S, Arechavala-Gomeza V, Guglieri M, Feng L, Torelli S, Anthony K, Abbs S, 
Garralda ME, Bourke J, Wells DJ, et al. Exon skipping and dystrophin restoration in 
patients with Duchenne muscular dystrophy after systemic phosphorodiamidate 
morpholino oligomer treatment: an open-label, phase 2, dose-escalation study. The 
Lancet. 2011 August;378(9791):595-605.
194. Lacadie S, Li P, Taylor A, Zon L. Small molecule screening in zebrafish: swimming 
in potential drug therapies. WIREs Developmental Biology. 2012.
195. Adam A, Bartfai R, Lele Z, Krone PH, Orban L. Heat-inducible expression of a 
reporter gene detected by transient assay in zebrafish. Experimental Cell Research. 2000 
April 10;256(1):282-290.
196. Bonnemann CG. The collagen VI-related myopathies Ullrich congenital muscular 
dystrophy and Bethlem myopathy. Handbook of clinical neurology / edited by P.J. Vinken 
and G.W. Bruyn. 2011;101:81-96.
197. Bernardi P, Bonaldo P. Dysfunction of mitochondria and sarcoplasmic reticulum in 
the pathogenesis of collagen VI muscular dystrophies. Annals of the New York Academy 
of Sciences. 2008 December;1147:303-311.
158
198. Merlini L, Angelin A, Tiepolo T, Braghetta P, Sabatelli P, Zamparelli A, Ferlini A, 
Maraldi NM, Bonaldo P, Bernardi P. Cyclosporin A corrects mitochondrial dysfunction 
and muscle apoptosis in patients with collagen VI myopathies. Proceedings of the 
National Academy of Sciences. 2008 April 1;105(13):5225-5229.
199. Irwin WA, Bergamin N, Sabatelli P, Reggiani C, Megighian A, Merlini L, Braghetta 
P, Columbaro M, Volpin D, Bressan GM, et al. Mitochondrial dysfunction and apoptosis 
in myopathic mice with collagen VI deficiency. Nature genetics. 2003 December;35(4): 
367-371.
200. Telfer WR, Busta AS, Bonnemann CG, Feldman EL, Dowling JJ. Zebrafish models 
of collagen VI-related myopathies. Human Molecular Genetics. 2010 June 15;19(12): 
2433-2444.
159
APPENDIX A
______________________ REVIEW ARTICLE
M olecular Reproduction &  D evelopm en t 77:475—488 (2010)
Dynamic Interactions Between Cells and Their Extracellular 
Matrix Mediate Embryonic Development
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SUMMARY
Cells and their surrounding extracellular matrix microenvironment interact throughout 
all stages of life. Understanding the continuously changing scope of cell-matrix 
interactions in vivo is crucial to garner insights into both congenital birth defects and 
disease progression. A current challenge in the field of developmental biology is to 
adapt in vitro tools and rapidly evolving imaging technology to study cell-matrix 
interactions in a complex 4-D environment. In this review, we highlight the dynamic 
modulation of cell-matrix interactions during development. We propose that individual 
cell-matrix adhesion proteins are best considered as complex proteins that can play 
multiple, often seemingly contradictory roles, depending upon the context of the 
microenvironment. In addition, cell-matrix proteins can also exert different short 
versus long term effects. It is thus important to consider cell behavior in light of the 
microenvironment because of the constant and dynamic reciprocal interactions 
occurring between them. Finally, we suggest that analysis of cell-matrix interactions 
at multiple levels (molecules, cells, tissues) in vivo is critical for an integrated 
understanding because different information can be acquired from all size scales.
[RJemodeling o f  the E C M  allows 
cells to integrate signaling and 
differentiation w ith  the structure  
o f their local microenvironment.
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INTRODUCTION
The extracellular matrix (ECM) was once thought to be 
merely a scaffold that occupied the spaces between cells in 
multicellular organisms. It was thought that ECM was only 
required for cell proliferation and inhibition of programmed 
cell death. However, the ECM is now recognized as a 
complex and dynamic structure that is critical for normal 
development and physiology. Cells interact constantly with 
the ECM: they adhere to/disengage from the ECM and 
secrete proteins that modify the e Cm  environment. Complex 
and changing cell-ECM interactions mediate cell survival, 
apoptosis, division, differentiation, and are a hallmark of 
embryonic development.
Although all tissues contain ECM, the composition of the 
ECM in different tissues varies tremendously. The ECM 
provides physical support to an organism and fills the space 
between cells and tissues. Not only does the ECM provide a
© 2010 W ILEY-LISS, INC.
three-dimensional substructure for cell adhesion and move­
ment, but the ECM also acts as a storage compartment for 
signaling molecules. Broadly, the ECM can be thought of as 
a hydrated meshwork comprised of proteins with different 
biophysical functions. The relative proportion of proteins 
with different physical characteristics generates different 
ECMs with varying biomechanical properties. The ECM in 
skin is fairly elastic, the ECM in bone is very stiff, and ECM 
stiffness/elasticity varies in connective tissues like tendons. 
Thus, there is an exquisite tissue specificity to ECM com­
ponents that reflects the biophysical requirements of each 
tissue— the epitome of coordination between form and 
function.
Abbreviations: CMAC =  cell m atrix adhesion complex; ECM =  extracellular 
matrix; F A = focal adhesion; FB =  fibrilla r adhesions; FC =  focal complex; 
FGF(R) =  fibroblast growth factor (receptor); Fn =  fibronectin; GAG =  glycosami- 
noglycan; MMP =  m atrixm eta lloprotease; PCP =  planar cell polarity
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Why is regulation of the interactions between cells and 
the ECM critical? This can perhaps best be understood with 
an imperfect (but informative) analogy. Imagine a cell as a 
hiker who can run up a well maintained gentle slope, pains­
takingly scramble up a steep slope, don crampons and rope 
up with other hikers to climb Mt. Rainier, or anything in 
between. In the case of the hiker, many choices are made: 
where to start, where to finish, how to get there, what 
footwear and clothing is most appropriate for the conditions, 
etc. The initial decision to hike up an easy climb in good 
weather can turn disastrous if conditions change and the 
hiker must adjust their path and/or clothing and gear.
Although migrating cells do not “choose” their path and 
instead follow their genetic program, their behavior is com­
plex and modified by constant interactions with the ECM. 
Cells can migrate individually or in groups. The speed and 
directionality of migration are critically dependent upon the 
extracellular environment. Migration tends to be slower in 
highly adhesive environments and faster in less adhesive 
environments. Cells can migrate on different matrices (the 
mountains) and with different receptors (the clothing and 
footwear of the hiker). The interaction of cells with their 
extracellular environment is dynamic like the conditions on 
a mountain and cells can adapt to perturbations, that is, a 
change in the weather.
ECM composition within the same tissue is also dynamic 
and reflects the delicate balance between ECM degradation 
and synthesis. The composition of the ECM within a tissue 
changes not only during morphogenetic events in early 
development, but also in aging and disease. One large focus 
of current research is to understand how the normal balance 
between ECM degradation and synthesis is maintained, with 
the goal being to understand how this system is deregulated 
during aging and disease.
The vast majority of studies investigating cellular adhe- 
siontothe ECM have beendone in vitro. It isclearfrom these 
studies that regulation of cell-ECM adhesion occurs on 
many different levels including gene expression, alternative 
splicing, translational regulation, post-translational modifi­
cation, and formation of multiprotein complexes. The next 
critical step for developmental biologists is to understand cell 
behavior in vivo. Pioneering efforts from a number of labo­
ratories generated targeted mouse knockouts and showed 
that: (1) inhibition of cell-ECM adhesion is frequently lethal 
and (2) different components of the cell-ECM adhesion 
machinery play specific roles during embryonic develop­
ment (Aszodi et al., 2006). These experiments showed that 
cell-ECM adhesion plays a critical role during embryonic 
development. However, due to early embryonic lethality, 
they did not elucidate many of the underlying mechanisms 
driving cell-ECM interactions.
The current challenge is to use new advances in technol­
ogy to study the dynamics of cell-ECM adhesion in vivo. In 
particular, understanding the intimate, bi-directional rela­
tionship between cells and their local ECM environment is 
critical. ECM remodeling accompanies cellular shape 
changes, cell migration, and differentiation. ECM remodel­
ing can also influence cell signaling via the release of 
secreted signaling molecules previously sequestered within 
the ECM. ECM remodeling is induced by many different
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signals, including cellular tension and growth factor signal­
ing. Thus, remodeling of the ECM allows cells to integrate 
signaling and differentiation with the structure of their local 
microenvironment. The term ''dynamic reciprocity” was in­
troduced to promote the view that tissue architecture is 
critically dependent upon reciprocal signals between cells 
and their extracellular environment (Bisselletal., 1982). The 
intent of this review is to provide the reader with a broad 
overview of: (1) the myriad of ways in which cell adhesion to 
the ECM is regulated and (2) how this regulation is critical for 
development and physiology. All of the proteins mentioned 
herein are themselves the primary subjects of multiple re­
views. This review focuses more on studies that integrate 
dynamic interactions between cells and their ECM. For 
details, readers are referred to the elegant and more focused 
reviews and primary research papers referenced.
It is worth noting that one current trend in biology is the 
undertaking of “omics-type” studies. This large scale, high- 
throughput approach is critical and invaluable. However, 
one of the concepts that we would like to convey, through 
examples illustrated below, is that detailed analysis of 
cell-ECM interactions is also absolutely fundamental to 
understanding embryonic development as well as the tran­
sition to disease states. It is our opinion that a comprehen­
sive picture of cell behavior will emerge only by combining 
the information learned from studies at all size scales, along 
with new imaging technologies and modeling efforts.
COMPONENTS INVOLVED IN CELL-ECM  
ADHESION
Cell-ECM adhesion involves: (1) ECM proteins them­
selves, (2) transmembrane receptors that bind ECM ligands 
(integrins are the major class of transmembrane ECM 
receptors), and (3) intracellular proteins that directly or 
indirectly bind to integrins and/or the cytoskeleton to affect/ 
strengthen/maintain cell-ECM attachment and influence 
downstream signaling. We will discuss some of the most 
well-known proteins in each class.
Extracellular M atrix Proteins
Although the major structural components of different 
ECMs are the same, their relative proportions and types 
vary, resulting in strikingly different physical properties. One 
uniting feature of different ECMs with diverse functions is the 
ability to maintain shape and to flexibly respond to deforma­
tion. The major structural components of the ECM include: 
collagens, proteoglycans, noncollagenous glycoproteins, 
and elastins (Fig. 1). These components play complemen­
tary biophysical roles. Maintenance of structural integrity is 
predominantly via collagens, which are the most abundant 
protein in the human body. Collagen is a major component of 
connective tissues such as skin and cartilage. These tissues 
flexibly maintain shape by absorbing deformation. Clearly, 
however, skin and cartilage have different biophysical prop­
erties. There are different collagen types (fibrillar, globular) 
that generate varying three-dimensional scaffolds. In addi­
tion, the alignment and density of collagen are the primary 
determinants of the tensile strength of the ECM (Kjaer,
M ol Reprod D e v  77:475-488 (2010)
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Figure 1. Extracellular matrix (ECM) components: collagens, glycoproteins, proteoglycans, and elas- 
tins. The basement membrane is an ECM structure whose major constituents are collagen type IV and 
thepolymerized glycoprotein laminin. Cellsadheretothebasementmembranethrough transmembrane 
receptors like integrins. Another glycoprotein to which transmembrane receptors adhere is fibronectin 
(Fn). Other ECM components include proteoglycans and elastins. Proteoglycans are proteins plus a 
glycosaminoglycan (GAG). The GAG portion of proteoglycans attractswater and cationsand allowsfor 
the ECM to resist compression forces. Elastins resist shape deformation and give the ECM elasticity.
2004). The importance ofcollagen is highlighted by thefact 
that mutations in collagens type I, III, V, or type III procolla­
gen can result in Ehlers-Danlos syndrome, which is charac­
terized by skin laxity and joint hypermobility (Superti-Furga 
et al., 1989; Sillence et al., 1991; Nicholls et al., 1996; 
Toriello et al., 1996; De Paepe et al., 1997; Smith et al., 
1997). Synthesized collagen scaffolds show great promise 
for tissue engineering and regeneration. Some current 
efforts directed towards understanding collagen elasticity 
involve applying engineering concepts to molecular me­
chanisms (Scott, 2003; Chaudhryetal., 2009). The potential 
for engineered collagen scaffolds to be used as transient and 
bioresorbable cartilage, skin, and cardiovascular grafts is 
exciting and is the focus of much research.
Proteoglycans are a protein plus a glycosaminoglycan 
(GAG). The GAG portion of proteoglycans has a net nega­
tive charge that attracts water (and cations) to form a 
hydrous gel that resists compressive forces. Proteoglycans 
regulate collagen fibrillogenesis. Thus, proteoglycans can 
indirectly regulatetissue remodeling in responsetomechan- 
ical forces by modifying the amount, type, and alignment of 
collagen fibrils. The application oftensional orcompressive 
loads to excised bovine tendons changed the amount and 
composition of proteoglycans (Robbins et al., 1997). Pro­
teoglycan composition and amount can also change in vivo.
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An increase in proteoglycans and GAG content was ob­
served in tendons from 6.5 weeks old chickens that had been 
exercised on treadmills compared to their more sedentary 
counterparts (Yoon and Halper, 2005). In addition to modu­
lating the physical properties of the ECM in response to 
mechanical stress, proteoglycans also modulate the move­
ment and activity of signaling molecules through the ECM. 
Perlecan is an exceedingly large, ubiquitous ECM protein 
thatsurroundscells. Ithas been proposed that Perlecan acts 
as a clearing house that controls local levels ofmitogens and 
morphogens (Whitelock et al., 2008). The complex pheno­
type of mice mutantfor Perlecan attests to the importance of 
proteoglycans for normal development (Arikawa-Hirasawa 
et al., 1999; Costell et al., 1999).
Glycoproteins are proteins with sugar modifications. Two 
prominent noncollagenous glycoproteins, fibronectin (Fn) 
and laminin, are discussed in further detail below. Finally, 
elastins, as their name suggests, are remarkable proteins 
that are resistant to shape deformation and are primarily 
responsible for the elasticity of connective tissues (Debelle 
and Tamburro, 1999; Tatham and Shewry, 2000; Li and 
Daggett, 2002; Mithieux and Weiss, 2005; Daamen et al.,
2007). Elastin-based biomaterials are becoming popularfor 
tissue engineering due to their elastic properties, the stable 
nature of insoluble elastin (half-life of 70 years), and the
477
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potential for self-assembly. Perhaps the most famous bio­
elastic material is flagelliform spider silks, which can extend 
approximately 200% of their length without breaking (Xu and 
Lewis, 1990; Dong et al., 1991; Gosline et al., 1999)!
Spotlight on fibronectin. Fibronectin is a major compo­
nent of many extracellular matrices and plays roles in both 
development and disease. Fn is perhaps most renowned for 
its functions during branching morphogenesis and cell mi­
gration (Romanetal., 1991;Roman, 1997; Jiang etal., 2000; 
Sakai et al., 2003; Trinh and Stainier, 2004; Davidson et al., 
2006; Larsen et al., 2006b; Matsui et al., 2007). Fn provides 
an excellent example of the regulation of cell-ECM adhesion 
components at multiple levels. Fn transcription during em­
bryonic development is spatially and temporally regulated 
(Julich etal., 2005; Koshida etal., 2005; Matsui etal., 2007). 
Post-transcriptionally, there are many alternatively spliced 
forms of Fn. The expression of different splice variants 
frequently correlates with disease and is regulated by multi­
ple pathways (White et al., 2008). Fn regulation is further 
complicated by the fact that there are two forms of Fn: (1) 
plasma Fn (pFn) which circulates in the blood and is globular 
and (2) cellular Fn (cFn) which is assembled into fibrils that in 
turn polymerize to form a fibrillar matrix. Fn fibril formation is 
regulated on many levels, including dimerization and integrin 
binding, as well as stretch-mediated uncovering of a cryptic 
self-binding site (Leisset al., 2008). The ability of fibrillar Fn 
to be stretched up to fourfold by living cells may be particu­
larly relevant for dynamic cell movements that occur during 
development (Erickson, 2002).
One critical function of Fn is to regulate deposition of 
collagens type I and III in the ECM (Sottile and Hocking, 
2002; Velling et al., 2002). Interestingly, it has recently been 
shown that the ability of Fn to bind to collagen is critical for Fn 
-stimulated cell migration during wound healing (Sottile 
et al., 2007). Although this study was in vitro, the dynamic 
interaction between Fn-dependent collagen deposition and 
Fn-dependent cell migration highlights the need for integra­
tion of multiple ECM components when studying develop­
mental processes.
In the pastdecade, Fn hasalso been shown to be a critical 
regulator of branching morphogenesis. Branching occurs 
most frequently in epithelial tissues and involves repeated 
elongation and forking to generate the complex shapes of 
lungs, kidneys, and mammary glands, for example. As 
branching bears some similarities to fractals, mathemati­
cians and biologists have long been fascinated by the 
morphogenic process. An excellent and entertaining book 
devoted to branched systems begins with Leonardo da 
Vinci's early studies of tree dimensions, and is highly 
recommended for interested readers (Davies, 2005). Here, 
we will focus on recent results highlighting dynamic roles 
for Fn during branching morphogenesis. One model for 
branching morphogenesis is the mouse mandibular salivary 
gland. Branching occurs first by the formation of localized, 
shallow clefts, which then deepen to become new buds 
(Grobstein, 1953). A key study showed that Fn expression 
transiently increases at cleft epithelial cells just as narrow 
clefts form. The increase in Fn expression correlates with a 
decrease in the cell-cell adhesion protein, E-cadherin
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(Sakai et al., 2003). Fn expression decreases as clefts 
broaden. Incubation of salivary glands with an antibody 
against Fn inhibited branching whereas adding exogenous 
Fn increased branching (Sakai et al., 2003) (Fig. 2A). Thus, 
the authors proposed that localized Fn assembly at clefts 
results in the conversion of E-cadherin-based cell-cell 
adhesion to integrin-based cell-ECM adhesion, resulting 
in cleft progression. This pioneering experiment not only 
elucidated a key role for Fn in branching morphogenesis, but 
also highlights the dynamic role of ECM regulation during 
morphogenesis.
One key question that arose, however, was how adding 
exogenous Fn could promote branching if Fn was providing 
a local cue for cleft formation. A very elegant study ad­
dressed this issue by asking if directional Fn assembly might 
provide the impetus for cleft formation. Mouse mandibular 
salivary glands were incubated in Alexa-fluor conjugated 
Fn, which was then washed out and replaced by unlabeled 
Fn (Larsen et al., 2006b). This experiment showed that 
older Fn remains coherent, and is actually translocated 
inward as newer Fn is assembled behind it. Thus, the polarity 
of Fn assembly may provide a critical local cue for cleft 
progression (Larsen etal., 2006b) (Fig. 2B). The “wedge” of 
Fn would also result in conversion of cell-cell adhesion to 
cell-matrix adhesion (Larsen et al., 2006b). One critical 
question that remains to be addressed is whether Fn plays 
a signaling role in this adhesion conversion, or the progres­
sion of the Fn wedge mechanically breaks cell-cell adhe­
sion. These studies, however, illustrate recurring themes of 
ECM regulation: ECM is dynamic, can play signaling and 
mechanical roles, and ECM modulation interacts with cell­
cell adhesion as well as cell-ECM adhesion.
Spotlight on laminins. Laminin is necessary, along with 
collagen type IV, for the assembly of the basement mem­
brane, a specialized part of ECM that provides a physical 
structure delineating cells from the ECM and also modulates 
cell signaling (Engvall, 1995; Gullbergetal., 1999; Minerand 
Yurchenco, 2004; Aumailley et al., 2005; Nguyen and Se­
nior, 2006; LeBleu etal., 2007; Tzu and Marinkovich, 2008). 
Laminins are cross-shaped heterotrimeric proteins com­
prised of an a, b, and g chain. Five a, four b, and three g 
chains (Miner and Yurchenco, 2004) assemble in different 
combinations to generate the 16 known isoforms (Aumailley 
et al., 2005) whose names reflect their composition (e.g., 
laminin 332, which is a3b3g2). Assembled laminin proteins 
self-polymerize, along with collagen type IV, to form base­
ment membranes. Tissue specific function of laminin iso­
forms during development arises not only through tissue 
specific expression of different laminin chains, but also 
through the generation of splice variants and post-transla­
tional glycosylation and processing. An excellent recent 
review (Tzu and Marinkovich, 2008) highlights the intricacies 
of laminin structure, the relationship between structure and 
function, and also includes a comprehensive list of knockout 
mice and their phenotypes.
Recent studies have provided new insight into roles 
for laminin during boundary formation. The formation of 
ECM-rich boundaries is an absolutely fundamental aspect 
of development. Boundary formation can separate and
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Figure 2. A : Outline of the experimental results obtained by Sakai et al. (2003). The expression of Fn transiently increases as narrow clefts form 
while the cell-cell adhesion protein E-cadherin decreases. An antibody against Fn inhibited branching whereas exogenous Fn increased 
branching. Localized Fn assembly at clefts results in the conversion of E-cadherin-based cell-cell adhesion to integrin-based cell-ECM adhesion, 
resulting in cleft progression. B: Outline of the experimental results obtained by Larsen etal. (2006 b). Alexa-fluor conjugated Fn was washed out 
and replaced by unlabeled Fn. The older Fn (green) is translocated inward as newer Fn (white with black outline) is assembled behind it. This 
''wedge'' of Fn could result in conversion of cell-cell adhesion to cell-matrix adhesion.
compartmentalize initially homologous cells. This compart- 
mentalization occurs in the hindbrain during rhombomere 
formation and in the paraxial mesoderm during somite 
formation. Boundaries can also divide different tissues. For 
example, the notochord-somite boundary separates noto­
chord cells from the paraxial mesoderm. In addition to 
separating structures, boundary formation contributes sig­
nificantly to generating the three-dimensional shape and 
structure of developing organisms. The cell biology of 
boundary formation has been elucidated in many contexts. 
During Xenopusdevelopment, the notochord-somite boundary 
functionsto “capture” o r‘‘trap” intercalating notochord cells. In 
this instance, intercalating notochord cells exhibit protrusive 
activity as they elongate. Upon reaching the notochord- 
somite boundary, protrusive activity and elongation ceases. 
This has been termed ‘‘boundary capture” (Keller et al., 
2000). However, the ECM proteins responsible for boundary 
capture are not known. One hint that laminin might play a role 
in the formation of the notochord-somite boundary came 
from analysis of zebrafish mutations in two laminin chains, 
laminin b1 and g1. In these embryos, notochords form but 
are not maintained (Parsons et al., 2002). Within the last 
year, two papers have shed new light on roles for laminin in 
boundary formation. In ascidians, laminin plays a role in
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‘‘trapping” or ‘‘boundary capture” of intercalating notochord 
cells (Veeman et al., 2008). In the absence of laminin, 
notochord cells invade and can cross the notochord-somite 
somite boundary. In the context of myotome boundary 
formation in zebrafish, laminin is required to trap elongating 
muscle cells. It was not known whether laminin in the 
basement membrane ceases elongation of muscle cells 
simply by providing a physical barrier, or by signaling 
prompted by laminin binding ceases elongation. Genetic 
mosaic analysis suggested that laminin signaling within the 
myotome boundary plays a role in trapping elongating mus­
cle cells (Snow et al., 2008a). Future work will likely focus on 
the signaling mechanisms that lie downstream of ‘‘boundary 
capture.''
Metalloproteases. Much of the dynamic remodeling of 
the ECM is dependent upon matrix metalloproteases 
(MMPs) and members of the a disintegrin and metallopro- 
tease (ADAM) and a disintegrin and metalloprotease with 
thrombospondin motifs (ADAMTS) families. Pro-MMPs lie 
dormantwithin the ECM and are activated by various signals 
(Murphy et al., 1999; Davidson et al., 2002; Tsuruda et al., 
2004; Nagase et al., 2006; Amalinei et al., 2007; Ra and 
Parks, 2007; Clark et al., 2008; Filiz et al., 2008; Fu et al.,
479
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2008). Misregulation of MMP activity contributes to multiple 
diseases (metastatic carcinoma, cardiovascular disease, 
rheumatoid arthritis, osteoarthritis, oral diseases) and is 
also implicated in preterm labor (Davidson et al., 2002; 
Abraham et al., 2005; Hofmann et al., 2005; Vadillo-Ortega 
and Estrada-Gutierrez, 2005; Lemaitre and D'Armiento, 
2006; Liu et al., 2006; Mon et al., 2006; Cockle et al.,
2007). The dynamic interaction between ECM synthesis/ 
assembly and degradation via MMPs is an exquisite balanc­
ing act that mediates both embryonic development and 
tissue homeostasis. For example, a migrating cell must 
release sufficient proteases such that it can move, but not 
too many such that excessive matrix degradation leads to 
loss ofcellular traction forces. The mechanisms that underlie 
the regulation of this balancing act are currently the subject 
of intense research with the hopes that it can be exploited for 
therapeutic purposes.
Transm em brane Receptors for ECM Proteins
Integrins are a major class of ECM receptors that transmit 
signals both from the ECM to within the cell (“outside-in” 
signaling) and from within the cell to the ECM (“ inside-out” 
signaling) (Arnaout et al., 2005). Binding of integrins to the 
ECM results in the assembly of complexes that link to and 
coordinate cytoskeletal morphology. Thus, integrins and 
their associated proteins physically link the ECM to the 
intracellular cytoskeleton. As integrins do not have inherent 
enzymatic activity, many of the proteins involved in complex 
assembly are kinases or phosphotases. Integrin ligation can 
also result in changes in the molecular composition of the 
ECM. Integrins are transmembrane heterodimers com­
prised of an a and a p subunit. Both a and p subunits have 
large extracellular domains and relatively short cytoplasmic 
domains (Arnaout et al., 2005). Twenty-four heterodimers 
formed from the 18 known a and 8 known p subunits have 
been identified in humans (Takada et al., 2007). Although 
integrin receptors are notoriously promiscuous, they are 
receptors for a unique subset of ligands. For example, 
integrin a5p1 is a receptor for Fn, osteopontin, fibrillin, L1, 
thrombospondin, and ADAM family members. Conversely, 
integrin a5 is one of six known receptors for Fn (Humphries 
et al., 2006). Integrin expression during development is 
regulated both spatially and temporally, and mutant analy­
ses indicate discrete roles for different integrins during 
vertebratedevelopment (Sheppard, 2000; Bokeland Brown, 
2002; Julich e ta l., 2005).
Integrins are highly responsive receptors that can exist in 
a bent (inactive) or an extended (active) state (Humphries 
et al., 2004). Post-translational modification of integrins can 
alter their affinity for ECM components and thus the overall 
adhesiveness of cells. One such example is the ADP-ribo- 
sylation of integrin a7 that occurs during myotube develop­
ment in vitro. Integrin a7 is ADP-ribosylated at multiple sites, 
depending upon NAD+ concentration. This ADP-ribosyla- 
tion by an ADP-ribosyltransferase is not readily reversible 
(Zolkiewska and Moss, 1995) and leads to increased laminin 
-binding affinity of integrin a7p1 (Zhao et al., 2005). Given 
that NAD+ is an obligatory substrate in ADP-ribosylation 
reactions, the authors hypothesized that integrin a7 ADP-
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ribosylation by this ecto-ADP-ribosyltransferase might be a 
protective mechanism that increases integrin a7p1 adhe­
sion to laminin when muscle cell membranes have 
been compromised (as frequently occurs in muscular 
dystrophies) and intracellular NAD+ leaks into the extracel­
lular space (Zhao et al., 2005). Although this paradigm has 
notyet been investigated in vivo, it is an excellent example of 
how post-translational modifications of integrins can affect 
their function.
Key Intracellular Com ponents
Given the diverse functions of cell-ECM adhesion and 
the rapid assembly and disassembly of adhesion com­
plexes, it is perhaps not surprising that different types of 
complexes that anchor the cell to the ECM can form. These 
differing classes have been defined with in vitro studies. The 
parameters that define the classes include the size, constit­
uency, and signaling effects. The context in which a cell is 
located— the differentiation state of the cell, the specific 
ECM to which a cell is adhering, the physical forces of the 
tissue— impacts the type and size of complexes formed 
(Romer et al., 2006). The classes, from smaller to larger, 
are FCs (focal complexes), FAs (focal adhesions), and FBs 
(fibrilar adhesions) (Geiger et al., 2001). A recent review, 
noting the controversy over the definitions, suggests an 
overarching term for these complexes: cell matrix adhesion 
complexes, or CMACs (pronounced see-macs) (Locketal., 
2008). This review is an excellent commentary on the 
dynamics of cellular adhesion, and suggests a systems 
biology approach to studying CMACs.
CMACs contain dozens, if not hundreds, ofproteins. Most 
of the proteins in CMACs are post-translationally regulated 
by phosphorylation and/or glycosylation, for example 
(Fig. 3). This regulation adds yet another layer of dynamic 
flexibility that mediates a cell's response to ECM adhesion. 
Some key components of CMACs (integrin-linked kinase, 
kindlins, paxillin, talin, zyxin) are the sole subjects of several 
recent reviews (Beckerle, 1997; Wang and Gilmore, 2003; 
McLean et al., 2005; Mitra et al., 2005; Boulter and Van 
Obberghen-Schilling, 2006; Legate et al., 2006; Hannigan 
et al., 2007; Deakin and Turner, 2008; Larjava eta l., 2008; 
McDonald et al., 2008; Chatzizacharias et al., 2008a,b) and 
thus will not be discussed here in detail.
Spotlight on focal adhesion kinase (FAK) and muscle 
differentiation. Attachment of muscle fibers to laminin in 
the basement membrane is necessary for musculoskeletal 
function. Mutations in genesthat inactivate proteins required 
for adhesion to the basement membrane lead to multiple 
myopathies such as Duchenne, Becker, merosin-deficient, 
and many of the limb girdle muscular dystrophies (Hoffman 
et al., 1987; Tome et al., 1994; Bonnemann et al., 1995; 
Mayer et al., 1997; Hayashi et al., 1998). Many lines of 
evidence suggest that one therapeutic option for treatment 
ofmyopathies is to restore adhesion of myotubes (bundlesof 
muscle fibrils) to the basement membrane. These studies 
indicate that the exact mechanism of increased adhesion is 
not critical. Thus, multiple studies have focused on elucidat­
M ol Reprod D ev  77:475-488 (2010)
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Figure 3. Simplified diagram of some cell-matrix adhesion complex 
(CMAC) components. When transmembrane receptors bind an ECM 
ligand, the receptors cluster and numerous intracellular proteins are 
recruited. Some of the recruited intracellular proteins bind to the 
cytoskeleton, some are involved in signal transduction, some function 
to strengthen the adhesion and some recruit or provide docking for 
other intracellular proteins. These clusters of proteins that form at sites 
of cell-matrix attachment are called CMACs. CMACs can rapidly 
assemble and disassemble during processes like cell migration as 
well as mature over the course of development. CMACs can involve 
different ECM ligands (i.e., laminin and Fn), their different correspond­
ing receptors (i.e., integrin heterodimers) and different intracellular 
proteins (i.e., FAK). The phosphorylation of intracellular proteins 
regulates their activity and the signaling that occurs through CMACs.
ing the molecular mechanisms that mediate muscle fiber 
adhesion to laminin in vitro.
FAK is a highly dynamic focal adhesion protein that is not 
only critical for cell migration and morphogenesis in vitro, but 
is also highly upregulated in many types of cancerous cells 
(Hecker and Gladson, 2003; McLean et al., 2003, 2005; 
Nikolopoulos and Giancotti, 2005; Mon et al., 2006; Giehl 
and Menke, 2008; Chatzizacharias et al., 2008a). FAK is a 
nonreceptor tyrosine kinase that is autophosphorylated on 
tyrosine residue 397 (pY397) as a result of integrin signaling. 
This autophosphorylation generates a binding site for src, 
which then phosphorylates other tyrosine residues on FAK 
such as pY576/577 in the kinase domain and pY861 in the 
proline-rich domain (Schlaepfer and Hunter, 1998; Cary 
et al., 2002). Within the context of myotube adhesion to the 
basement membrane, several lines of evidence in cell cul­
ture systems indicate that FAK regulation is important for 
myotube differentiation and physiology. Interestingly, FAK
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appears to be involved in the formation of strong, long- 
lasting CMACs that mediate muscle-tendon adhesion. FAK 
activation, or autophosphorylation on pY397, can also be 
induced by mechanical stress in cardiac myocytes (Fonseca 
et al., 2005). The activation of FAK correlates with many 
events during myotube formation in cell culture. FAK is 
activated via a PKC dependent pathway during insulin- 
mediated skeletal muscle cell spreading (Goel and Dey, 
2002a,b). FAK expression and activation are modulated in 
response to mechanical force in vivo, and the response is 
different in predominantly slow-twitch versus predominantly 
fast-twitch muscles (Flucket al., 1999; Gordon et al., 2001). 
During the differentiation of C2C12 myoblasts into myo- 
tubes, the ratio of inactivated FAK to activated FAK is 
transiently decreased, but then increases and activated FAK 
localizes to the tip of actin stress fibers. These data indicate 
rolesfor FAK in myotube morphogenesis in vitro. In vivo data 
regarding FAK function in muscle development are sparse 
due to the fact that FAK is required for earlier developmental 
processes (Ilic et al., 1995; Kragtorp and Miller, 2006). A 
descriptive study has shown that FAK activation correlates 
with myotube adhesion to the nascent myotendinous junc­
tion in Zebrafish (Snow and Henry, 2009). It is tantalizing to 
hypothesize that dynamic regulation of FAK may play a role 
during musculoskeletal development in vivo, however more 
sophisticated tools are necessary to test this hypothesis and 
determine the molecular and cellular consequences of FAK 
regulation in nascent muscle tissue.
b r o a d  f u n c t io n s  o f  c e l l - e c m  a d h e s io n
Cell-ECM Interactions Regulate Cell Signaling, 
Tissue Integrity, and Homeostasis
The ECM within all tissues provides a necessary scaffold 
for generation and maintenance of tissue architecture. It is 
impossible to list the plethora of functions that the ECM plays 
in development and physiology because virtually every 
developmental and physiological process relies, either di­
rectly or indirectly, on cell-ECM interactions. Cell-ECM 
interactions also modulate cellular responses to major sig­
naling pathways. One major signaling pathway includes the 
fibroblast growth factors (FGFs) and their receptors 
(FGFRs). Recent experiments elucidating the extracellular 
“ interactome” of the FGF receptor-ligand system have 
shown that ECM receptors act as noncanonical co-receptors 
that impart specificity to FGF signaling (Polanska et al.,
2008). For example, inhibition of alpha V integrin can block 
FGF induced cell adhesion, migration, and angiogenesis 
(Rusnati et al., 1997; Santulli et al., 2008). This type of 
regulation provides mechanistic insight into how crosstalk 
between cell adhesion receptors and signaling pathways 
mediates cellular behavior.
Another mechanism for ECM-mediated regulation of 
growth factor signaling is the extensive crosstalk observed 
between growth factor and integrin signaling pathways. 
Integrin-based adhesion to the ECM is required for some 
cells to respond to growth factor signaling (Giancotti, 1996, 
1997, 2000, 2003; Frisch and Ruoslahti, 1997). For exam­
ple, the proliferation and/or differentiation of many cell types 
during development requires both adhesion to the ECM as
481
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well as the appropriate growth factors (Sastry and Horwitz, 
1996). Since the first experiments demonstrating crosstalk 
between growth factor signaling and integrin mediated sig­
naling, it has become clear that crosstalk is frequent, dy­
namic, and involves a complex network of interactions 
(Schwartzand Ginsberg, 2002; Comoglio etal., 2003; Chan 
eta l., 2006; Larsen et al., 2006a; Muller et al., 2008). Many 
laboratories are endeavoring to elucidate and exploit the 
complexity of integrin-growth factor signaling crosstalk with 
the hopes that more specific therapeutics with fewer side 
effects can be developed.
Adhesion to the ECM modulates expression and activa­
tion of growthfactors and growth factor signaling can, in turn, 
regulate cell adhesion. One recently studied example is the 
pleiotrophiccytokinetransforming growth factor beta 1 (TGF 
-p1) that is sequestered as a large latent protein complex 
within the ECM. Misregulated activation of this complex 
results in excess TGF-p1 signaling that promotes myofibro­
blast differentiation and ultimately contributes to fibrosis in 
many organs. Activation of latent TGF-p1 is dependent upon 
tension, ECM composition, and the interaction of integrin 
receptors with MMPs (Wipff et al., 2007; Wipff and Hinz,
2008). This paradigm is just one example of the complex 
regulation of growth factor release from ECM stores.
ECM receptors are both modulated and activated by 
signaling pathways. Notch signaling plays a major role in 
regulating cell fate and differentiation during development. 
Angiogenesis is a complex process that involves Notch 
signaling. Notch-4 inhibits angiogenesis by increasing in­
tegrin p1-mediated adhesion to collagen, and thus inhibiting 
sprouting of endothelial cells from preexisting vessels. In­
terestingly, ectopicexpression of activated Notch-4 does not 
increase the levels of integrin p1, but rather results in more 
integrin p1 molecules adopting the active, high affinity con­
formation (Leong et al., 2002). The mechanism underlying 
integrin activation by Notch-4 is not known. However, recent 
results suggest that Notch-1 mediates integrin activation 
via activating R-ras (Hodkinson et al., 2007). Thus, the 
''ECM interactome” is ubiquitous and may play a central 
role in integrating cellular responses to multiple signaling 
pathways.
Disrupted cell-ECM interactions can also perturb homeo­
stasis. It is becoming increasingly recognized that disrupted 
interactions between cells and the ECM underlie the etiology 
of metastatic carcinomas, cardiovascular diseases, muscu­
lar dystrophies, kidney dysfunction, and skin disorders, 
among many other diseases and syndromes (Nelson and 
Bissell, 2006; Spinale, 2007; Stenina et al., 2007; Hamilton, 
2008; Libby, 2008; Tzuand Marinkovich, 2008). Many of the 
less comfortable aspects of aging also result from de­
creased strength of cell-ECM interactions. For example, 
tendon failure leading to tendinopathies is exacerbated by 
age due to load-induced degradation of ECM (Dudhia et al., 
2007). Osteoarthritis occurs when abnormal cell/ECM sig­
naling disrupts the homeostasis of cartilage and bone tissue 
(lannoneand Lapadula, 2003). Age-related maculardegen- 
eration can also stem from abnormal ECM (Zarbin, 2004). 
Clearly, proper regulation of cell-ECM adhesion is critical 
for physiological homeostasis and the prevention of certain 
diseases.
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C ell-ECM  Interactions Regulate Cell M igration
The extracellular milieu influences migration, signaling, 
proliferation, and death of cell cohorts as well as individual 
cells. Cell migration requires dynamic interactions of cells 
with their ECM: adhesion assembly and disassembly are 
both necessary for migration. One classic system for study­
ing roles for cell-ECM interactions during embryonic devel­
opment is the neural crest. Neural crest cells originate from 
the dorsal neural tube and migrate great distances to give 
rise to neurons, pigment cells, cartilage, and connective 
tissue as well as other cell types. From the first descriptive 
data showing expression of cell-ECM adhesion compo­
nents during neural crest migration (Krotoski et al., 1986; 
Krotoski and Bronner-Fraser, 1990) to functional studies 
shortly thereafter (Bronner-Fraser, 1986; Lallier and 
Bronner-Fraser, 1991, 1992, 1993; Perris et al., 1993a,b; 
Lallier et al., 1994; Kil et al., 1998; Peters etal., 2002), neural 
crest migration has proved to be an excellent model system 
to study cell migration. Recent advances in understanding 
neural crest cell migration have shown that efficient migra­
tion requires internalization and recycling of ECM receptors. 
Interestingly, internalization and recycling of ECM receptors 
is dependent upon the composition of the ECM in vitro— an 
example of dynamic reciprocity that may also function in vivo 
(Strachan and Condic, 2004). There is exquisite specificity 
within this system: trunk and cranial neural crest cells re­
spond differently to varying concentrations of Fn when 
integrins are activated. Trunk neural crest cells are unaffect­
ed by increasing Fn concentration, whereas cranial neural 
crest cells slow with increasing Fn concentration (Strachan 
and Condic, 2008). It will be exciting to determine if similar 
mechanisms function in vivo. The complexity of cell migra­
tion in vivo is apparent in that another component of the 
ECM, laminin 111, also regulates neural crest cell spreading, 
migration, and survival. These different cell behaviors are 
regulated by the interaction of cell surface receptors with 
different laminin binding domains (Desban et al., 2006). 
Although neural crest is by no means the only paradigm of 
cell migration during development, neural crest migration 
has been an exceedingly informative model of dynamic 
cell-ECM interactions regulating cell behavior.
FUNCTIONS FOR DYNAM IC M ODULATION OF 
CELL-ECM ADHESION IN VIVO
Many groups have devised elegant and novel techniques 
to elucidate the molecular mechanisms of morphogenesis 
during development. Unfortunately, there is only space to 
highlight a few recent and especially intriguing studies.
Convergent Extension During Xenopus  
Gastrulation Involves Dynamic Interactions 
Between Cells and Their Environm ent
One excellent model system for the study of how polar­
ized interactions of cells with the ECM can drive morpho­
genesis is convergent extension. During convergent 
extension, the intercalation of cells in one plane causes 
elongation of the tissue in the perpendicular plane. Xenopus
M ol Reprod D e v  77:475-488 (2010)
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Figure 4. Schematic of the cell shape changes, signaling pathways and dynamic reciprocity involved in 
mediolateral intercalation behavior synthesized from the results of (Shih and Keller, 1992a,b; Habas 
e ta l., 2003; Tahinci and Symes, 2003; Goto et al., 2005). The cell outlined in black has been drawn 
larger than the cells outlined in gray to allow for depiction of signaling behavior while the gray cells show 
that groups of cells undergo these same behaviors. First, cells send out protrusions in all directions and 
Wnt signaling through prickle results in polarized Fn on a tissue level. Then, Wnt signaling through 
dishevelled and small GTPases rac and rho results in stable and oriented protrusions that generate 
traction and again remodel Fn. The combination of mediolaterally oriented protrusions and Fn alteration 
in the matrix results in mediolateral intercalation behavior. [Color figure can be viewed in the online issue 
which is available a t www.interscience.wiley.com]
has long served as a model for the study of cell behaviors 
and for convergent extension in particular. In Xenopus, 
convergent extension of the embryonic axis during gastru- 
lation is driven by mediolateral intercalation behavior (Shih 
and Keller, 1992a,b). Cells exhibiting mediolateral interca­
lation behavior become polarized in that they elongate and 
extend lamellipodia in the direction of interdigitation. Con­
vergent extension depends upon this cell polarization and 
bipolar lamella formation.
Cell polarization during convergent extension during Xe­
nopus gastrulation requires interpretation of spatial informa­
tion and interactions with the ECM. Surprisingly, in this 
context, the planar cell polarity (PCP) signaling cascade 
mediates both cell polarization and interactions with the 
ECM. The PCP cascade activates the small GTPases rho 
and rac that are critical for polarized lamellipodia formation 
(Habas et al., 2003; Tahinci and Symes, 2003). In addition, 
PCP signaling modulates the ECM protein Fn in two ways: 
(1) to regulate normal deposition of the Fn matrix and (2) to 
effect cellular polarization in response to the Fn matrix (Goto 
et al., 2005) (Fig. 4). Thus, future studies need to consider 
the potential dual requirements for the PCP cascade during 
other morphogenetic processes (Wallingford, 2005).
At this point, the mechanisms by which Fn mediated 
cellular polarization were not known. Subsequent elegant 
experiments showed that adhesion of mesodermal cells to 
Fn via integrin a5p1 functions in two ways to promote 
mediolateral intercalation behavior: (1)Fn binding represses 
the number of cellular protrusions extended and (2) Fn 
binding promotes the mediolateral orientation of protrusions 
required for effective convergent extension (Davidson et al.,
2006). An important insight derived from this study is that 
binding to Fn is required to initiate, but not maintain, med- 
iolaterally polarized cell morphology. The authors used both 
chronic and acute disruption of Fn binding to separate 
initiation and maintenance (Davidson et al., 2006). Clearly, 
these results not only provide new molecular insight to the
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regulation of cell behavior by Fn, but should also encourage 
researchers to design experiments to distinguish between 
short and long-term requirements for cell-ECM adhesion.
One common theme of the above experiments is that the 
same signaling cascade or protein can play more than one 
role within the context of the same process. The methods 
used to parse multiple roles differed: one study asked if a Fn 
surface could rescue polarity and the other used chronic 
versus acute disruption of Fn-mediated adhesion. The pro­
gressive nature of morphogenesis further complicates a 
mechanistic understanding of embryonic development. In 
other words, processes that occur later in development 
necessarily rely on earlier morphogenetic events. It is thus 
sometimes difficult to attribute cause and effect. Towards 
this end, we have recently applied a fractal-based method 
that quantifies cellular structure within a lattice to show that 
Fn plays distinct roles through time in the same tissue (Snow 
et al., 2008b). Taken together, these experiments all high­
light the spatial and temporal complexity of cell-ECM inter­
actions during development, and provide different tools with 
which to tease apart discrete requirements for cell-ECM 
interactions during morphogenesis.
ln V ivo Observation of Fn Dynamics and Correlation 
W ith  Protrusive Activity
One critical method for elucidating the dynamics of cell 
interactions with the ECM is high-resolution time-lapse 
analysis of these interactions. Recently, live imaging of Fn 
and cellular protrusions in Xenopus animal cap explants has 
provided new insights into Fn fibril assembly (Davidson 
et al., 2008). Interestingly, there was not a strong correlation 
between lamellipodia extension and Fn fibril movement, and 
Fn fibrils move without apparent contact with lamellipodia. It 
was shown that there are two mechanisms that underlie fibril 
thickening and that they occur on different time-scales. Fn 
polymerization can take hours, but fibrils can also shorten
483
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and thicken within minutes. Not surprisingly, disruptionof the 
actin cytoskeleton resulted in fibril collapse. Taken together, 
these novel experiments show that it is possible to visualize 
cell-ECM dynamics within a tissue and show that different 
ECM remodeling events can occur on different time-scales 
(Davidson et al., 2008). The lackofclear correlation between 
Fn fibril dynamics and cellular protrusions is somewhat 
confusing given the data mentioned above showing clear 
roles for Fn binding in regulating cell protrusions. However, 
different populations of cells were observed and it would be 
very interesting to use these newly developed tools to further 
study the acquisition and maintenance of mediolateral in­
tercalation behavior. Furthermore, the use of GFP-tagged 
integrins in live embryos (Julich etal., 2005; DeSimone etal., 
2007) concurrent with visualization of the ECM should add 
further insights.
But Do Cells Actually M igrate Across Fn?
''Galileo described the concept of motion relativity— 
motion with respect to a reference frame—in 1632. He 
noted that a person below deck would be unable to discern 
whether the boat was moving.” So begins a recent paper by 
Zamir, Rongish, and Little, published in PLoS Biology (Zamir 
et al., 2008). Recent time-lapse microscopy studies have 
described the cellular movements that result in chicken 
primitive streak (PS) formation (the PS is the organizing 
center for gastrulation) (Chuaietal., 2006; Voiculescu etal.,
2007). However, the movements of cells and their ECM had 
not been simultaneously visualized during PS formation. 
Zamir and colleagues analyzed the relative movements of 
epiblast cells compared to the meshwork of Fn fibrils they 
termed SE ECM (the mesh of Fn fibrils that lie subjacent to 
the epiblastic epithelium). Their findings suggest that the 
movement of epiblast cells and the SE ECM is highly 
correlated. This methodology allowed them to also analyze 
cell autonomous movements (movements of cells relative to 
the SE ECM). Interestingly, although there was a small 
degree of cell autonomous movements, they resembled 
more of a ''random walk” than a coordinated morphogenetic 
event. This exciting and highly informative study should 
change the way that developmental biologists investigate 
cell migration in different contexts. In particular, as noted by 
the authors, the concept of extracellular chemotactic gra­
dients becomes exponentially more complex when it is 
considered that the ECM itself may move along with the 
cells.
SU M M A RY
The studies described herein, along with many other 
fantastic experiments that were not discussed due to space 
constraints, clearly show that dynamic modulation of both 
the ECM and cell adhesion to the ECM are critical for 
development and physiology. These studies also highlight 
the complexity of cell-ECM adhesion complexes. CMACs 
contain hundreds ofproteins, mostofwhich are regulated by 
post-translational modification. At least two major technical 
issues currently hinder progress within the field. One is the 
paucity of technology for high resolution in vivo imaging of
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CMAC components. Some laboratories have developed the 
technology for in vivo imaging of Fn, as described above. 
This is a critical step, but more remains to be done. Multiple 
CMACs and their post-translational modifications need to be 
imaged and manipulated in vivo. A recent, exciting paper 
describes a method for visualizing glycans in vivo during 
zebrafish development (Laughlin et al., 2008). One can 
envision refinement of this tool for visualization of proteogly­
can synthesis and assembly into three-dimensional scaf­
folds in vivo. This is an area of rapidly developing technology 
and also rapid incorporation of excellent tools developed in 
vitro for in vivo use. The other major hindrance in under­
standing ofthe dynamic modulation of CMAC function in vivo 
is a lack of quantitative readouts of cell-ECM signaling. Until 
quantitative methods are available to assess the type and 
amount of cell-ECM signaling, it will be quite difficult to 
synthesize an integrative view of CMAC function in devel­
opment and physiology. Finally, in this era of deep sequenc­
ing, proteomics, and chemical genetic screens, it is 
important to remember that understanding the dynamics 
and mechanics of cell adhesion to the matrix in vivo is 
fundamentally required for true progress towards ameliora­
tion of most diseases. In this sense, cell-ECM adhesion 
can be thought of as fractal: detail is found at all scales 
analyzed.
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Abstract
Skeletal muscle morphogenesis transforms short muscle precursor cells in to long, multinucleate myotubes that anchor to  
tendons via the myotendinous junction (MTJ). In vertebrates, a great deal is known about muscle specification as well as 
how somitic cells, as a cohort, generate the early myotome. However, the cellular mechanisms that generate long muscle 
fibers from  short cells and the molecular factors that lim it elongation are unknown. We show that zebrafish fast muscle fiber 
morphogenesis consists o f three discrete phases: short precursor cells, intercalation/elongation, and boundary capture/ 
myotube formation. In the first phase, cells exhibit randomly directed protrusive activity. The second phase, intercalation/ 
elongation, proceeds via a two-step process: protrusion extension and filling. This repetition o f protrusion extension and 
filling continues until both the anterior and posterior ends o f the muscle fiber reach the MTJ. Finally, both ends o f the 
muscle fiber anchor to  the MTJ (boundary capture) and undergo further morphogenetic changes as they adopt the 
stereotypical, cylindrical shape o f myotubes. We find that the basement membrane protein laminin is required for efficient 
elongation, proper fiber orientation, and boundary capture. These early muscle defects in the absence o f either iamininfi 1 or 
iamininyl contrast w ith  later dystrophic phenotypes in iaminina2 mutant embryos, indicating discrete roles for different 
laminin chains during early muscle development. Surprisingly, genetic mosaic analysis suggests that boundary capture is a 
cell-autonomous phenomenon. Taken together, our results define three phases o f muscle fiber morphogenesis and show 
that the critical second phase o f elongation proceeds by a repetitive process o f protrusion extension and protrusion filling. 
Furthermore, we show that laminin is a novel and critical molecular cue mediating fiber orientation and lim iting muscle cell 
length.
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In tro ductio n
M uscle specification and  morphogenesis during early develop­
m ent are  critical for norm al muscle physiology. In  vertebrates, 
m ost of the m usculature is derived from  somites [1—3]. Somites are 
segmentally reiterated structures delineated by somite boundaries.
As developm ent proceeds, a portion of the somite gives rise to 
skeletal muscle fibers th at comprise the m yotom e. T he term inal 
ends o f m yotom al muscle fibers attach to somite boundaries, 
which then  becom e m yotom e boundaries. In  teleost fishes, 
m yotom e boundaries give rise to the m yotendinous junction  
(MTJ) [4].
M yotom e developm ent is perhaps best understood in amniotes. 
M yogenesis in amniotes begins w hen muscle precursor cells 
translocate from  the overlying derm om yotom e to the m yotome 
[3]. T he first myocytes to translocate come from  the dorsomedial 
lip, b u t later in developm ent myocytes translocate from  all 
derm om yotom e borders as well as the central region [5—7].
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Time-lapse analysis in the chick em bryo has shown th at spatial 
dom ains o f the somite differ in cell behaviors th at generate the 
p rim ary  m yotom e [8]. T he above studies have elucidated cell 
m ovem ents that generate the myotom e. However, although it is 
known th at short, m ononucleate, muscle precursor cells generate 
long, functional m ultinucleate muscle fibers, it is no t know n how 
this occurs. Interestingly, the early zebrafish and  chick m yotomes 
have been  described as containing m ononucleate muscle fibers 
[8,9]. O u r  intent in undertaking this study was to utilize the 
advantages o f the zebrafish system to shed light on early muscle 
developm ent in a vertebrate model.
Elucidation o f the cellular m echanism s th at underlie muscle 
fiber developm ent and  tendon attachm ent is critical for a 
comprehensive understanding of muscle developm ent. Tow ards 
this end, muscle morphogenesis has been studied in different 
m odel systems. C2C 12 myoblasts in culture elongate slightly prior 
to differentiation, align with each other, and  fuse to generate a 
m ultinucleate m yotube [10]. W e have called this scenario elliptical
October 2008 | Volume 4 | Issue 10 | e1000219
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A u th o r Sum m ary
Despite the importance o f muscle fiber development and 
tendon attachment, this process is incompletely under­
stood in vertebrates. One critical step is muscle fiber 
elongation; muscle precursor cells are short and subse­
quent elongation/fusion generates long, multinucleate 
muscle fibers. Using a vertebrate model organism, the 
zebrafish, we find that single round myoblasts elongate to 
span the entire w idth o f the myotome prior to  fusion. 
Using rigorous and objective mathematical characteriza­
tion techniques, we can further divide muscle develop­
ment into three stages: short precursor cells, intercalation/ 
elongation, and boundary capture/m yotube formation. 
The second phase, elongation, occurs via a two-step 
mechanism o f protrusion extension and filling. Myotube 
form ation involves boundary capture, where the ends of 
muscle fibers anchor themselves to  the m yotome bound­
ary and stop elongating. We show that the protein laminin 
is required for boundary capture, normal fiber length, and 
proper fiber orientation. Genetic mosaic experiments in 
laminin-deficient embryos reveal that boundary capture is 
a cell autonomous phenomenon. W ild-type (normal) cells 
capture the boundary appropriately and stop elongating 
in laminin-deficient embryos. Although adhesion to 
laminin has been implicated in muscular dystrophies 
where the attachment between muscle cells and tendons 
fails, no early developmental requirements for laminin in 
fast muscle morphogenesis have been shown until now.
growth. In  grasshopper embryos, the first muscle cells elongate 
betw een attachm ent sites p rio r  to fusion. These cells extend many 
processes in m ultiple directions while elongating [11]. W e have 
term ed this scenario branching. E legant studies in Drosophila have 
shown th at muscle morphogenesis occurs w hen myoblasts fuse to 
generate long, m ultinucleate m yotubes and  identified a num ber of 
proteins required for m yoblast fusion [12,13]. Extrem ely exciting 
recent studies have shown th at there is some conservation of 
m olecular mechanisms that m ediate muscle cell fusion between 
Drosophila and  zebrafish [14,15]. Interestingly, however, the 
prim ary  m yotom e in chick and  zebrafish is m ononucleate [8,9]. 
This suggests th at m yoblast fusion does not m ediate the earliest 
stages of muscle morphogenesis in vertebrates, b u t occurs after 
initial muscle fiber elongation. These distinct m echanism s of 
m orphogenesis in different systems highlight the fact th at a 
m echanistic study o f muscle fiber morphogenesis in vertebrates has 
not yet been undertaken. Identification o f discrete m orphogenetic 
steps th at m ediate muscle fiber morphogenesis in vertebrates is 
necessary to provide a fram ew ork for future m olecular analyses.
A dhesion of muscle fibers to the basem ent m em brane is critical 
for muscle function. T he basem ent m em brane attaches muscle 
fibers to connective tissue th at then  attaches to the skeletal system; 
this attachm ent is critical for force transduction from  muscle to 
bone. O ne  m ajor com ponent o f  the basem ent m em brane is 
lam inin. Lam inin is a heterotrim eric p ro te in  com posed of a , b and 
C subunits th at generate a t least 15 different isoforms [16]. T he 
im portance o f lam inins in muscle physiology is evidenced by the 
fact th at m utations in lama2 result in m uscular dystrophies [17— 
20]. R ecent w ork has shown th at muscle fibers in zebrafish m utant 
for lama2 elongate and  attach  to the M TJ, b u t at 48 hours post 
fertilization (hpf) fibers detach before death, providing novel 
insight into roles for lama2 in muscle disease [21].
Significantly less is know n abou t spatiotem poral m echanism s of 
basem ent m em brane assembly during early skeletal muscle
PLoS Genetics | www.plosgenetics.org 2
developm ent and  w hether adhesion to the basem ent m em brane 
contributes to m orphogenesis. R ecent data suggest th at the 
lam inin receptor Integrin a6b1 is necessary for bo th  basem ent 
m em brane assembly an d  norm al expression o f m yogenic regula­
tory factors in cultured m ouse explants [22]. However, Integrin 
a6b1 binds to m ultiple lam inins with distinct affinities [23] and 
roles for individual lam inin chains during early muscle develop­
m ent in vivo have not been  identified. In  o rder to determ ine 
w hether the basem ent m em brane is critical during early 
developm ent for muscle fiber elongation and  attachm ent, it is 
first necessary to understand  the cellular basis o f muscle fiber 
elongation and  attachm ent.
T he  relative simplicity of zebrafish skeletal muscle, w here slow 
and  fast-twitch fibers are spatially segregated, makes it an ideal 
m odel system to study muscle cell elongation and  M TJ 
morphogenesis. M orphogenesis of the somite boundary  into the 
M T J involves three stages: initial epithelial somite boundary  
form ation, transition and  m yotom e b o u n d ary /M T J form ation 
[24]. T ransition encompasses the lateral displacem ent of slow- 
twitch muscle fibers and  the subsequent elongation and  differen­
tiation o f fast-twitch fibers [25—28]. T he initial m yotom e forms by 
26 h p f and  contains long muscle fibers attached  to the m yotome 
bo u n d ary /M T J. A t this point, the extracellular m atrix  (ECM) 
proteins Fibronectin, lam inin and  Periostin concentrate a t the 
M T J [29—31]. M orpholino-m ediated inhibition of Periostin 
disrupts M T J form ation [29,32,33], b u t discrete and  mechanistic 
requirem ents for o ther E C M  proteins and  their receptors are  not 
known. In  addition, the precise m echanism  by which elongating 
muscle fibers a ttach  to the M T J and  cease elongation has not been 
elucidated.
T he  purpose of this study was to rigorously and  quantitatively 
characterize, for the first tim e in vertebrate embryos, the cellular 
events th at generate long m yotubes from  initially short muscle 
precursor cells. W e focused on  fast-twitch fiber m orphogenesis in 
zebrafish embryos. O u r  goal was to develop m ethods with which 
discrete functions for proteins involved in muscle morphogenesis 
could be identified. Tow ards this goal, we utilized time-lapse 
analysis, genetic mosaic analysis, and  three different m athem atical 
tools including a powerful wavelet-based image analysis formalism 
to provide novel insight into cellular and  m olecular mechanisms 
th at underlie muscle fiber elongation and  subsequent a ttachm ent 
to the nascent M TJ.
Results
Three Phases o f Fast-Twitch Muscle Cell Elongation
Although the elongation of somitic cells is critical for actin- 
m ediated contractility th at underlies muscle function, the cellular 
and  m olecular basis of elongation in vertebrates is not well 
understood. A n understanding of how muscle cells elongate is 
critical in order to determ ine m echanistic roles for genes required 
in elongation. W e used time-lapse m icroscopy of zebrafish 
embryos labeled w ith BO D IPY -Ceram ide to outline cells. This 
type of time-lapse analysis, w here all cells are  labeled, provides an 
initial fram ew ork with which to focus further investigation into 
fast-twitch fiber morphogenesis. Fast-twitch muscle cells can  be 
identified because, in contrast to slow-twitch muscle fibers, they 
are not m igrating m edially-laterally [25]. T he transition from  a 
somite to a m yotom e is a dynam ic process (Figure 1, M ovie S1) 
w ith a t least three phases. T h e  first phase is short muscle precursor 
cells. Second, muscle fibers elongate by extending narrow  
protrusions to intercalate betw een o ther cells (Figure 1 A2 at 
80 min, blue pseudocolored cell). Elongation ends w hen cells 
adhere to the an terior and  posterior boundaries. T he third phase is
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A  Time-lapse of muscle cell elongation, 22-somite stage embryo
Figure 1. Myoblasts Intercalate betw een Each O ther as They Elongate. (See also M ovies S1 and S2.) A) Cartoon dep ic ts  th e  a n te rio r to  
pos te rio r progression o f  m yo fib e r e lon g a tio n  in  a 22 som ite  em bryo . A1-A 2) Confocal tim e-lapse  sequence show ing  fast m uscle cell e lo nga tion  in  a 
s ing le  focal p lane o f  a zebrafish em bryo  v ita lly  labeled w ith  BODIPY-Ceramide. A n te rio r le ft, dorsal to p , som ite  n um ber deno ted , tim e  elapsed 
ind ica ted  on panels. The co lo red  cells w e re  pseudoco lo red  to  fac ilita te  v isualization. By 80 m in, th e  b lue  cell is b eg inn ing  to  in terca late, in te rca la tion  
is com p le te  by 84 m in. D uring  th is  tim e , th e  orange and purp le  cells are e longa ting . The green cell transits fro m  a long, b u t irregu la rly  shaped cell 
(w h ite  arrow head ind icates a g roove at 20 m in) in to  a rod-shaped m yo tu b e  by 124 m in. Scale bars: 50 mm. 
doi:10.1371/journal.pgen.1000219.g001
m yotube form ation. Recently elongated cells are long, but 
irregularly shaped (Figure 1 A1 green cell a t 0 min, A2 blue cell 
a t 84—168 min, M ovie S1). D uring m yotube form ation, long cells
with grooves continue to change shape until they form  a m ore 
uniformly shaped tube w ithout grooves (Figure 1 A1 green cell at 
208 min). An additional time-lapse is shown in M ovie S2.
PLoS Genetics |  w w w .p losgenetics .o rg O ctobe r 2008 |  V o lum e 4  |  Issue 10 |  e10002193
176
Dynamics o f Zebrafish Muscle Morphogenesis
Phase 1: Short Muscle Precursor Cells
A  three-dim ensional quantification o f  cell m orphology is critical 
to distinguish betw een scenarios o f  muscle cell elongation 
(Figure 2A). W e transplanted  dextran-filled cells into unlabeled 
host embryos and  three-dim ensionally reconstructed the behavior 
o flab e led  cells through tim e (Figure 2B). F or each  tim e po in t, the 
z-series was three-dim ensionally pro jected  and  the area, perim eter, 
an d  m ajor axis w ere m easured. Thus two-dim ensional param eters 
(area, perim eter, and  m ajor axis) w ere obtained  from  three­
dim ensional projections ofcells. T he analysis o flab e led  cells in an 
unlabeled field o f  cells allows unam biguous determ ination  o f 
cellular shape dynam ics an d  quantification o f  m orphom etric 
param eters. W e analyzed cell behaviors in two ways: (1) analysis o f 
the filam ent index an d  (2) analysis o f  the relative dynam ics o f area  
an d  perim eter changes through time. As shown below, this 
approach  supports and  extends w hat was observed in B O D IPY - 
C eram ide labeled embryos.
T he filament index is an  excellent m athem atical p aram eter that 
describes cell m orphology. T he filam ent index is a m easure that 
quantifies the departure o f a  shape from  a circle (see methods). A  
circle has a filament index o f1  and  a higher filam ent index indicates 
a larger departure from  a circular shape. S h o rt muscle precursor cells 
have a low filament index (FI) indicating th at their m orphology is 
close to a  circle (Figure 2F, G1, F I=  1 .660 .6 , T able 1).
S h o rt muscle p recursor cells ex tend  and  retract very short 
(< 2  mm) filopodia-like protrusions in all directions (Figure 2C, 
M ovie S3). Small changes in the area, perim eter, an d  length o f 
m uscle p recursor cells reflect the  dynam ic shape changes o f 
p recursor cells (not shown). How ever, their overall shape an d  size 
rem ains consistent.
Phase 2: Elongating Fast-Twitch Muscle Precursor Cells
Elongating cells lengthen towards their a ttachm en t site, the 
M TJ. Elongating cells have a higher filam ent index th an  short 
p recursor cells (Figure 2F, 2 .9 6 0 .8 , T able  1). T h e  filam ent indices 
o f  elongating cells increase slightly th rough  tim e (Figure 2G1, G2), 
reflecting their departure  from  a circular shape.
O n e  purpose o f this experim ent was to distinguish betw een 
possible scenarios o f  muscle fiber elongation sum m arized in 
Figure 2A. T he  difference betw een the fusion and  rem aining 
scenarios is the tim ing o f fusion relative to elongation. In  the fusion 
scenario, fusion o fsh o rt myoblasts is the m ajor m orphogenetic event 
th at drives fiber elongation. Fusion ofm ultiple short cells generates a 
long, multinucleate m yotube in one step as in Drosophila [12]. In  the 
rem aining scenarios, cells elongate prio r to fusion. W e analyzed 
nuclear content o felongating and recently elongated cells and found 
th at m ononucleate fast-twitch cells elongate to the M T J prio r to 
fusion (Figure 4F  H , n =  108 cells). Thus, the first fast-twitch fibers 
in zebrafish do not fuse prio r to elongation.
T he rem aining scenarios are  branching , elliptical growth, and  
pro trusion  (Figure 2A). T h e  difference betw een the branching  
scenario an d  the elliptical g row th /p ro tru sio n  scenarios is the 
am ount, size, and  direction o f  protrusive activity. In  grasshopper, 
the first muscle cells to elongate have extensive protrusions in 
m any  different directions [11]. This is depicted in the b ranching  
scenario (Figure 2A). In  contrast, the elliptical grow th and  
pro trusion  scenarios depict cells th at elongate in a fixed direction. 
Both tim e-lapse analysis an d  analysis o f  cell m orphology in fixed 
embryos indicate th at fast-twitch fibers in zebrafish embryos 
elongate in a fixed direction and  do n o t exhibit a branching  
m orphology w ith m ultiple protrusions ex tended in different 
directions (Figures 2, 4). R ather, fast-twitch cells ex tend  long 
(> 4  mm) protrusions along their long axis (Figure 2D, M ovie S3).
These results indicate th at the branching  scenario does not apply 
to initial fast-twitch muscle m orphogenesis in zebrafish.
T h e  two rem aining scenarios differ in the nature  o f elongation. 
T h e  elliptical grow th scenario depicts elongation as a continuous 
process rem iniscent o f  a balloon filling. T h e  pro trusion  scenario 
suggests th a t elongation is increm ental an d  proceeds via a 2-step 
m echanism : pro trusion  extension an d  pro trusion  thickening. 
Tim e-lapse analysis suggests th a t fast-twitch cells extend p ro tru ­
sions th a t subsequently thicken (Figures 1, 2). G eom etrical models 
were developed and  used to determ ine how area  and  perim eter 
w ould change through tim e if  cells were elongating via the two 
different scenarios. T h e  m ajor difference betw een the  two models 
is the na tu re  o f dynam ic changes in area  an d  perim eter during 
elongation (see m ethods for details). A rea and  perim eter increase 
linearly  in the elliptical grow th m odel (Figure 3A) and  increm en­
tally in the pro trusion  m odel (Figure 3 A1). T he increm ental 
na tu re  o f  grow th in the pro trusion  m odel is because the perim eter 
increases slightly m ore w hen the pro trusion  extends, b u t the area 
increases slightly m ore w hen the pro trusion  thickens (Figure 3 A1). 
Therefore  the difference betw een the two m odels is how  area  and 
p erim eter values change as the cell grows: linear changes occur in 
the elliptical grow th m odel and  increm ental changes in the 
p ro trusion  model. In  all cells exam ined, the rate  o f  a rea  increase is 
higher th an  the rate  o f  perim eter increase as is predicted  by  both  
models (Figure 3 B3). How ever, area and  perim eter increase 
increm entally during fast-twitch muscle cell elongation (Figure 3 
B1, B2). Thus, analysis o f  a rea  an d  perim eter dynam ics supports 
the two-step intercalation model.
Phase 3: Boundary Capture/Myotube Formation
Boundary  capture  occurs w hen elongating muscle cells reach 
m yotom e boundaries and  stop extending. T h e  filam ent index of 
cells in the bo u n d ary  cap tu re /m y o tu b e  form ation phase is 
significantly higher than  the preceding two phases (Figure 2F, 
T able  1). T h e ir filam ent indices decrease slightly through time 
(Figure 2 G 1, G2). This decrease reflects the fact th a t a  rod-shaped 
cell has a sim ilar perim eter and  length, b u t larger area than  a long, 
irregularly shaped cell.
R ecently  elongated cells can b e  irregularly shaped an d  of 
varying diam eters (Figure 2E). T h e  th in n er portions o f the cell 
then  thicken until the entire cell consists o f  a m ore uniform  
diam eter (Figure 2E, M ovie S3). N o te  th a t changes in area  and 
p erim eter o f  cells in the  m yotube form ation phase are  distinct: in 
this phase the area increases m uch m ore than  the perim eter 
(Figure 3C, com pare C 3 to B3). T h e  increase in a rea  w ithout a 
substantial increase in perim eter reflects the adoption  o f  a m ore 
tube-shaped, regular m orphology in the  m yotube form ation phase.
T aken  together, the  tim e-lapse da ta  along w ith two different 
quantitative analyses (area an d  perim eter dynam ics through time 
and  the filam ent index) indicates th at there  are three  discrete 
m orphogenetic phases th at generate the first fast-twitch muscle 
fibers: short muscle precursor, in tercalation /elongation  and 
b ou n d ary  cap tu re /m y o tu b e  form ation.
Analysis of Fast-Twitch Muscle Cells in Fixed Embryos
M orphom etric  analysis o ffixed  cells corroborates the time-lapse 
data. M yotom e form ation proceeds in an  anterior-posterior 
progression. Thus, this approach  allows analysis o f  muscle cells 
in various stages o f elongation w ithin the same em bryo. As 
observed in live em bryos, fixed muscle p recursor cells are  short 
(< 5  mm) and  have short protrusions (Figure 4A, F, white 
arrowheads). Protrusions in fixed cells are also observed to extend 
in all directions (Figure 4A). T he filam ent index o f  live precursor 
cells an d  fixed p recursor cells is sim ilar (Figure 4E live cells
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Figure 2 . Three Phases o f Muscle Morphogenesis: Short Muscle Precursor Cells, Intercalation/E longation, and Boundary Capture/ 
M yotube Form ation. (See also M ovie  S3.) Pro jections o f  A poTom e m icrographs are show n, side views, a n te rio r le ft, dorsal to p . Cells w ere  
pseudoco lo red  to  fa c ilita te  v isua liza tion . A) C artoon de p ic tin g  possible scenarios fo r  e lo n g a tio n  o f  m yofibers. B) C artoon d e p ic tio n  o f  th e  m ethods
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used. Dextran fille d  W T cells (red) w e re  tran sp la n te d  in to  an un labe led  e m b ryo  a t th e  blastu la  stage, tim e-lapse  data w as co llec ted  at 20 hpf, th e n  Z- 
s ta c k s w e re th re e  d im ens iona lly  p ro jec ted  fo r  m o rp h o m e trica n a lys is . C) S hort m uscle p re c u rs o rc e lls d o  n o t u n d e rg o  large-scale shape changes. A21 
som ite -s tage  em bryo , app ro x im a te  loca tion  o f  som ite  15 a t left. The b lue  cell ex tends a filo p o d ia -like  p ro trus ion  (8 m in , w h ite  a rrow ) th a t is th e n  
re tracted  (30 m in , th e  b lue  cell is en la rged in  th e  b o tto m  panels). The p ro trus ion  in  th e  g reen cell (red a rro w  a t 0 m in) is also re tracted  by 30 m in . D) 
E longating  m uscle p recursor cells extend p ro trus ions  a long  th e ir  m a jo r axis as th e y  e longa te . A 22 som ite -s tage  em bryo , som ite  18 a t le ft. The y e llo w  
cell ex tends a long , th in  p ro tru s io n  (w h ite  a rrow ) a t 18 m in  th a t increases in th ickness, resu lting  in  a lo n g e r cell. The orange cell ex tends a p ro tru s io n  
(red a rrow ) a t 80 m in  th a t becom es th ic k e r by 120 m in . E) M y o tu b e  fo rm a tio n  invo lves th e  tra n s itio n  fro m  an irre g u la rly  shaped cell t o  a m ore 
h o m ogenous ly  shaped tu b e . A t 0 m in , th e  b lue  cell w ith  a w h ite  a rro w  is n o t y e t tube -shaped , i.e. part o f  th e  cell is s ig n ifica n tly  n a rrow er th a n  th e  
o th e r parts (w h ite  arrow ). O ver tim e , th e  na rrow  p o rtio n  th ickens, e ven tua lly  gen e ra tin g  a long  tube -shaped  m yo tu b e  (120 m in, w h ite  arrow s in 
b o tto m  en la rged panels are in th e  same loca tion  in  all panels). F) The fila m e n t in d e x  is s ig n ifica n tly  d iffe re n t be tw een  th e  th re e  phases (**, p<0 .01). 
G1) The fila m e n t in d e x  o f  th e  th re e  phases th ro u g h  tim e . G2) Average slopes o f  linear tre n d lin e s  fro m  data in  G1 (*, p< 0 .05 ). 
do i:10.1371/jou rna l.pgen.1000219.g002
1 .6 6 0 .6 , fixed cells 1 .460 .2 ). T he correlation  o f  the  length w ith 
perim eter is also sim ilar to live cells (Table 1).
Both the qualitative appearance and  the m orphom etric 
properties o f fixed cells presum ed to have b een  elongating (those 
betw een 5 mm and  40 mm in fixed embryos) are  sim ilar to live 
elongating cells. T h e  m ajo r axis is very strongly correlated  w ith 
perim eter an d  a rea  in bo th  populations (Table 1). S im ilar to live 
cells, long  n arro w  protrusions are  only observed along the m ajor 
axis (Figure 4B, G , yellow arrow heads, M ovie S4). W e also 
analyzed the nuclear con ten t of dextran-filled cells during 
elongation. A z-series was taken  and  cells were exam ined in three 
dim ensions. N o  elongating cells contained  m ore than  one nucleus 
(Figure 4G , n > 1 0 0  cells).
Cells th at w ere fully elongated b u t irregularly shaped were 
presum ed to be in the b o u n d ary  cap tu re /m y o tu b e  form ation 
phase (Figure 4C  is a  three-dim ensional projection of an 
irregularly shaped b u t elongated cell). T h e  filam ent index of these 
cells was also sim ilar to live cells (Figure 4E). Fast-tw itch cells in 
this phase w ere m ononucleate (Figure 4 H  shows one focal plane 
of a  m ononucleate cell th at is elongated b u t irregularly shaped 
w hen exam ined in three dim ensions, M ovie S4, n  = 108). 
Interestingly, all m uscle cells th a t contained  m ultiple nuclei 
exhibited a  stereotypical tubu lar shape (n = 57, see Figure 4I). 
T hese da ta  suggest the intriguing possibility th at the transition 
from  an  irregularly shaped long cell to a  rod-shaped m yotube m ay 
involve fusion. O u r  use of dextran-labeled cells in a  field of 
unlabeled cells clearly highlights the m orphological com plexity o f 
e longating fast-tw itch muscle cells and  indicates th at it is not 
possible to unam biguously identify m ultinucleate cells utilizing a
nuclear m ark er as well as a  m arker th at denotes all cells (such as 
phalloidin). Thus, we do not know  the exact tim ing o f  m uscle cell 
fusion or w hether fusion contributes to the m orphogenesis o f  
irregularly shaped long fibers into regularly  shaped, cylindrical 
m yotubes. H ow ever, it is evident th at the first fast-twitch muscle 
cells do not fuse in o rder to elongate.
T h e  filam ent index o f  fixed m uscle cells, as in live cells, is 
significantly different betw een each  phase (data not shown, tw o­
tailed t-test, p < 0 .0 1  for all comparisons). These d a ta  support the 
tim e-lapse analyses and  provide new tools for analysis o f  
m orphogenetic  defects in various m u ta n t/m o rp h a n t embryos.
Quantification of Anisotropy Indicates that Each Phase of 
Muscle Fiber Morphogenesis Is Accompanied by a 
Significant Increase in Ordered Structure
T h e  identification o f  discrete, m athem atically  distinct phases 
provides a  p arad igm  by  w hich muscle m orphogenesis in m u tan t 
embryos can be assessed. T h e  above d a ta  also indicate th at the 
m orphology o f  fixed cells is n o t significantly different th an  live 
cells. H ow ever, a lthough obtaining single labeled  cells w ithin a 
field o f  unlabeled cells in fixed em bryos is easier th an  time-lapse 
analysis, it is no t feasible in all m odel systems. W e thus looked for a 
different m athem atical tool to quantify  cellular organization. 
Ideally such a  tool w ould allow objective quantification o f  cellular 
structure w ith an  easier experim ental p rep ara tio n  such as staining 
w ith phalloidin to outline all cells. Therefore, we ad ap ted  and  
applied the 2D  W avelet-T ransform  M odulus M axim a (W TM M ) 
m ethod  [34,35]. This m ethod  can be used to quantify  the am ount 
o f  structure, o r order, o f objects th at do not necessarily have a  well
Table 1. M orphom etric analysis o f muscle cells.
Su b ca te go ry N A verage  slope 6 S E  Major A x is  vs. Perim eter R Filam ent In d e x ± S DPhase
Short precursor WT live 12 0.57 1.6 ±  0.6
WT fixed 31 0.59 1.4 ±  0.2
Laminin-deficient fixed 8 0.92 1.4 ±  0.3
E longating precursor WT live 6 0.9 2.9 ±  0.8
W T live % change in area 6 2.7 ±  0.8
W T live % change in perimeter 6 1.8 ±  0.8
WT fixed 255 0.90
Laminin-deficient fixed 166 0.89 3.0 ±  1.5
Form ing m yotube WT live 6 0.31 4.9 61.1
W T live % change in area 6 1.5 ±  0.5
W T live % change in perimeter 6 0.2 ±  0.1
WT fixed 13 0.16 6.0 ±  0.9
Laminin-deficient fixed 11 0.9 5.1 62.2
doi:10.1371/journal.pgen.1000219.t001
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Figure 3 . M athem atical Analysis o f Area and Perim eter Dynamics. A) G eom etric m o de ling  o f  re la tive changes in  area and pe rim e te r th a t 
w o u ld  resu lt i f  cells e longated  as ellipses, as i f  th e y  w ere  fillin g  like balloons. Both area and pe rim e te r w o u ld  increase linearly. A1) Geom etric 
m o de ling  o f  re la tive changes in  area and pe rim e te r th a t w o u ld  result i f  cells e longa ted  via a tw o -s te p  process: p ro trus ion  extens ion  and f illin g . Both 
area and pe rim e te r w o u ld  increase increm enta lly . B) Area and pe rim e te r dynam ics d u ring  th e  e lo n g a tio n  phase. B1) Percent change o f  area (solid 
line) and pe rim e te r (do tte d  line) th ro u g h  tim e . Enlarged traces are show n in  B2. B3) Average slope o f lin e a rtre n d lin e s . The area increased m ore than  
th e  pe rim e te r in all cells. C) Area and pe rim e te rd yn a m ics  d u ring  th e  m y o tu b e fo rm a tio n  phase.The g ro w th  rate o fa re a  and p e rim e te ra re  d iffe re n t in 
th e  m yo tu b e  fo rm a tio n  phase th a n  th e  e lo n g a tio n  phase. As th e  cell trans itions  fro m  be ing  irregu la rly  shaped to  a m ore  hom ogenous ly  shaped 
m yo tube , th e  increase in  area represents th e  fillin g  in o fa n  in itia lly  narrow  aspect o f th e  cell. F illing in does no t d ram atica lly  increase th e  perim eter, 
b u t does result in an increase in  area. 
do i:10.1371/journal.pgen.1000219.g003
defined boundary . W e used this approach  to quantify the 
structural organization o f cellular lattices during  muscle fiber 
elongation. T h e  W T M M  analysis filters an  image with the 
gradient of a sm oothing function (i.e. a wavelet) a t a given size 
scale. Places w ithin the image w here the intensity variation is 
m axim al are  given by  the w avelet-transform  m odulus m axim a (i.e.
PLoS Genetics | www.plosgenetics.org
the W T M M ). N ext, the positions of m axim al intensity variation 
along these m axim a chains are  identified. These are the W T M M  
m axim a, o r W T M M M . A t these nodes, the direction where the 
signal has the sharpest variation is calculated. A n arrow  th at points 
upw ard  has an  angle o f  p /2  and  an  arrow  th at points down has an 
angle o f  — p /2 .  T he anisotropy factor Fa is th en  calculated from
7 October 2008 | Volume 4 | Issue 10 | e1000219
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Figure 4. M athem atical Characterization o f Fixed Cells Supports Time-Lapse Analysis o f Live Cells. (See also M ovie  S4.) A poTom e 
im ages, side views, a n te rio r le ft, dorsal to p , 22 som ite -s tage  fixed  em bryos. A -D ) D extran-labeled cells (red), b -caten in s ta in ing  ou tlines  cells (white). 
Rotated 90° p ro jec tions  w ere  s tre tc h e d < 3  fo ld  in th e  Z d im ens ion  due to  th e  re la tive th inness o f th e  tissue. Scale bars: 50 mm. A) Short m uscle 
precursor cells are short and extend  small p ro trus ions  (w h ite  arrowheads). B) Long pro trus ions extended a long  th e  m a jo ra x is  o f th e  cell are observed 
(ye llow  arrowheads). C) Irregu la rly  shaped cells th a t span th e  en tire  w id th  o f  the  m yo to m e  are observed (ye llow  arrows). D) Long regu la rly  shaped 
m yo tube . E) Graph sh o w in g  th a t th e  fila m e n t indexes fo r  live and fixed  cells are sim ilar. F-H) 22 som ite -s tage  fixed  em bryo , nuclei are sta ined w ith  
Sytox g reen, dextran-labe led  cells are red, b -catenin in  b lue ou tlines  cells. A lth o u g h  th e  nuclear c o n te n t o fc e lls  w as analyzed in  all foca l planes, on ly  
one foca l p lane is show n  fo r  c larity. W h ite  a rrow s p o in t to  nuclei. F) Precursor cells are short and have one nucleus (w h ite  arrow head in  F4 shows 
short p ro trus ion). G) Cells th a t w e re  e lo nga ting  w h e n  fixed  w ere  never observed to  con ta in  m ore  th a n  1 nucleus (ye llow  arrow head shows a long 
pro trus ion). H) An e longa ted  cell w ith  1 nucleus. I) M u ltinuc lea te  m yotube. 
do i:10 .1371/jou rnal.pgen.1000219.g004
the  probability  density function, Pa(A), o f  the angles A o f the 
W T M M M  vectors. Fa is defined in such a  way th a t random ness, 
isotropy, has a  value o f  Fa = 0. A ny value o f Fa> 0  quantifies the 
extent o f departure  from  isotropy. A  random ly structured cell 
lattice has arrows pointing in all directions and  a  low anisotropy 
factor. T h e  arrows po in t in all d irections because the direction of 
m axim al intensity variation is random . A  m ore organized cell 
lattice will have m ore arrow s pointing in the same direction an d  a 
stronger anisotropic signature. M ore arrows will po in t in the same
direction in an o rdered  cell lattice because the direction of 
m axim al intensity variation will be the  same betw een m ultiple 
cells. Thus, this form alism  objectively provides a  quantitative 
assessment o f m orphological structure. A  step-by-step explanatory 
diagram  is presented in Figure 5.
T h e  W T M M  analysis was applied for all size scales betw een 
a ~ 4  and  a ~  13 mm (see m ethods for details on  staining and  image 
preparation). Short muscle p recursor cells have a  low anisotropy 
factor indicating th a t there  is only a  small departure  from  isotropy.
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Figure 5. The 2D W TM M  M ethod Is Used to  Q uantify  Cellular Structure w ith in  a Lattice, and Indicates th a t Cellular Organization  
Increases during Muscle Morphogenesis. A) D escrip tion o f how  th e  2D W TM M  form alism  quan tifies  s tructu re . The s ta rting  im age is o f 
e lo nga ting  m uscle precursor cells sta ined fo r  b -caten in to  o u tlin e  cells. B) Short m uscle precursor cells have a lm ost all W TM M M  ve c to r arrows 
p o in tin g  in  random  d irections, ind ica tin g  th a t the re  is o n ly  a sm all depa rtu re  fro m  iso tro p y  (iso tro p y  means random ly s tructu red). C) O rganization 
increases as m uscle cells beg in  to  e longate . N o te  m ore g reen arrows p o in tin g  e ith e r up  o r d ow n  in  C th a n  B. D) O rgan iza tion  con tinues  to  increase 
d u rin g  th e  m yo tu b e  fo rm a tio n  phase. E) O rgan iza tion  is readily appa ren t w h e n  m yotubes have fo rm ed . N o te  th a t m ost o f  th e  green arrows are 
p o in tin g  e ith e r up o r do w n  ind ica tin g  h igh  levels o f o rgan iza tion . F) Averaged Pa(A) fo r  one  particu la r size scale (a ~ 7  mm) fo r  th e  m yo tu b e  stage 
(lim e green curve), th e  fo rm in g  m yo tube  stage (dark green curve), e longa ting  precursor stage (blue curve), short precursor (red curve) as w e ll as fo r  
th e  iso trop ic  fBm  surfaces analyzed fo r  ca lib ra tion  purposes (black curve f lu c tu a tin g  around p/2). Also show n is th e  fla t 1 /2p curve th a t w o u ld  be 
ob ta in e d  fo r  a pure ly  theo re tica l iso trop ic  process (flat po in te d  line a t 1/2p). G) The an iso tropy  fa c to r Fa was averaged o v e ra ll size scales analyzed. An 
in d ica to r o f  o rganized s tructu re , i t  shows s ign ifican tly  d is tin c t values fo r  all stages o f  deve lop ing  m uscle cells. 
doi:10.1371/journal.pgen.1000219.g005
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O rgan iza tion  increases th roughou t muscle elongation. This 
increase in organization  th rough  tim e is visible as the  increase in 
the p ro p o rtio n  o f  arrow s poin ting  in the same directions (C om pare 
Figure 5B to 5E). T h e  averaged probability  density functions Pa(A) 
over all size scales a are  show n in Figure 5F an d  the resulting 
averaged aniso tropy factors Fa are  show n in Figure 5G . Each 
phase o f  muscle developm ent has a  significantly higher anisotropy 
factor indicating  increasing cellular organization  th rough  time 
(im portantly , statistical significance is m ain tained  w hen only single 
size scales are  used).
T aken  together, all the m ethods used (time-lapse analysis, a re a /  
perim eter dynamics, filam ent index, and  2D W TM M ) show that 
there are  discrete phases o ffast muscle m orphogenesis. Furtherm ore, 
the fact th a t the 2D W T M M  analysis supports the other 
m orphom etric analyses used indicates th at this is an exceedingly 
valuable tool th at can objectively quantify how  o rdered /struc tu red  a 
field o f  cells is w ithout having to isolate o r segm ent individual cells.
I a m b i  and l a m y l  Are Required fo r Normal Fast Muscle 
Cell O rienta tion
T h o ro u g h  knowledge o f the cellular m echanism s underlying 
muscle fiber elongation provides a  fram ew ork fo r elucidating the 
m olecular basis o f  muscle cell elongation. W e asked if  a  p rom inen t 
basem ent m em brane pro te in , lam inin, is requ ired  for muscle 
m orphogenesis. It is know n th a t a la m in in  receptor, In tegrin  a6p1 , 
is requ ired  for no rm al m yofiber developm ent in cu ltured  m ouse 
explants [2 2 ] b u t the  relevant lam inin  ligands are  unknow n.
W e find th a t muscle cell elongation in Iambi and  y1 m utants 
and  m orphan ts is delayed. In  zebrafish, slow-twitch fibers m igrate 
laterally  and  trigger fast m uscle cell elongation [28]. T hus, slow 
fiber location is an  excellent m arker for assaying fast muscle cell 
elongation: fast cells m edial to slow fibers should b e  fully 
elongated. A lthough slow m uscle fiber m igration  is d isrupted in 
Iambi and  y1-deficient embryos (Figure S1), some slow fibers 
m igrate laterally. H ow ever, fast muscle cells m edial to m igrating 
slow fibers are  short in Iambi o r lamyl m utants an d  m orphants 
(Figure 6B, C , and  d a ta  n o t shown, n  =  6 grumpy/lambl m u tan t 
embryos, 16 Iambi m o rp h an t em bryos, 5 wi390/lamy1  m u tan t 
embryos an d  10 lamyl m o rp h an t embryos).
Fast-twitch muscle cells belatedly elongate in lamb1 an d  y1 - 
deficient embryos and  the filam ent index ofcells in all three phases is 
similar to control embryos (Table 1). How ever, fast muscle cells 
frequently appear m isoriented in lamb1 and  y 1 -deficient embryos 
(Figure 6E, note the abnorm al angle ofcells th at a re  not aligning in a  
parallel array, data  not shown). Application o f  the 2D  W T M M  
m ethod indicates th at m yotubes in lamy1-deficient embryos are 
significantly m ore disorganized th an  in control embryos. E longated 
m yotubes in control embryos form  an  organized array as indicated 
by  the strong polarization o f the yellow arrows (Figure 6 G3). T he 
arrows tend  to poin t either up  or down resulting in high peaks at p /2  
and  — p /2  (Figure 6 K lim e  green line) and  a  higher anisotropy factor 
(Figure 6L). In  contrast, arrows in lamy1-deficient embryos are far 
less polarized (com pare Figure 6 H 3  to G3). T he peaks at p /2  and 
—p /2  are lower than  in wild-type embryos (Figure 6 K  lime green 
line) and  the anisotropy factor is significantly lower (Figure 6L). 
Thus, application o f  the 2D  W T M M  form alism  quantitatively 
supports the qualitative perception  th at muscle fibers are disorga­
nized in laminin-deficient embryos.
T h e  next question th at follows is when does the anisotropic 
signature in laminin-deficient embryos becom e different from  wild- 
type embryos? N o  overt m orphological differences betw een control 
and  laminin-deficient cells in the short precursor phase are visible to 
the eye (Figure 6I, J). How ever, there is a  slight b u t significant 
difference betw een the anisotropy factors (Figure 6L). T he difference
betw een anisotropy factors increases a t every phase o f  muscle 
morphogenesis. These da ta  indicate th at laminin is required for 
cellular organization as early as the short precursor phase. Thus, 
subsequent m yotube disorganization m ay reflect b o th  early and  late 
requirem ents for lam inin during muscle m orphogenesis.
Laminin Is a M olecular Cue tha t Stops Fiber Elongation
I t has b een  proposed  th at muscle fibers elongate until they reach  
a  small p a tch  o fE C M  th a t functions to cap tu re  elongating muscle 
cells an d  p reven t th em  from  extending into the next m yotom e 
[24]. H ow ever, it is n o t know n w hich o f  the m any  E C M  
com ponents o f  the M T J are  requ ired  o r  if  m ultiple proteins are 
required . W e find th at b o th  lamb1 an d  lamy1 p lay a  role in M T J 
m orphogenesis. Som e fast muscle cells in lamb1 an d  lamy1 m utants 
an d  m orphan ts do not stop elongating a t the M T J (Figure 6 F1 
w hite arrow head, note  th a t the  m uscle cell extends a  long, thin 
pro trusion  across the boundary). T h e  M T J is visible in 48 hpfw ild- 
type (WT) embryos as a  dark  line devoid o f  filam entous actin 
(Figure 7A, white arrow). In  wi390/lamy1  m u tan t em bryos, some 
m uscle fibers inappropria tely  cross the M T J an d  are  approx i­
m ately twice as long as their counterparts th a t did not cross the 
bou n d ary  (Figure 7 A1 red  arrow head). These cells are 
m ultinucleate (data not shown), indicating th a t bo u n d ary  capture 
is n o t requ ired  for fusion. T h e  crossing o f  a  bou n d ary  by a  few 
m uscle fibers results in an asym m etrical m yotom e: some o f  the 
m yotom e has longer fibers while the m ajority  o f  fibers are  an 
appropriate  length  (Figure 7 A1). Fast fibers in gup/lamb1  m utants 
also cross M T J boundaries (Figure 7 A2 red  arrow head). A t 48 
hpf, some boundaries w ere crossed w ithin every laminin-deficient 
em bryo exam ined. G enerally, 16 24% o f boundaries w ere crossed 
(average % o f boundaries crossed: W T , 0% , n > 1 0 0 ; gup/lamb1, 
20%  crossed, n =  12 em bryos, 3 experim ents; w i390/lam y1 , 22% 
crossed, n  =  9 embryos, 1 experim ent; lamb1 M O , 24% crossed, 
n  =  26 embryos, 5 experim ents; lamy1 M O , 16% crossed, n = 1 8  
em bryos, 3 experiments).
Boundary Capture as a Cell Autonom ous Phenom enon
O u r  da ta  show th a t lamb1 and  y1  p lay a  role in boundary  
cap tu re  o f  elongating m uscle fibers, b u t the m echanism  o f  capture 
is n o t yet known. A  dense netw ork o f  polym erized lam inin  m ay 
function as a  physical b a rrie r  th a t stops elongating muscle fibers. 
Interestingly, however, lam inin  polym erization can  trigger chang­
es in the organization  o f  the m atrix, E C M  receptors and 
cytoskeletal com ponents [36]. C ell-autonom ous changes in 
cytoskeletal organization  upon lam inin  b ind ing  provide an 
a lternate  hypothesis: th a t signaling th at results from  lam inin 
b inding  m ay m ediate boundary  cap tu re  in a  cell-autonom ous 
fashion. W e hypothesized th at W T  cells transplanted  in lam inin- 
deficient em bryos m ight be  able to secrete small am ounts o f 
lam inin  th a t w ould facilitate their cap tu re  an d  reduce the 
likelihood o f  elongating th rough  the boundary . T o  test this, cells 
from  dextran-injected control em bryos w ere transp lan ted  into 
lamy1 m o rp h an t hosts. C on tro l cells w ere less likely th an  lamy1 
m o rp h an t cells to cross the bo u n d ary  (Figure 7C, D). O nly  6 
percen t o f  control cells crossed boundaries (19/311 cells) whereas 
25%  o f  m o rp h an t cells crossed boundaries (407/1631 cells). 
C on tro l cells undergo  bo u n d ary  cap tu re  even w hen  ad jacen t to 
lamy1 m o rp h an t cells crossing boundaries (Figure 7 B1, B2 note 
th a t the red  control cell, w hite arrow head  respects the boundary , 
b u t adjacent m o rp h an t cells cross the  boundary , red  arrow head). 
T hese d a ta  n o t only provide the first evidence th at lam inin  plays a 
role in ceasing initial m yofiber elongation, b u t the  cell autonom ous 
rescue o f  bo u n d ary  integrity by  W T  cells suggests th at boundary  
cap tu re  is m ediated  a t the single cell level.
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Control gup/lamlH lam yl MO Control lam y1 MO 26 hpf
G-H Myotube l-J Short precursor
■n -it/2 0 n/2 k - it -ji/2 0 tc/2 n short elongating myotube
Figure 6 . lam tntn/ 1 and y 1 are Required fo r  Norm al Fast Muscle Cell E longation. Panels A -C  are con foca l im ages and D -J are A poT om e 
m icrographs. Panels A -C  are side v iew s, a n te rio r le ft, dorsa l to p  o f  18 som ite -s tage  em bryos  s ta ined w ith  F59 (w h ite ) t o  d e n o te  s lo w -tw itc h  m uscle 
and p h a llo id in  (red) t o  o u tlin e  fa s t m uscle  cells. Panels labe led  1 are la tera l sections fro m  a z-series and panels labeled 2 are m ed ia l sections fro m  th e  
sam e z-series. A) In  W T em bryos, fa s t- tw itc h  m uscle  cells m ed ia l (A1, w h ite  a rrow ) to  m ig ra tin g  s lo w -tw itc h  f ib e rs  (A, g reen  arrow ) have e lo nga ted . B) 
A lth o u g h  som e s lo w -tw itc h  fib e rs  do  m ig ra te  in  g u p /la m  @1 m u ta n t em bryos, n o t all fa s t m usc le  p recursor cells have  e lo n g a te d  (B1 w h ite  a rrow head: 
sh o rt cell, B green a rrow : s lo w -tw itc h  m uscle f ib e r th a t  has m ig ra ted  la tera lly). C) N o t all fa s t m usc le  p recursor cells m ed ia l to  m ig ra tin g  s lo w  fibers  
have e lo n g a te d  in  la m y l m o rp h a n t em bryos  (C1 w h ite  a rrow head : sh o rt cell, C g reen  arrow : s lo w -tw itc h  m uscle  f ib e r  th a t  has m ig ra te d  laterally). 
Panels D -E  are p ro jec ted  v iew s o f  dextran  fille d  cells (red) and p -ca ten in  th a t  o u tlin e s  cells (blue). D) E longated fibe rs  in a W T em bryo , n o te  th e  
o rgan ized , para lle l array o f  fibers . E) E longated fib e rs  in a la m y l--defic ient e m b ryo , w h ite  a rrow head  d eno tes  a f ib e r  th a t is n o t para lle l. F-F2) A 
d e x tra n -fille d  cell in  a la m y l  m o rp h a n t e m b ry o  extends  a th in  p ro tru s io n  across th e  MTJ. W h ite  a rrow s d e n o te  th e  MTJ, w h ite  a rrow head  denotes 
th in  p ro tru s io n  e x te n d in g  across th e  MTJ. F59 d eno tes  s lo w  m uscle  in b lue  and  dextrans are red. Panel F1 is a s ing le  foca l p lane  fro m  a z-series, 
panels F and  F2 are p ro jec tions . Scale bars F: 50 mm, F1: 20 mm. G -H ) Cells in  th e  m y o tu b e  phase are less o rgan ized  in  la m y l  m o rp h a n t em bryos  than  
in c o n tro l em b ryo s  as sh o w n  by m ore  ra n d o m ly  o rie n te d  W TM M M  v e c to r arrows. Panels nu m b e re d  3 are h ig h e r m a g n ifica tio n  v iew s. I-J) A lth o u g h  
d iffe rences in  ce llu la r s tru c tu re  are n o t o b v io u s  to  th e  eye (com pare  I1 and  J1), la m y l sh o rt p recu rso r cells are less o rgan ized  th a n  c o n tro l cells as 
show n  by m ore  ra n d o m ly  o rie n te d  W TM M M  v e c to r arrows. Panels nu m b e re d  3 are h ig h e r m a g n ifica tio n  v iew s. K: The W TM M M  v e c to r a ng le  pd fs  are 
d isp layed fo r  all stages (co lo r coded  pe r panel L), th e  iso tro p ic  fBm  surfaces (b lack cu rve  flu c tu a tin g  a round  p/2 ), and th e  f la t  1 /2p  cu rve  th a t w o u ld
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be ob ta in e d  fo r  a pu re ly  the o re tica l iso trop ic  process (flat p o in te d  line at 1/2p). Note th e  s tro n g e r (higher) peaks in  co n tro l em bryos. L) The 
an iso tro p y  fa c to r o f  m uscle cells in la m in in -d e fic ie n t em bryos  is s ig n ifican tly  lo w e r th a n  in co n tro l em bryos a t all fo u r  stages o f  m uscle 
m orphogenesis  (p< 0 .01 ). These results ind ica te  th a t even th o u g h  d iffe rences in  o rgan iza tion  as fa r  back as th e  precursor stage are n o t obv ious 
visually, th e y  are unequ ivoca lly  m ore  d isorgan ized  th a n  in co n tro ls  w h e n  th e  a n iso trop ic  va lue is de te rm ined . 
do i:10 .1371/jou rnal.pgen.1000219.g006
Discussion
A  m echanistic understanding  o f  the cellular basis o f  muscle cell 
elongation an d  tendon  a ttachm ent is critical to elucidate 
underlying m olecular m echanism s th at m ediate morphogenesis. 
W e show here the first quantitative analysis o f indiv idual fast muscle 
cell elongation in a  living vertebrate  embryo. T h ree  b ro ad  phases 
o f  m orphogenesis underlie the  transition from  a  somite com prised 
o f  short muscle precurso r cells to a  m yotom e com prised o f 
elongated muscle fibers. First, short muscle p recursor cells exhibit
dynam ic protrusive activity, b u t do  not undergo  large-scale shape 
changes. T h e  second phase, in tercala tion /elongation , occurs via a 
repetitive two-step process o f  pro trusion  extension and  filling and 
requires lamp! an d  y l  to p roceed  efficiently. T h e  th ird  phase 
encom passes bo u n d ary  capture as well as shape changes th at 
generate a  m ore regularly shaped m yotube. A lthough m yotubes 
do form  in laminin-deficient em bryos, they are  significantly less 
organized than  in wild-type em bryos. W e find th a t b o th  lamp!  and  
y l  are  required  for bou n d ary  capture and  thus provide the first 
m olecular insight into bou n d ary  capture a t the M T J. Taken
Figure 7 . Lam inin Plays a Role in Boundary Capture o f Elongating Muscle Fibers. ApoTom e m icrographs, side views, a n te rio r le ft, dorsal 
to p  o f4 8  h p f em bryos. A -A 2 ) MTJ boundaries are som etim es crossed in  la m p !  and lam y  7-defic ient e m bryos .T he  MTJ in  WT em bryos  isv is ib le  as th e  
da rk  line o f  no p h a llo id in  s ta in ing  in be tw een m yo to m e s (A, w h ite  arrow ). In b o th  la m ft1 and y7 m utan ts , MTJs are observed (A 1 -A 2 ,w h ite  arrows), 
b u t som etim es a p o rtio n  o f an MTJ is crossed by a m uscle f ib e r  (red a rrow heads, A 1-A 2). Scale bar: 50 mm. B-B2) Cell au to n o m o u s  rescue o f  
b ounda ry  crossing by co n tro l cells in  lam y 1 m o rp h a n t em bryos. W h ite  box in  B1 ind ica tes th e  h ighe r m a g n ifica tion  v ie w  in  B2. T ransp lan ted  con tro l 
cells do  n o t cross th e  MTJ bou n d a ry  (w h ite  arrowheads, o n ly  19/311 tran sp la n te d  co n tro l cells crossed MTJ boundaries in  lamy1 m o rp h a n t em bryos 
com pared to  402/1631 m o rp h a n t cells). The red arrow head ind ica tes m o rp h a n t cells th a t cross boundaries. Scale bars: 20 mm. C -D) Graphs show ing  
b ounda ry  crossing by c o n tro l cells and m o rp h a n t cells. 
do i:10 .1371/jou rnal.pgen.1000219.g007
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together, these da ta  indicate th a t muscle m orphogenesis is 
spatiotem porally  com plex and  involves interactions betw een 
muscle fibers an d  the basem ent m em brane during  elongation 
an d  attachm ent to the M T J. I t is n o t yet know n if there is some 
conservation betw een m orphogenetic m echanism s underlying 
early  m orphogenesis betw een vertebrates. G iven  recent da ta  
indicating th a t the zebrafish somite has a  derm om yotom e an d  is 
thus m ore hom ologous to am niotes as previously thought [37 39], 
it is tem pting  to speculate th at the m orphogenetic m echanism s 
described here m ay apply  to h igher vertebrates as well.
Three Phases of Early Fast Muscle Morphogenesis
Both qualitative an d  quantitative assessments o f  early muscle 
developm ent are  critical to facilitate identification of m olecular 
m echanism s th a t underlie m orphogenesis. W e find th a t the three 
phases o f early fast muscle m orphogenesis are qualitatively and  
quantitatively different. T hese stages are  short muscle precursor 
cells, elongating muscle cells and  m yotube form ation. Short 
muscle p recursor cells have a  low filam ent index and  ex tend  and  
re trac t short (< 2  mm) protrusions in all directions. E longating fast 
muscle cells ex tend  long protrusions along the axis o f elongation 
an d  have a  higher filam ent index. Long muscle cells form ing 
m yotubes have an even higher filam ent index indicating yet a 
fu rther departu re  from  a  circular shape. T hus, we provide a  novel 
p arad igm  w hereby m orphom etric  analysis can  distinguish different 
phases o f  early  muscle developm ent.
Mathematical Modeling and Time-Lapse Analysis Indicate 
that a Repetitive Two-Step Mechanism Underlies Fast 
Muscle Cell Elongation
It  is no t known how  the first fast-twitch muscle cells elongate 
during vertebrate developm ent. W e utilized an  experim ental 
approach  to distinguish betw een potential scenarios (Figure 2A). 
C 2C 12 myoblasts in culture elongate prio r to differentiation and  fuse 
to generate a  m ultinucleate m yotube [10] that we term ed the 
elliptical growth scenario. T h e  first muscle cells to elongate in 
grasshopper embryos (muscle pioneers) exhibit a  m orphology similar 
to th at ofpathfinding  neurons [11], we have called this the b ranching 
scenario. D uring Drosophila embryogenesis, muscle cells elongate via 
fusion [12,13] and  zebrafish homologues o f  genes required for 
muscle cell fusion in Drosophila are  also required for norm al muscle 
developm ent in zebrafish [14,15]. I t has also been proposed that 
zebrafish muscle cell elongation m ay be similar to n o tochord /neura l 
plate cell intercalation [24], represented by  the protrusion scenario. 
Tim e-lapse analysis indicates th at elongating cells extend local 
protrusions along their long axis (Figure 8C , D). Protrusions are 
extended in the direction o f  elongation and  betw een o ther cells. 
Protrusions then  thicken, resulting in elongation o f  the cell. 
Repetition o f protrusion extension/thickening results in an elongated 
muscle cell. M athem atical m odeling o f expected changes in a rea  and 
perim eter supports the protrusion m odel o f  morphogenesis. Thus, 
we show th at a  novel two-step m echanism  underlies elongation o fthe  
first fast muscle fibers in a  vertebrate m odel system, the zebrafish.
Muscle Cell Fusion
Muscle developm ent is perhaps best understood in Drosophila, 
where muscle morphogenesis is accom plished via fusion o f  founder 
cells (FCs) with fusion com petent myoblasts (FCMs) [13]. R ecent 3­
D  imaging has dem onstrated th at there are two phases offusion and 
suggests th at the spatial relationship o fF C s and  FC M s influences the 
frequency o f fusion events [12]. Exciting recent studies using 
zebrafish suggest th at m olecular events underlying muscle cell fusion 
in vertebrates m ay be at least partially conserved [14,15,40]. In  the
future it will b e  im portan t to understand  the cellular basis o ffusion as 
well. In  this regard, we show th at e longating/recently  elongated 
muscle cells possess complex 3-D shapes. Thus, a  comprehensive 
analysis o f  cell behaviors underlying muscle cell fusion during 
zebrafish developm ent will require developm ent o fm ultip le  m arkers 
th at label entire muscle cells such th at fusion can unam biguously be 
analyzed. Genetic mosaic approaches such as those used previously 
[41] will facilitate analysis o f  both  the tim ing o f fusion as well as 
identifying w hat cells fuse.
Attachment to Laminin Is Necessary for Timely Fast 
Muscle Cell Elongation
W e show th a t lamfil an d  y l  are requ ired  for efficient fast muscle 
cell elongation an d  p ro p er organization. A pplication o f  the 2D 
W T M M  m ethod indicates th at even in early stages o f  muscle 
developm ent where organizational differences are  not visually 
obvious, anisotropic signatures reveal unequivocally the m orpho­
logical discrepancies betw een /aminin-deficient an d  control em bry­
os. This em phasizes the strength o f  the 2D  W T M M  m ethod. This 
novel use o f  the 2D W T M M  m ethod  will give researchers an 
invaluable tool to rigorously an d  quantitatively distinguish subtle 
differences in cellular m orphology an d  organization.
W e do not know  why fast muscle cell elongation is delayed in 
lamfil and  yl-defic ien t embryos. E longation m ay be delayed 
because fast cells are  less organized than  in controls. I t  is also 
possible th a t fast cells in lamfil and  y l  m u ta n t/m o rp h a n t embryos 
do  not elongate efficiently because slow muscle cells do not 
m igrate efficiently. A lthough W T  slow fibers can  rescue elongation 
in m u tan t embryos th a t do  not have slow muscle fibers [28], it is 
unknow n if  d isrupted  slow muscle m igration  a n d /o r  m orphology 
m ay delay fast muscle cell elongation.
A  th ird  m odel is th at adhesion to lam inin  m ay p lay  a  role in 
generation o f  traction  forces th at allow muscle cells to elongate. 
M uscle cells extend protrusions as they elongate an d  these 
protrusions likely a ttach  to o th er cells o r the EC M . A ttachm ent 
would provide a  m echanism  for cells to stabilize an  ex tended 
pro trusion  an d  continue elongation. Interestingly, adhesion to 
lam inin  via the In tegrin  a7p1 receptor prom otes m igration o f 
C2C 12 an d  M M 14 cells in culture [42]. Elongating fast muscle 
cells in zebrafish do not m igrate p e r se, b u t future studies will 
address w hether adhesion to lam inin  during  fast muscle cell 
elongation in zebrafish p rom otes efficient p ro trusion  extension and  
thickening. T hese studies w ould b e  facilitated by  identification o f 
the relevant lam inin  receptor (there are  m ultiple lam inin  receptors) 
such th a t genetic m osaic analysis could readily  b e  used.
Fast muscle cells do belatedly elongate in the absence o f 
lam inin. I t is possible, even likely, th at elongating muscle cells m ay 
utilize different m odes o f  adhesion to the substrate a n d /o r  other 
cells. Thus, if  one m ode o f  adhesion is disrupted, muscle cell 
elongation w ould b e  delayed, b u t not entirely inhibited. O u r  
results indicating th a t muscle cell elongation is delayed, ra th er 
th an  inhibited, are  sim ilar to the finding th at m yofiber form ation is 
delayed, b u t recovers in m ouse knockouts o f  the cell-cell adhesion 
pro tein  C D O  [43]. T aken  together, these results suggest th at 
muscle cells elongate by  extension o fp ro trusions th at adhere  both  
to o th er cells and  the E C M . I f  one m ode o f  adhesion is disrupted, 
cells are delayed in their elongation, b u t utilize the alternative 
m ode o f adhesion to eventually elongate (Figure 8C, D).
Laminin Participates in Boundary Capture o f Elongating 
Muscle Cells
O n e  fundam ental process during  em bryonic developm ent is 
b o u n d ary  form ation. Som e o f  the first work describing boundary
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Figure 8. M odel o f Muscle M orphogenesis in W T and lam inin M utan t Embryos. A -A 1) C artoon  o f  WT em bryo  show ing  th e  th ree  phases o f 
muscle e longa tion . In th e  o ld e s t/m o s t a n te rio r som ites, m yo tubes have fo rm e d  and are attached to  th e  MTJs. The tra n s itio n  reg ion  con ta ins cells 
in te rca la ting  by e x tend ing  pro trus ions th a t are su b se q u e n tly fille d . M uscle precursor cells e xh ib it p ro trus ive  a c tiv ity  in  all d irections. A1: M agn ifica tion  
o fa  som ite  in panel A show ing  p ro te ins concentra ted  a t th e  MTJ and b oundary  cap tu re  o f  re ce n tlye lo n g a te d  cells. B-B1) C artoon o f  lam in in  m u tan t 
e m bryo  at th e  same age as WT em bryo  in  panel A show ing  th e  same th ree  phases o f  m uscle m orphogenesis, b u t w ith  a deve lopm en ta l delay. Cells in 
y e llo w  are aberran tly  long  and have invaded in to  n e ighbo ring  m yotom es. B1: M a g n ifica tion  o f tw o  som ites in  panel B th a t dep ic ts  a m ode l o f  how  
boundary  crossing cou ld  occu r in  lam in in  m u ta n t em bryos. If lam in in  is absent, the re  m ay be random ly spaced locations a t th e  MTJ d e vo id  o f 
p ro te ins th a t fu n c tio n  in  boundary cap tu re . E longating m uscle cells w o u ld  invade th e  MTJ at these locations. C) C artoon m ode l show ing  th e  tw o -s te p  
m echanism  o f e longa ting . We show  th a t adhesion to  th e  m a trix  is required fo r  norm al e lo nga tion  and hypothesize  th a t cells also u tilize  cell-cell 
adhesion  to  generate tra c tio n  forces needed fo r  p ro trus ion  extens ion  and f illin g . D) M ode l accoun ting  fo r  deve lopm en ta l de lay in  muscle 
m orphogenesis  th a t occurs in lam in in  m utan ts . C artoon d e p ic tin g  a lam in in  m u ta n t cell u n d e rgo ing  tw o -s te p  e lo nga tion  via p ro trus ion  extension 
and f illin g . Lack o f  th e  ce ll-m atrix  adhesion p ro te in  lam in in  results in less tra c tio n  and the re fo re  s low er extension a n d /o r fillin g . 
do i:10 .1371/journal.pgen.1000219.g008
form ation was done by  Jacobson  and  colleagues [44 46], where 
they  showed th at cells th at reach  the no to p la te /n eu ra l plate 
b o u n d ary  rem ain  on the boundary  perm anently  in bo th  axolotl 
an d  new t embryos. This phenom enon was referred to as trapping.
PLoS Genetics | www.plosgenetics.org
K eller and  colleagues have since expanded upon this m odel and 
term ed it bo u n d ary  capture [47]. R ecent w ork dem onstrated that 
laminin plays a  critical role in boundary  capture during notochord 
m orphogenesis in the ascidian Ciona savignyi [48]. W e have
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previously dem onstrated th at the M T J captures elongating muscle 
fibers, b u t it was not known w hat E C M  com ponents were relevant 
[24]. I t was also not known if the cessation of muscle fiber 
elongation is cell autonom ous or m ediated by comm unity effects. 
H ere  we show th at lam inin is one com ponent of the M T J that 
stops elongating fibers. This result, com bined with the work of 
V eem an et al., suggests th at roles for lam inin in b oundary  capture 
m ay be conserved, at least within chordates. W e also show that 
wild-type cells in lamyl m orphan t embryos have a reduced ability 
to cross the M TJ. T he fact that wild-type cells are  less able to cross 
the M TJ, b u t do not rescue their lamy l -deficient neighbors, 
suggests th at boundary  capture is a cell autonom ous process. 
These data also suggest th at M T J breakdow n in hamftland y l-  
deficient embryos is a local event caused by the failure of 
elongating muscle fibers to stop w hen they reach  the M TJ. W e do 
not currently know why 75% o f elongating muscle cells in lam ^l 
and  y l -deficient embryos do stop elongating, b u t 25% do not. W e 
hypothesize th at the M T J boundary  is not hom ogenous. In  this 
scenario, the absence of lam inin would leave ‘‘holes’’ in the M TJ 
and  muscle cells w ould elongate through these holes (Figure 8B, 
B1). Future experiments will be directed towards identifying 
additional m olecular cues involved in boundary  capture.
Methods
Zebrafish Husbandry
Zebrafish embryos were obtained from  natural spawnings of 
adult fish kept a t 28.50C  on a 16 h  lig h t/8  h  dark cycle and  were 
staged according to [49].
Immunocytochemistry
F59 was utilized to visualize slow fibers as previously described 
[25,50]. Alexa Fluor 488 and  546 phalloidin and  Sytox green were 
obtained from  M olecular Probes. W e used the H2A :G FP 
transgenic line of zebrafish to visualize nuclei [51]. A ‘‘scatter’’ 
label of cells filled w ith fluoro-ruby dextrans (Molecular Probes) 
was obtained by m icroinjecting embryos at the 512—1000 cell 
stage w ith dextrans into the yolk cell close to the margin.
Antibodies used were: m ouse m onoclonal anti-myosin (F59) 
(Devoto, e ta l. 1996, generous g ifto fF ran k  Stockdale) 1:10, mouse 
monoclonal anti-b-catenin (Sigma) 1:500 and  Alexa-Fluor 488, 
546 and  633 conjugated goat anti-mouse and goat anti-rabbit 
secondary antibodies (Invitrogen) 1:200.
Imaging
Images were acquired using a Leica SP2 confocal m icroscope 
and  a Zeiss ApoT om e running  on  a Zeiss Axio Im ager Z1. All 
m athem atical analyses were done on  images acquired on the 
Apotom e using a 20 x  lens, N A  0.8, yielding a resolution of 
1.5 pixels /  mm. Images were linearly processed in Adobe 
Photoshop and  collated in Adobe Illustrator.
Morpholinos
M orpholino-m odified antisense oligonucleotides (MOs) were 
synthesized by Gene-Tools, LC C. T he m orpholinos used were 
previously described and  recapitulate the  m utant phenotypes [31].
Time-Lapse Analysis
Embryos were vitally stained and  imaged with the fluorescent, 
lipophilic dye BODIPY-Ceram ide (Molecular Probes, Eugene, OR) 
using the procedures outlined by [52,53]. Time-lapse recordings 
were m ade using a scanning laser confocal microscope (Leica SP2, 
Heidelburg, Germany). Time-lapse analysis with transplanted 
dextran-filled cells was perform ed utilizing the Zeiss ApoTome.
Morphometrics
To m easure properties of dextran-filled cells, the z-series of the 
cell was projected such as to visualize the cell three-dimensionally. 
Cells were then  segm ented with ImageJ and  the perim eter, area 
and  m ajor axis were m easured. T he  m ajor axis as determ ined by 
ImageJ is the longest length o f the best fitting ellipse. T he  filament 
index was also calculated [54]:
f  =  P D
4 A
where P, D  and  A are the perim eter, diam eter and  area 
respectively. For this study, the diam eter was taken to be equal 
to the m ajor axis. N ote that a circle has a filam ent index F  = 1 and 
an object having a value of F  larger th an  1 quantifies its departure 
from  a circular shape. A two sample T-test was perform ed using 
SYSTAT. * denotes p < 0 .0 5  and  ** denotes p< 0 .0 1 .
Mathematical Modeling
In  order to quantitatively characterize the m orphology of muscle 
fiber growth, two geometrical models were developed. For simplicity, 
bo th  the elliptical and  protrusion models start with a unit circle (with 
radius = 1). For both models, w hen the cell is growing we assume that 
it does so only in the m ajor direction and  that the semi-minor axis 
stays constant, and for m athematical simplicity (and w ithout any loss 
of generality), is equal to 1. Therefore, we have
A =  p a  an d  P  =  2 p W — ^—
The growth ratios for the area and  perim eter o fb o th  models can be 
defined analytically. For the elliptical model, the growth ratio for the 
area at time t, AeilipticaL(t), is equal to the m ajor axis at time t, which 
grows continuously:
A elliptical (0  =  a ( t ) .
The perim eter growth ratio a t time t, P elliptical(t), is given by
P elliptical(t)
a ( t )2 + 1
For the protrusion model, the cell grows in a two-step m anner, 
expanding a thin protrusion of relatively small area DA and 
perim eter D P at time t, and then  filling the area until the cell 
becomes an ellipse at time t+1. Therefore, the growth ratio for the 
area of the protrusion model will depend on  w hether it is growing a 
protrusion o r filling that protrusion. For simplicity, we assume that 
the cell is growing a protrusion if t is even and  it is filling the area 
opened by protrusion w hen t is odd:
A protrusion (t) = a (t) , i f  t is even o r  A protrusion(t) = a (t -  1) +  D A , 
i f  t is od d
Similarly for the perim eter of the protrusion m odel cell:
P protrusion (t) if  t is even o r  Pprotrusion (t) =
( t - 1 ) 2 + 1 +  D P, if  t is odd.
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Since DA is relatively small w ith respect to the area  o f  the  whole cell, 
the extension o f a  protrusion will n o t significantly increase the area o f 
the cell. Conversely, since DP  is relatively large with respect to the 
perim eter o fth e  whole cell, the perim eter o fth e  cell will significantly 
increase. T h e  evolution o f the a rea  and  perim eter as a  function of 
time for both  models is shown in Figure 3A, A1.
Characterizing Anisotropy with the 2D WTMM Method
Preparation o f im ages. Embryos w ere stained w ith b-catenin 
to outline all cells and  fixed a t 20 hpf. This stage is ideal because 
anterior, older somites have form ed muscle but posterior somites 
have not. Thus, all the phases o f muscle morphogenesis are 
represented within single embryos. Images representing all phases 
were obtained utilizing a  Zeiss Axioimager equipped with an 
Apotom e as m entioned above. Each image and  focal plane was 
evaluated and  the phase (short precursor, etc.) determ ined. The 
phase that was identified represented most cells within a  focal plane. 
Because muscle cell elongation is an  exceedingly dynamic process, 
cells within different focal planes within the same z-series are 
sometimes at different phases o f elongation. Each image was then 
cropped into 256x256 pixel sub-images. This cropping is necessary 
to eliminate o ther tissues in the embryos such as residual yolk 
platelets and  neural tissue. C ropping was also necessary because fast 
muscle cells in the dorsal and  ventral halves ofsom ites angle slightly 
towards the middle. W e thus flipped all ventrally derived panels so 
that the W T M M M  vector angles for dorsal and  ventral halves would 
not cancel each o ther out within a  single sub-image. At least 10 
images for a t least 5 different embryos w ere analyzed for each phase.
T he 2D W T M M  m ethod is a  multifractal image analysis 
formalism introduced in [34], where the different dilations o f  the 
analyzing wavelet reveal quantitative roughness information a t every 
length scale considered. By considering two wavelets that are, 
respectively, the partial derivatives with respect to x  a n d y  o f a  2D 
smoothing Gaussian function, the W avelet Transform  is thus the 
gradient vector o f the analyzed image smoothed by  dilated versions 
o f the Gaussian filter. A  very efficient way to perform  point-wise 
regularity analysis is to use the W avelet Transform  M odulus 
M axim a (W TMM ) [55,56]. A t a  given scale a, the W T M M  are 
defined by  the positions where the W avelet T ransform  M odulus is 
locally m axim um  in the direction A  o f  the gradient vector. W hen 
analyzing rough surfaces, these W T M M  lie on  connected chains 
called maxima chains [34], as shown in Figure 5, green lines. O ne only 
needs to record the position o f the local m axim a o f the gradient 
along the m axim a chains together w ith the angle A  at the 
corresponding locations. A t each scale a, the wavelet analysis thus 
reduces to store those W T M M  m axim a (W TM M M ) only (red dots 
in Figure 5). T h ey  indicate locally the direction where the signal has 
the sharpest variation.
An im age having an  anisotropic signature m eans th at the 
intensity variation in the im age will differ according to the 
direction considered. Such images having an  anisotropic signature 
can be easily characterized  from  the directional inform ation 
provided by  the continuous 2D W avelet T ransform  [35]. This is 
done by  considering, at all size scales a, the probability  density 
functions (pdfs), Pa(A), o f the  angles, A , associated to each 
W T M M M  vector. A  flat p d f  indicates unprivileged random  
directions o f sharpest intensity variation (i.e. isotropy), while any 
d eparture  from  a  flat distribution is in terpreted  as the signature o f 
anisotropy. F or the present study, a  strong anisotropic signature is 
in terpreted  as a  strongly structured  cell lattice.
Anisotropy Factor
In  o rder to obtain quantitative inform ation from  the angle pdfs 
Pa(A ), they  are  com pared  to a  theoretical flat distribution
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representing an  ideal isotropic signature (see Figure 5F). T h e  
anisotropy factor, Fa, defined for each value o f  the scale p a ram eter a, 
is given by  the a rea  betw een the curve corresponding to the 
observed pdfs an d  a  flat distribution:
F„= J |Pa( A) -  2-|dA.
Therefore Fa has been  defined in such a  w ay th a t a  theoretically 
isotropic surface will have a  value o f  Fa = 0, while any value greater 
than  0 quantifies a  departure  from  isotropy.
Construction o f Simulated Isotropic Surfaces for 
Calibration Purposes
Following the standard  procedures presented in [34,35], 
fractional B row nian m otion (fBm) isotropic surfaces were gener­
ated. Tw o-dim ensional fBm ’s are  processes w ith stationary zero- 
m ean G aussian increm ents that are  statistically invariant under 
isotropic dilations. T h ey  are  therefore expected to reproduce quite 
faithfully the isotropic scaling invariance properties.
Genetic Mosaic Analysis
W T  embryos were injected with 10,000 M W  dextrans 
(M olecular Probes). Cells w ere rem oved at the sphere stage and 
p laced into hosts th at h ad  been  injected with lamyl M O s. Hosts 
were grown up until the appropriate  stage, stained w ith phalloidin 
and  the num ber o f  transplanted  control cells that crossed M T J 
boundaries was com pared  with the num ber o f  lamyl m orphan t 
cells that crossed M T J boundaries.
Supporting Information
Figure S1 Som ite B oundary Shape, Slow M uscle M igration and 
Fast M uscle Elongation are  D isrupted in lam ininb1 and  7 1 - 
deficient Em bryos. All panels are A poT om e images at the  18 
somite stage. Side views, an te rio r left, dorsal top, except panels 
num bered  4 that are transverse views, lateral left, m edial right. 
Panels 2 4 are higher m agnification views o f the embryos shown 
in panels num bered  1. Panels num bered  1 and  2 are  single focal 
planes from  a  Z-series and  show phalloidin staining th at outlines 
all cells. Panels num bered  3 and  4 are  projections o f the entire Z- 
series o f  panels num bered  2. In  these panels, F59 expression 
denotes slow-twitch muscle fibers. All panels (A1 C1, A2 C2) are 
from  approxim ately the same anterior-posterior and  m edial-lateral 
position in control and  m o rp h an t embryos. A1 C1) W T  control 
embryos contain  robust, chevron shaped boundaries. lamftl and 
lamyl m orphants have rounder, flatter shaped boundaries. N ote 
that intial somite boundaries, albeit less chevron-shaped, do form 
in lamftl and  lamyl m o rp h an t embryos. A2 C2) W hereas fast 
muscle cells are  elongating in control embryos (A2, white arrow), 
fast-twitch muscle cell elongation is disrupted in bo th  lamftl (B2, 
white arrow head) and  lamyl (C2, white arrow head) m orphant 
embryos b u t some elongation does occur (white arrows). A3 C 3 /  
A4 C4) M yosin organization in slow-twitch muscle fibers is 
disrupted in lamftl and  lamyl m orphan t embryos. In  control 
embryos, the p rojected (panels num bered  3) and  ro ta ted  transverse 
views (panels num bered  4) show organized slow-twitch fibers that 
have m igrated laterally (muscle pioneers: red  asterisk). Slow-twitch 
fiber organization, spacing, an d  m igration, are  disrupted in lamfil 
and  lamyl m o rp h an t embryos.
Found at: doi:10.1371/journal.pgen.1000219.s001 (7.8 M B TIF) 
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Movie S1 Tim e-lapse confocal m icroscopy using BO D IPY - 
ceram ide to outline cell borders suggests th at cells intercalate 
during elongation. Side views, an terio r left. C olored cells were 
tracked in Im age J and  pseudocolored in Adobe Photoshop. T he  
purple cell initiates elongation as does the orange cell. T h e  blue 
cell elongates through time, extending a  thin pro trusion  betw een 
the orange and  green cells eventually reaching the an terior 
boundary. T h e  long but irregularly shaped green cell becom es a 
rod  shaped m yotube through time.
Found at: doi:10.1371/journal.pgen.1000219.s002 (2.0 MB 
M OV)
Movie S2 Tim e-lapse analysis o f  three-dim ensional projections 
from  A poT om e m icrographs shows the three phases o f m orpho­
genesis. Short dextran-filled cells exhibit protrusive activity as they 
begin elongating. Elongating cells initially extend long protrusions 
that subsequently grow, resulting in the elongation o f the cell. 
G reen  arrow heads denote extensions. Cells in the myotube 
form ation phase are  initially irregularly shaped b u t becom e rod 
shaped m yotubes through time.
Found at: doi:10.1371/journal.pgen.1000219.s003 (1.0 MB 
M OV)
Movie S3 Three-dim ensional shapes o f  fixed cells in different 
phases o f  m orphogenesis. Part 1: A lateral-m edial Z-series o f  a
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